𐋇¦severe¦ ¦acute¦ ¦respiratory¦ ¦syndrome¦ ¦coronavirus¦ ¦2¦ ▁( 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ )▁ ¦is¦ ¦a¦ ¦novel¦ ¦virus¦ ,▁ ¦first¦ ¦isolated¦ ¦from¦ ¦three¦ ¦people¦ ¦with¦ ¦pneumonia¦ ¦connected¦ ¦to¦ ¦the¦ ¦cluster¦ ¦of¦ ¦acute¦ ¦respiratory¦ ¦illness¦ ¦cases¦ ¦in¦ 𐋇¦wuhan¦ .
𐋇¦on¦ 𐋇¦thursday¦ ,▁ ¦the¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦of¦ ¦the¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦coronavirus¦ ¦infections¦ ¦surp as sed¦ ¦one¦ ¦million¦ ¦worldwide¦ ,▁ 𐋇¦johns¦ 𐋇¦hopkins¦ 𐋇¦university¦ ¦data¦ ¦indicated¦ .
𐋇¦before¦ ¦the¦ ¦first¦ ¦isolation¦ ¦of¦ 𐊣¦hc𐊼o𐋇v¦ - ¦229𐋇e¦ ¦strain¦ 𐋇¦b 8 14¦ ¦from¦ ¦the¦ ¦nasal¦ ¦disc harge¦ ¦of¦ ¦patients¦ ¦who¦ ¦had¦ ¦contracted¦ ¦common¦ ¦cold¦ ,▁ ¦different¦ 𐋇¦co𐋇vs¦ ¦had¦ ¦been¦ ¦isolated¦ ¦in¦ ¦various¦ ¦infected¦ ¦animals¦ ,▁ ¦including¦ ¦tur k ey¦ ,▁ ¦mo use¦ ,▁ ¦co w¦ ,▁ ¦pi g¦ ,▁ ¦c at¦ ¦and¦ ¦do g¦ .
𐋇¦fe line¦ ¦coronavirus¦ ▁( 𐊣¦f c𐊼 o 𐋇v¦ )▁ ¦causes¦ ¦mild¦ ¦enteritis¦ ¦in¦ ¦c ats¦ ¦as¦ ¦well¦ ¦as¦ ¦severe¦ 𐋇¦fe line¦ ¦infectious¦ ¦peri to ni tis¦ ▁( ¦other¦ ¦variants¦ ¦of¦ ¦the¦ ¦same¦ ¦virus¦ ).
𐋇¦the¦ 𐋇¦chinese¦ ¦government¦ ' ¦s¦ ¦senior¦ ¦medical¦ ¦adviser¦ 𐋇¦z h ong¦ 𐋇¦na ns han¦ ¦argu ed¦ ¦that¦ ▁" ¦it¦ ¦could¦ ¦be¦ ¦over¦ ¦by¦ 𐋇¦june¦ "▁ ¦if¦ ¦all¦ ¦countries¦ ¦can¦ ¦be¦ ¦mobi lized¦ ¦to¦ ¦follow¦ ¦the¦ 𐊣¦who¦𐊼 ' ¦s¦ ¦advice¦ ¦on¦ ¦measures¦ ¦to¦ ¦stop¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ .
𐊣¦covid¦𐊼 - ¦19¦ ¦surveillance¦ ¦is¦ ¦expected¦ ¦to¦ ¦monitor¦ ¦epidemiological¦ ¦trends¦ ,▁ ¦rapidly¦ ¦detect¦ ¦new¦ ¦cases¦ ,▁ ¦and¦ ¦based¦ ¦on¦ ¦this¦ ¦information¦ ,▁ ¦provide¦ ¦epidemiological¦ ¦information¦ ¦to¦ ¦conduct¦ ¦risk¦ ¦assessment¦ ¦and¦ ¦guide¦ ¦disease¦ ¦preparedness¦ .
𐋇¦based¦ ¦on¦ ¦clinical¦ ¦studies¦ ¦reported¦ ¦thus¦ ¦far¦ ,▁ ¦the¦ ¦following¦ ¦factors¦ ¦may¦ ¦affect¦ ¦or¦ ¦be¦ ¦associated¦ ¦with¦ ¦the¦ ¦prognosis¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦patients¦ ▁( 𐋇¦table¦ ▁ ​( 𐋇¦tab le 33¦ ) :
𐋇¦given¦ ¦such¦ ¦rapid¦ ¦progress¦ ¦in¦ ¦research¦ ¦on¦ 𐊣¦covid¦𐊼 - ¦19¦ ,▁ ¦several¦ ¦critical¦ ¦issues¦ ¦remain¦ ¦to¦ ¦be¦ ¦sol ved¦ ,▁ ¦as¦ ¦follows¦ :
𐋇¦on¦ ¦13¦ 𐋇¦march¦ ,▁ ¦he¦ ¦declared¦ ¦a¦ ¦national¦ ¦emergency¦ ,▁ ¦which¦ ¦made¦ ¦federal¦ ¦funds¦ ¦available¦ ¦to¦ ¦respond¦ ¦to¦ ¦the¦ ¦crisis¦ .
𐋇¦chinese¦ ¦clinical¦ ¦trials¦ ¦in¦ 𐋇¦wuhan¦ ¦and¦ 𐋇¦shenzhen¦ ¦claimed¦ ¦to¦ ¦show¦ ¦that¦ ¦favipiravir¦ ¦was¦ ▁" ¦clearly¦ ¦effective¦ ".
𐋇¦ma u ri zi o¦ 𐋇¦m ass ari¦ ,▁ 𐋇¦italy¦ ' ¦s¦ ¦amb ass ad or¦ ¦to¦ ¦the¦ 𐊣¦eu¦𐊼 ,▁ ¦said¦ ¦that¦ ▁" 𐋇¦only¦ 𐋇¦china¦ ¦responded¦ ¦bilater ally¦ .
𐋇¦some¦ ¦can¦ ¦kill¦ ¦more¦ ¦than¦ ¦30¦ %▁ ¦of¦ ¦those¦ ¦infected¦ ,▁ ¦such¦ ¦as¦ 𐊣¦mers¦𐊼 - 𐋇¦co𐋇v¦ ,▁ ¦and¦ ¦some¦ ¦are¦ ¦relatively¦ ¦harmless¦ ,▁ ¦such¦ ¦as¦ ¦the¦ ¦common¦ ¦cold¦ .
𐋇¦the¦ 𐋇¦u¦ . 𐋇¦s¦ .▁ ¦administration¦ ¦of¦ 𐋇¦donald¦ 𐋇¦trump¦ ¦has¦ ¦referred¦ ¦to¦ ¦the¦ ¦coronavirus¦ ¦as¦ ▁" 𐋇¦chinese¦ ¦virus¦ "▁ ¦or¦ ▁" 𐋇¦wuhan¦ ¦virus¦ "▁ ¦saying¦ ¦that¦ 𐋇¦china¦ ' ¦s¦ ▁" ¦ce ns or ship¦ ¦sup erc har ged¦ ¦a¦ ¦virus¦ ¦that¦ ¦has¦ ¦now¦ ¦turned¦ ¦into¦ ¦a¦ ¦global¦ ¦pandemic¦ ",▁ ¦which¦ ¦has¦ ¦in¦ ¦turn¦ ¦been¦ ¦criticized¦ ¦by¦ ¦some¦ ¦crit ics¦ ¦as¦ ¦rac ism¦ ¦and¦ ▁" ¦dis tr act¦ [ ¦ ing¦ ]▁ ¦from¦ ¦his¦ ¦administration¦ ' ¦s¦ ¦failure¦ ¦to¦ ¦contain¦ ¦the¦ ¦disease¦ ".
𐋇¦in¦ ¦addition¦ ¦to¦ ¦replic ating¦ ¦in¦ ¦the¦ ¦lower¦ ¦respiratory¦ ¦tract¦ ,▁ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦can¦ ¦efficie ntly¦ ¦replicate¦ ¦in¦ ¦the¦ ¦upper¦ ¦respiratory¦ ¦tract¦ ¦and¦ ¦causes¦ ¦mild¦ ¦or¦ ¦no¦ ¦symptoms¦ ¦in¦ ¦the¦ ¦early¦ ¦phase¦ ¦of¦ ¦infection¦ ,▁ ¦similar¦ ¦to¦ ¦other¦ 𐋇¦co𐋇vs¦ ¦that¦ ¦cause¦ ¦common¦ ¦colds¦ .
𐋇 ¦cl us tered¦ ¦onset¦ ¦often¦ ¦happens¦ ¦in¦ ¦the¦ ¦same¦ ¦family¦ ¦or¦ ¦from¦ ¦the¦ ¦same¦ ¦gathering¦ ¦or¦ ¦vehicle¦ ¦such¦ ¦as¦ ¦a¦ ¦cruise¦ ¦ship¦ .
𐋇 ¦authorities¦ ¦worldwide¦ ¦have¦ ¦responded¦ ¦by¦ ¦implementing¦ ¦travel¦ ¦restrictions¦ ,▁ ¦quarantines¦ ,▁ ¦curfews¦ ,▁ ¦workplace¦ ¦hazard¦ ¦controls¦ ,▁ ¦and¦ ¦facility¦ ¦closures¦ .
𐋇¦a¦ ¦more¦ ¦recent¦ ¦study¦ ,▁ ¦as¦ ¦described¦ ¦above¦ ,▁ ¦demonstr ates¦ ¦that¦ ¦the¦ ¦incubation¦ ¦period¦ ¦was¦ ¦4¦ . ¦8¦ ▁( ¦3¦ . ¦0¦ - ¦7¦ . ¦2¦ )▁ ¦days¦ ¦based¦ ¦on¦ ¦the¦ ¦dem ography¦ ¦of¦ ¦8¦ , ¦86 6¦ ¦cases¦ .
𐋇¦in¦ ¦severe¦ ¦cases¦ ,▁ ¦patients¦ ¦quickly¦ ¦prog ressed¦ ¦to¦ ¦develop¦ ¦acute¦ ¦respiratory¦ ¦syndrome¦ ,▁ ¦sep tic¦ ¦shock¦ ,▁ ¦met ab ol ic¦ ¦ac id osis¦ ,▁ ¦and¦ ¦coa g ul opa thy¦ .
𐋇¦supp ression¦ ¦can¦ ¦be¦ ¦preferred¦ ¦but¦ ¦needs¦ ¦to¦ ¦be¦ ¦maintained¦ ¦for¦ ¦as¦ ¦long¦ ¦as¦ ¦the¦ ¦virus¦ ¦is¦ ¦circulating¦ ¦in¦ ¦the¦ ¦human¦ ¦population¦ ▁( ¦or¦ ¦until¦ ¦a¦ ¦vaccine¦ ¦becomes¦ ¦available¦ ,▁ ¦if¦ ¦that¦ ¦comes¦ ¦first¦ ),▁ ¦as¦ ¦transmission¦ ¦otherwise¦ ¦quickly¦ ¦re b ounds¦ ¦when¦ ¦measures¦ ¦are¦ ¦relaxed¦ .
𐋇 ¦pres um ably¦ ,▁ ¦it¦ ¦has¦ ¦already¦ ¦been¦ ¦adapted¦ ¦to¦ ¦another¦ ¦host¦ ¦close¦ ¦to¦ ¦humans¦ .
𐋇¦in¦ ¦this¦ ¦study¦ ,▁ ¦we¦ ¦assess¦ ¦the¦ ¦trends¦ ¦in¦ ¦the¦ ¦cumulative¦ ¦incidence¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦in¦ ¦each¦ 𐋇¦european¦ 𐋇¦union¦ / 𐋇¦european¦ 𐋇¦economic¦ 𐋇¦area¦ ▁( 𐊣¦eu¦ / ¦eea¦𐊼 )▁ ¦country¦ ¦and¦ ¦the¦ 𐋇¦united¦ 𐋇¦kingdom¦ ▁( 𐊣¦uk¦𐊼 )▁ ¦and¦ ¦compare¦ ¦them¦ ¦to¦ ¦that¦ ¦of¦ 𐋇¦hubei¦ 𐋇¦province¦ ,▁ 𐋇¦china¦ .
𐋇¦the¦ ¦two¦ ¦types¦ ¦of¦ ¦can ine¦ ¦coronavirus¦ ▁( 𐊣¦c c𐊼 o 𐋇v¦ )▁( ¦one¦ ¦causing¦ ¦enteritis¦ ,▁ ¦the¦ ¦other¦ ¦found¦ ¦in¦ ¦respiratory¦ ¦diseases¦ ).
𐋇¦the¦ ¦same¦ ¦day¦ ¦travel¦ ¦restrictions¦ ¦were¦ ¦ea sed¦ ¦in¦ 𐋇¦hubei¦ ,▁ ¦apart¦ ¦from¦ 𐋇¦wuhan¦ ,▁ ¦two¦ ¦months¦ ¦after¦ ¦the¦ ¦lockdown¦ ¦was¦ ¦imposed¦ . 𐋇¦the¦ 𐋇¦chinese¦ 𐋇¦ministry¦ ¦of¦ 𐋇¦foreign¦ 𐋇¦affairs¦ ¦announced¦ ¦on¦ ¦26¦ 𐋇¦march¦ ¦2020¦ ¦that¦ ¦entry¦ ¦for¦ ¦vis a¦ ¦or¦ ¦residence¦ ¦permit¦ ¦holders¦ ¦would¦ ¦be¦ ¦suspended¦ ¦from¦ ¦28¦ 𐋇¦march¦ ¦on w ards¦ ,▁ ¦with¦ ¦no¦ ¦specific¦ ¦details¦ ¦on¦ ¦when¦ ¦this¦ ¦policy¦ ¦will¦ ¦end¦ .
𐋇 ¦damage¦ ¦to¦ ¦the¦ ¦global¦ ¦economy¦ ¦has¦ ¦been¦ ¦felt¦ ¦in¦ 𐋇¦china¦ :▁ ¦according¦ ¦to¦ ¦a¦ ¦media¦ ¦report¦ ¦on¦ ¦16¦ 𐋇¦march¦ ,▁ ¦the¦ ¦economy¦ ¦in¦ 𐋇¦china¦ ¦was¦ ¦very¦ ¦hard¦ ¦hit¦ ¦in¦ ¦the¦ ¦first¦ ¦two¦ ¦months¦ ¦of¦ ¦2020¦ ¦due¦ ¦to¦ ¦the¦ ¦measures¦ ¦taken¦ ¦by¦ ¦the¦ ¦government¦ ¦to¦ ¦cur ta il¦ ¦virus¦ ¦spread¦ ,▁ ¦and¦ ¦retail¦ ¦sales¦ ¦pl un ged¦ ¦20¦ . ¦5¦ %.
𐋇¦the¦ ¦2019¦ ¦novel¦ 𐊣¦hc𐊼o𐋇v¦ ▁( ¦2019¦ - ¦n𐋇co𐋇v¦ ),▁ ¦which¦ ¦has¦ ¦subsequently¦ ¦been¦ ¦re na med¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ,▁ ¦is¦ ¦the¦ ¦ca us ative¦ ¦agent¦ ¦of¦ ¦the¦ ¦ongoing¦ ¦epidemic¦ ¦of¦ ¦coronavirus¦ ¦disease¦ ¦2019¦ ▁( 𐊣¦covid¦𐊼 - ¦19¦ ),▁ ¦which¦ ¦has¦ ¦claimed¦ ¦more¦ ¦than¦ ¦3¦ , ¦120¦ ¦lives¦ ¦and¦ ¦infected¦ ¦more¦ ¦than¦ ¦91¦ , ¦000¦ ¦people¦ ¦as¦ ¦of¦ 𐋇¦march¦ ¦3¦ ,▁ ¦2020¦ .
𐋇 ¦pres um ably¦ ,▁ ¦the¦ ¦intermediate¦ ¦animal¦ ¦hosts¦ ¦of¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦should¦ ¦be¦ ¦among¦ ¦the¦ ¦wi ld li fe¦ ¦species¦ ¦sold¦ ¦and¦ ¦killed¦ ¦at¦ ¦the¦ 𐋇¦huan an¦ 𐋇¦seafood¦ 𐋇¦wh oles ale¦ 𐋇¦market¦ ,▁ ¦with¦ ¦which¦ ¦many¦ ¦of¦ ¦the¦ ¦initial¦ ¦cases¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦were¦ ¦associated¦ ,▁ ¦indic ative¦ ¦of¦ ¦a¦ ¦probable¦ ¦animal¦ - ¦to¦ - ¦human¦ ¦transmission¦ ¦event¦ .
𐋇¦south¦ 𐋇¦korea¦ ' ¦s¦ ¦programme¦ ¦is¦ ¦considered¦ ¦to¦ ¦be¦ ¦a¦ ¦success¦ ¦in¦ ¦controlling¦ ¦the¦ ¦outbreak¦ ¦despite¦ ¦not¦ ¦quarantining¦ ¦entire¦ ¦cities¦ . 𐋇¦the¦ 𐋇¦south¦ 𐋇¦korean¦ ¦society¦ ¦was¦ ¦initially¦ ¦pol ar ized¦ ¦on¦ 𐋇¦president¦ 𐋇¦m oon¦ 𐋇¦ja e¦ - ¦in¦ ' ¦s¦ ¦response¦ ¦to¦ ¦the¦ ¦crisis¦ .
𐋇¦nevert heless¦ ,▁ ¦the¦ ¦features¦ ¦of¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦including¦ ¦its¦ ¦transmissibility¦ ,▁ ¦patho genicity¦ ¦and¦ ¦susta in able¦ ¦spreading¦ ¦after¦ ¦pass ages¦ ¦in¦ ¦humans¦ ¦will¦ ¦be¦ ¦inf lu ential¦ ¦on¦ ¦the¦ ¦ ult imate¦ ¦f ate¦ ¦of¦ ¦the¦ ¦ongoing¦ ¦outbreak¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ .
𐋇¦moreover¦ ,▁ ¦the¦ ¦high¦ ¦level¦ ¦of¦ ¦reactive¦ ¦oxygen¦ ¦species¦ ▁( 𐊣 ¦ro s¦𐊼 )▁ ¦generated¦ ¦from¦ ¦high¦ ¦met ab ol ic¦ ¦activity¦ ¦of¦ ¦bats¦ ¦could¦ ¦both¦ ¦suppress¦ 𐋇¦co𐋇v¦ ¦replication¦ ¦and¦ ¦affects¦ ¦pr oo f rea ding¦ ¦by¦ ¦ex o rib on ucle ase¦ ,▁ ¦thus¦ ¦providing¦ ¦the¦ ¦sel ection¦ ¦pressure¦ ¦for¦ ¦the¦ ¦generation¦ ¦of¦ ¦virus¦ ¦strains¦ ¦highly¦ ¦pathogenic¦ ¦when¦ ¦introduced¦ ¦into¦ ¦a¦ ¦new¦ ¦host¦ .
𐋇¦several¦ ¦train¦ ¦stations¦ ¦and¦ ¦fer ry¦ ¦ por ts¦ ¦have¦ ¦also¦ ¦been¦ ¦closed¦ .
𐋇¦coronaviruses¦ ¦vary¦ ¦significantly¦ ¦in¦ ¦risk¦ ¦factor¦ .
𐋇¦for¦ ¦clarity¦ ,▁ ¦the¦ ¦current¦ ¦knowledge¦ ¦on¦ ¦animal¦ ¦origins¦ ¦of¦ ¦known¦ 𐊣¦hc𐊼o𐋇vs¦ ¦is¦ ¦sum mar ized¦ ¦in¦ 𐋇¦figure¦ ▁ ​ ¦1¦ ¦and¦ 𐋇¦table¦ ¦2¦ .
𐋇¦in¦ ¦both¦ ¦cases¦ ,▁ ¦the¦ ¦hosts¦ ¦are¦ ¦na turally¦ ¦infected¦ ¦and¦ ¦are¦ ¦the¦ ¦natural¦ ¦hosts¦ ¦of¦ 𐊣¦hc𐊼o𐋇v¦ ¦or¦ ¦its¦ ¦parental¦ ¦virus¦ .
𐋇¦on¦ ¦the¦ ¦same¦ ¦day¦ ,▁ ¦21 5¦ 𐋇¦ca na di ans¦ ▁( ¦17 6¦ ¦from¦ ¦the¦ ¦first¦ ¦plane¦ ,▁ ¦and¦ ¦39¦ ¦from¦ ¦a¦ ¦second¦ ¦plane¦ ¦char tered¦ ¦by¦ ¦the¦ 𐋇¦u¦ . 𐋇¦s¦ .▁ ¦government¦ )▁ ¦were¦ ¦evacuated¦ ¦from¦ 𐋇¦wuhan¦ ¦to¦ 𐊣¦cf b¦𐊼 𐋇¦tr en ton¦ ¦to¦ ¦be¦ ¦quarantined¦ ¦for¦ ¦two¦ ¦weeks¦ .
𐋇¦the¦ ¦polyp rotein¦ ¦has¦ ¦its¦ ¦own¦ ¦prot ea ses¦ ¦which¦ ¦clea ve¦ ¦the¦ ¦polyp rotein¦ ¦into¦ ¦multiple¦ ¦non st ructural¦ ¦proteins¦ .
𐋇¦the¦ 𐋇¦bharatiya¦ 𐋇¦jana ta¦ 𐋇¦party¦ ' ¦s¦ 𐋇¦state¦ ¦unit¦ ¦president¦ ¦in¦ 𐋇¦west¦ 𐋇¦bengal¦ 𐋇¦dilip¦ 𐋇¦g ho sh¦ ¦stated¦ ¦that¦ ¦the¦ 𐋇¦chinese¦ ¦had¦ ¦destroyed¦ ¦nature¦ ¦and¦ ▁" ¦that¦ ' ¦s¦ ¦why¦ ¦the¦ 𐋇¦god¦ ¦took¦ ¦rev en ge¦ ¦against¦ ¦them¦ ."
𐋇 ¦studies¦ ¦have¦ ¦found¦ ¦that¦ ¦an¦ ¦unc ov ered¦ ¦coughing¦ ¦can¦ ¦lead¦ ¦to¦ ¦droplets¦ ¦trave lling¦ ¦up¦ ¦to¦ ¦4¦ . ¦5¦ ¦metres¦ ▁( ¦15¦ ¦feet¦ )▁ ¦to¦ ¦8¦ . ¦2¦ ¦metres¦ ▁( ¦27¦ ¦feet¦ ).
𐋇¦in¦ ¦chickens¦ ,▁ ¦the¦ ¦infectious¦ ¦bronchitis¦ ¦virus¦ ▁( 𐊣¦ib v¦𐊼 ),▁ ¦a¦ ¦coronavirus¦ ,▁ ¦targets¦ ¦not¦ ¦only¦ ¦the¦ ¦respiratory¦ ¦tract¦ ¦but¦ ¦also¦ ¦the¦ ¦u ro ge ni tal¦ ¦tract¦ .
𐋇¦inter es ti ngly¦ ,▁ ¦the¦ ¦nucleotide¦ ¦a na lo gue¦ 𐋇¦remdesivir¦ ¦is¦ ¦known¦ ¦to¦ ¦suppress¦ 𐋇¦co𐋇v¦ ¦replication¦ ¦through¦ ¦inhibition¦ ¦of¦ ¦this¦ ¦ex o rib on ucle ase¦ ¦and¦ ¦the¦ 𐊣¦rna¦𐊼 - ¦dependent¦ 𐊣¦rna¦𐊼 ¦polymerase¦ .
𐋇¦taking¦ ¦over¦ - ¦the¦ - ¦counter¦ ¦cold¦ ¦medications¦ ,▁ ¦drinking¦ ¦fluids¦ ,▁ ¦and¦ ¦r esting¦ ¦may¦ ¦help¦ ¦alleviate¦ ¦symptoms¦ .
𐋇¦thus¦ ,▁ ¦if¦ ¦needed¦ ,▁ ¦steroids¦ ¦should¦ ¦be¦ ¦used¦ ¦at¦ ¦low¦ ¦d os age¦ ¦and¦ ¦for¦ ¦a¦ ¦short¦ ¦time¦ ¦in¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦patients¦ .
𐋇¦in¦ 𐋇¦september¦ ¦2012¦ ,▁ ¦a¦ ¦new¦ ¦type¦ ¦of¦ ¦coronavirus¦ ¦was¦ ¦identified¦ ,▁ ¦initially¦ ¦called¦ 𐋇¦novel¦ 𐋇¦coronavirus¦ ¦2012¦ ,▁ ¦and¦ ¦now¦ ¦officially¦ ¦named¦ 𐋇¦middle¦ 𐋇¦east¦ ¦respiratory¦ ¦syndrome¦ ¦coronavirus¦ ▁( 𐊣¦mers¦𐊼 - 𐋇¦co𐋇v¦ ).
𐋇¦a¦ 𐊣¦cn n¦𐊼 ¦report¦ ¦indicated¦ ¦that¦ ¦the¦ ¦combination¦ ¦of¦ 𐋇¦italy¦ ' ¦s¦ ¦large¦ ¦elderly¦ ¦population¦ ¦and¦ ¦in ability¦ ¦to¦ ¦test¦ ¦all¦ ¦who¦ ¦have¦ ¦the¦ ¦virus¦ ¦to¦ ¦date¦ ¦may¦ ¦be¦ ¦cont ribu ting¦ ¦to¦ ¦the¦ ¦high¦ ¦fatality¦ ¦rate¦ .
𐋇¦on¦ 𐋇¦january¦ ¦20¦ ,▁ ¦the¦ ¦infection¦ ¦of¦ ¦health¦ - ¦care¦ ¦providers¦ ¦was¦ ¦reported¦ ,▁ ¦suggesting¦ ¦that¦ ¦human¦ - ¦to¦ - ¦human¦ ¦transmission¦ ¦was¦ ¦possible¦ .
𐋇¦surgical¦ ¦masks¦ ¦are¦ ¦recommended¦ ¦for¦ ¦those¦ ¦who¦ ¦may¦ ¦be¦ ¦infected¦ ,▁ ¦as¦ ¦wearing¦ ¦a¦ ¦mask¦ ¦can¦ ¦limit¦ ¦the¦ ¦volume¦ ¦and¦ ¦travel¦ ¦distance¦ ¦of¦ ¦exp ir atory¦ ¦droplets¦ ¦disp er sed¦ ¦when¦ ¦talking¦ ,▁ ¦sneezing¦ ,▁ ¦and¦ ¦coughing¦ .
𐋇¦we¦ ¦also¦ ¦review¦ ¦the¦ ¦trend¦ ¦of¦ 𐊣¦hc𐊼o𐋇v¦ ¦evolution¦ ¦in¦ ¦which¦ ¦the¦ ¦increase¦ ¦in¦ ¦transmissibility¦ ¦often¦ ¦comes¦ ¦with¦ ¦the¦ ¦decrease¦ ¦in¦ ¦patho genicity¦ .
𐋇¦since¦ ¦cases¦ ¦have¦ ¦so¦ ¦far¦ ¦cl us tered¦ ¦in¦ ¦certain¦ ¦regions¦ ¦in¦ 𐊣¦eu¦ / ¦eea¦𐊼 ¦countries¦ ¦and¦ ¦the¦ 𐊣¦uk¦𐊼 ,▁ ¦and¦ ¦hospitals¦ ¦and¦ ¦intensive¦ ¦care¦ ¦units¦ ¦usually¦ ¦serve¦ ¦a¦ ¦defined¦ ¦regional¦ ¦cat ch ment¦ ¦population¦ ,▁ ¦information¦ ¦about¦ ¦cases¦ ¦and¦ ¦intensive¦ ¦care¦ ¦beds¦ ¦should¦ ¦preferably¦ ¦be¦ ¦made¦ ¦available¦ ¦at¦ ¦the¦ 𐋇¦no me nc l ature¦ ¦of¦ ¦ter ri to rial¦ ¦units¦ ¦for¦ ¦statistics¦ ¦2¦ ▁( 𐊣¦n ut s¦𐊼 - ¦2¦ )▁ ¦level¦ .
𐋇¦it¦ ¦is¦ ¦therefore¦ ¦not¦ ¦too¦ ¦surpr ising¦ ¦that¦ ¦bats¦ ¦might¦ ¦transmit¦ 𐊣¦hc𐊼o𐋇v¦ - ¦229𐋇e¦ ¦to¦ ¦humans¦ ¦directly¦ .
𐋇¦three¦ ¦major¦ ¦risk¦ ¦factors¦ ¦for¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦were¦ ¦sex¦ ▁( ¦m ale¦ ),▁ ¦age¦ ▁( ≥ ¦60¦ ),▁ ¦and¦ ¦severe¦ ¦pneumonia¦ .
𐋇¦according¦ ¦to¦ ¦a¦ ¦human¦ ¦volunte er¦ ¦study¦ ,▁ ¦healthy¦ ¦individuals¦ ¦infected¦ ¦with¦ 𐊣¦hc𐊼o𐋇v¦ - ¦229𐋇e¦ ¦developed¦ ¦mild¦ ¦common¦ ¦cold¦ .
𐋇¦some¦ ¦art ists¦ ¦have¦ ¦explo red¦ ¦ways¦ ¦to¦ ¦continue¦ ¦to¦ ¦produce¦ ¦and¦ ¦share¦ ¦work¦ ¦over¦ ¦the¦ ¦internet¦ ¦as¦ ¦an¦ ¦alternative¦ ¦to¦ ¦traditional¦ ¦live¦ ¦performance¦ ,▁ ¦such¦ ¦as¦ ¦live¦ ¦st reaming¦ ¦conc erts¦ ¦or¦ ¦creating¦ ¦web¦ - ¦based¦ ▁" ¦festivals¦ "▁ ¦for¦ ¦art ists¦ ¦to¦ ¦perform¦ ,▁ ¦distribute¦ ,▁ ¦and¦ ¦public ize¦ ¦their¦ ¦work¦ .
𐋇¦on¦ 𐋇¦february¦ ¦18¦ ,▁ ¦2020¦ ,▁ 𐋇¦b oli¦ 𐋇¦zhang¦ ¦and¦ ¦co workers¦ ¦published¦ ¦a¦ ¦study¦ ¦to¦ ¦compare¦ ¦w est ern¦ ¦medicine¦ ▁( 𐊣¦w m¦𐊼 )▁ ¦treatment¦ ¦alone¦ ¦with¦ ¦combined¦ ¦treatment¦ ¦of¦ 𐊣¦w m¦𐊼 ¦and¦ 𐊣¦tcm¦𐊼 .
𐋇¦the¦ ¦cases¦ ¦mostly¦ ¦had¦ ¦lin ks¦ ¦to¦ ¦the¦ 𐋇¦huan an¦ 𐋇¦seafood¦ 𐋇¦wh oles ale¦ 𐋇¦market¦ ¦and¦ ¦so¦ ¦the¦ ¦virus¦ ¦is¦ ¦thought¦ ¦to¦ ¦have¦ ¦a¦ ¦zoonotic¦ ¦origin¦ .
𐋇¦the¦ ¦ex o rib on ucle ase¦ ¦non st ructural¦ ¦protein¦ ,▁ ¦for¦ ¦instance¦ ,▁ ¦provides¦ ¦extra¦ ¦f id el ity¦ ¦to¦ ¦replication¦ ¦by¦ ¦providing¦ ¦a¦ ¦pr oo f rea ding¦ ¦function¦ ¦which¦ ¦the¦ 𐊣¦rna¦𐊼 - ¦dependent¦ 𐊣¦rna¦𐊼 ¦polymerase¦ ¦l acks¦ . 𐋇¦one¦ ¦of¦ ¦the¦ ¦main¦ ¦functions¦ ¦of¦ ¦the¦ ¦complex¦ ¦is¦ ¦to¦ ¦replicate¦ ¦the¦ ¦viral¦ ¦genome¦ .
𐋇¦seven¦ ¦trials¦ ¦were¦ ¦eva lu ating¦ ¦repurposed¦ ¦drugs¦ ¦already¦ ¦approved¦ ¦to¦ ¦treat¦ ¦malaria¦ ,▁ ¦including¦ ¦four¦ ¦studies¦ ¦on¦ ¦hydroxychloroquine¦ ¦or¦ ¦chloroquine¦ ¦ph os ph ate¦ .
𐋇¦in¦ ¦response¦ ¦to¦ ¦the¦ ¦rapidly¦ ¦increasing¦ ¦number¦ ¦of¦ ¦public ations¦ ¦on¦ ¦the¦ ¦emerging¦ ¦disease¦ ,▁ ¦this¦ ¦article¦ ¦attempts¦ ¦to¦ ¦provide¦ ¦a¦ ¦timely¦ ¦and¦ ¦comprehensive¦ ¦review¦ ¦of¦ ¦the¦ ¦s wi ft ly¦ ¦developing¦ ¦research¦ ¦subject¦ .
𐋇¦it¦ ¦is¦ ¦directly¦ ¦involved¦ ¦in¦ ¦the¦ ¦replication¦ ¦and¦ ¦transcription¦ ¦of¦ 𐊣¦rna¦𐊼 ¦from¦ ¦an¦ 𐊣¦rna¦𐊼 ¦str and¦ .
𐋇¦the¦ 𐊣¦sars¦𐊼 ¦epidemic¦ ¦resulted¦ ¦in¦ ¦8¦ , ¦0 96¦ ¦reported¦ ¦cases¦ ¦with¦ ¦7 74¦ ¦deaths¦ ,▁ ¦spreading¦ ¦across¦ ¦many¦ ¦countries¦ ¦and¦ ¦conti ne nts¦ .
𐋇¦most¦ 𐊣¦hc𐊼o𐋇vs¦ ¦origin ated¦ ¦from¦ ¦bats¦ ¦where¦ ¦they¦ ¦are¦ ¦non¦ - ¦pathogenic¦ .
𐊣¦mers¦𐊼 - 𐋇¦co𐋇v¦ ,▁ ¦although¦ ¦related¦ ¦to¦ ¦several¦ ¦bat¦ ¦coronavirus¦ ¦species¦ ,▁ ¦appears¦ ¦to¦ ¦have¦ ¦diver ged¦ ¦from¦ ¦these¦ ¦several¦ ¦cen tur ies¦ ¦ago¦ .
𐋇 ¦physical¦ ¦distancing¦ ¦measures¦ ¦are¦ ¦also¦ ¦recommended¦ ¦to¦ ¦prevent¦ ¦transmission¦ . 𐋇¦many¦ ¦governments¦ ¦have¦ ¦restricted¦ ¦or¦ ¦advised¦ ¦against¦ ¦all¦ ¦non¦ - ¦essential¦ ¦travel¦ ¦to¦ ¦and¦ ¦from¦ ¦countries¦ ¦and¦ ¦areas¦ ¦affected¦ ¦by¦ ¦the¦ ¦outbreak¦ .
𐋇¦as¦ ¦the¦ ¦situation¦ ¦is¦ ¦rapidly¦ ¦ev ol ving¦ ,▁ ¦the¦ ¦final¦ ¦scope¦ ¦and¦ ¦severity¦ ¦of¦ ¦the¦ ¦outbreak¦ ¦remain¦ ¦to¦ ¦be¦ ¦determined¦ .
𐋇¦in¦ ¦the¦ 𐋇¦united¦ 𐋇¦states¦ ,▁ ¦over¦ ¦24 4¦ ¦thousand¦ ¦coronavirus¦ ¦cases¦ ¦were¦ ¦recorded¦ ,▁ ¦lin king¦ ¦to¦ ¦at¦ ¦least¦ ¦5¦ , ¦900¦ ¦deaths¦ .
𐋇¦in¦ ¦st ar k¦ ¦contrast¦ ,▁ ¦the¦ 𐊣¦rb d 𐊼s¦ ¦of¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦and¦ 𐋇¦ra𐊣tg𐊼13¦ ¦are¦ ¦more¦ ¦diver gent¦ ,▁ ¦al be it¦ ¦a¦ ¦higher¦ ¦degree¦ ¦of¦ ¦sequence¦ ¦homology¦ ¦genome¦ - ¦wide¦ .
𐋇¦as¦ ¦of¦ ¦early¦ 𐋇¦april¦ ¦2020¦ ,▁ ¦10 3¦ ¦candidate¦ ¦therap eut ics¦ ¦were¦ ¦in¦ ¦preclinical¦ ¦or¦ ¦a¦ ¦stage¦ ¦of¦ 𐋇¦phase¦ 𐋇¦i¦ - 𐊣¦iv¦𐊼 ¦development¦ ,▁ ¦with¦ ¦trial¦ ¦results¦ ¦for¦ ¦29¦ ¦drug¦ ¦candidates¦ ¦expected¦ ¦during¦ 𐋇¦april¦ .
𐋇¦bat¦ 𐋇¦co𐋇v¦ - 𐊣¦hku𐊼 4¦ ¦and¦ 𐊣¦mers¦𐊼 - 𐋇¦co𐋇v¦ ¦uti lize¦ ¦the¦ ¦same¦ ¦host¦ ¦receptor¦ ,▁ ¦d ipe ptid yl¦ ¦pe ptid ase¦ ¦4¦ ▁( 𐊣¦d pp 𐊼 4¦ ),▁ ¦for¦ ¦virus¦ ¦entry¦ .
𐋇¦however¦ ,▁ 𐋇¦co𐋇v¦ ¦can¦ ¦inhibit¦ 𐋇¦t¦ ¦cell¦ ¦functions¦ ¦by¦ ¦indu cing¦ ¦a po pt osis¦ ¦of¦ 𐋇¦t¦ ¦cells¦ .
𐋇¦they¦ ¦are¦ ¦enveloped¦ ¦viruses¦ ¦with¦ ¦a¦ ¦positive¦ - ¦sense¦ ¦single¦ - ¦stranded¦ 𐊣¦rna¦𐊼 ¦genome¦ ¦and¦ ¦a¦ ¦nucleocapsid¦ ¦of¦ ¦h el ical¦ ¦sym m et ry¦ .
𐋇¦this¦ ¦is¦ ¦the¦ ¦highest¦ ¦number¦ ¦of¦ ¦fat alities¦ ¦in¦ ¦a¦ ¦day¦ ¦due¦ ¦to¦ ¦the¦ ¦virus¦ .
𐋇¦evidence¦ ¦to¦ ¦date¦ ¦is¦ ¦that¦ ¦ca¦ ¦80¦ %▁ ¦of¦ ¦individuals¦ ¦with¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦have¦ ¦a¦ ¦mild¦ ¦disease¦ ,▁ ¦i¦ . ¦e¦ .▁ ¦a¦ ¦respiratory¦ ¦tract¦ ¦infection¦ ¦with¦ ¦or¦ ¦without¦ ¦pneumonia¦ ,▁ ¦and¦ ¦most¦ ¦of¦ ¦these¦ ¦recover¦ .
𐋇¦on¦ ¦14¦ 𐋇¦february¦ ,▁ ¦a¦ 𐊣¦who¦𐊼 - ¦led¦ 𐋇¦joint¦ 𐋇¦mission¦ 𐋇¦team¦ ¦with¦ 𐋇¦china¦ ¦was¦ ¦ac tivated¦ ¦to¦ ¦provide¦ ¦international¦ ¦and¦ 𐊣¦who¦𐊼 ¦experts¦ ¦on¦ ¦the¦ ¦ground¦ ¦in¦ 𐋇¦china¦ ¦to¦ ¦assist¦ ¦in¦ ¦the¦ ¦domestic¦ ¦management¦ ¦and¦ ¦eva lu ate¦ ▁" ¦the¦ ¦severity¦ ¦and¦ ¦the¦ ¦transmissibility¦ ¦of¦ ¦the¦ ¦disease¦ "▁ ¦by¦ ¦h os ting¦ ¦wor ks ho ps¦ ¦and¦ ¦meetings¦ ¦with¦ ¦key¦ ¦national¦ - ¦level¦ ¦institutions¦ ¦and¦ ¦to¦ ¦conduct¦ ¦field¦ ¦visits¦ ¦to¦ ¦assess¦ ¦the¦ ▁" ¦impact¦ ¦of¦ ¦response¦ ¦activities¦ ¦at¦ ¦provi n cial¦ ¦and¦ ¦county¦ ¦levels¦ ,▁ ¦including¦ ¦urban¦ ¦and¦ ¦rural¦ ¦settings¦ ". 𐋇¦on¦ ¦25¦ 𐋇¦february¦ ,▁ ¦the¦ 𐊣¦who¦𐊼 ¦declared¦ ¦that¦ ▁" ¦the¦ ¦world¦ ¦should¦ ¦do¦ ¦more¦ ¦to¦ ¦prepare¦ ¦for¦ ¦a¦ ¦possible¦ ¦coronavirus¦ ¦pandemic¦ ,"▁ ¦st ating¦ ¦that¦ ¦while¦ ¦it¦ ¦was¦ ¦still¦ ¦too¦ ¦early¦ ¦to¦ ¦call¦ ¦it¦ ¦a¦ ¦pandemic¦ ,▁ ¦countries¦ ¦should¦ ¦non et heless¦ ¦be¦ ▁" ¦in¦ ¦a¦ ¦phase¦ ¦of¦ ¦preparedness¦ ".
𐋇¦cases¦ ¦began¦ ¦to¦ ¦rise¦ ¦sharply¦ ,▁ ¦which¦ ¦prompted¦ ¦the¦ 𐋇¦italian¦ ¦government¦ ¦to¦ ¦susp end¦ ¦all¦ ¦flights¦ ¦to¦ ¦and¦ ¦from¦ 𐋇¦china¦ ¦and¦ ¦decl are¦ ¦a¦ ¦state¦ ¦of¦ ¦emergency¦ .
𐋇¦a¦ ¦variety¦ ¦of¦ ¦zoonotic¦ 𐋇¦co𐋇vs¦ ¦are¦ ¦circulating¦ ¦in¦ ¦the¦ ¦wild¦ .
𐋇¦based¦ ¦on¦ ¦the¦ ¦experience¦ ¦from¦ 𐋇¦italy¦ ,▁ ¦countries¦ ,▁ ¦hospitals¦ ¦and¦ ¦intensive¦ ¦care¦ ¦units¦ ¦should¦ ¦increase¦ ¦their¦ ¦preparedness¦ ¦for¦ ¦a¦ ¦sur ge¦ ¦of¦ ¦patients¦ ¦with¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦who¦ ¦will¦ ¦require¦ ¦healthcare¦ ,▁ ¦and¦ ¦in¦ ¦particular¦ ¦intensive¦ ¦care¦ .
𐋇¦to¦ ¦conclu de¦ ,▁ ¦we¦ ¦hope¦ ¦more¦ ¦direct¦ ¦evidence¦ ¦coming¦ ¦up¦ ¦and¦ ¦call¦ ¦for¦ ¦rea ders¦ ¦to¦ ¦provide¦ ¦their¦ ¦com ments¦ .
𐋇¦individuals¦ ¦may¦ ¦apply¦ ¦social¦ ¦distancing¦ ¦methods¦ ¦by¦ ¦staying¦ ¦at¦ ¦home¦ ,▁ ¦limiting¦ ¦travel¦ ,▁ ¦avoiding¦ ¦crowded¦ ¦areas¦ ,▁ ¦using¦ ¦no¦ - ¦contact¦ ¦gre et ings¦ ,▁ ¦and¦ ¦physically¦ ¦distancing¦ ¦themselves¦ ¦from¦ ¦others¦ .
𐋇¦diagn osing¦ ¦the¦ ¦confirmed¦ ¦case¦ ¦should¦ ¦b ase¦ ¦on¦ ¦suspected¦ ¦case¦ ¦with¦ ¦any¦ ¦one¦ ¦i tem¦ ¦of¦ ¦pathogenic¦ ¦or¦ ¦serological¦ ¦evidence¦ ¦as¦ ¦following¦ :▁( ¦1¦ )▁ ¦real¦ - ¦time¦ 𐊣¦pcr¦𐊼 ¦test¦ ¦positive¦ ¦for¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ;▁( ¦2¦ )▁ ¦viral¦ ¦whole¦ ¦genome¦ ¦sequencing¦ ¦showing¦ ¦high¦ ¦ho mo gene ity¦ ¦to¦ ¦the¦ ¦known¦ ¦novel¦ ¦coronaviruses¦ ;▁( ¦3¦ )▁ ¦positive¦ ¦for¦ ¦the¦ ¦specific¦ 𐋇¦ig𐋇m¦ ¦antibody¦ ¦and¦ 𐋇¦ig𐋇g¦ ¦antibody¦ ¦to¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦in¦ ¦serum¦ ¦test¦ ;▁ ¦or¦ ¦a¦ ¦change¦ ¦of¦ ¦the¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ - ¦specific¦ 𐋇¦ig𐋇g¦ ¦antibody¦ ¦from¦ ¦negative¦ ¦to¦ ¦positive¦ ,▁ ¦or¦ ¦ti ter¦ ¦rising¦ ▁≥ ¦4¦ ¦times¦ ¦in¦ ¦the¦ ¦recovery¦ ¦phase¦ ¦above¦ ¦that¦ ¦in¦ ¦the¦ ¦acute¦ ¦phase¦ .
𐋇¦eight¦ ¦of¦ ¦these¦ ¦doctors¦ ,▁ ¦including¦ 𐋇¦li¦ 𐋇¦w en li ang¦ ,▁ ¦were¦ ¦ad mo ni shed¦ ¦by¦ ¦the¦ ¦police¦ ¦for¦ ¦spreading¦ ¦false¦ ¦r um ours¦ ,▁ ¦and¦ ¦another¦ ,▁ 𐋇¦a i¦ 𐋇¦f en¦ ,▁ ¦was¦ ¦re pri ma nded¦ ¦by¦ ¦her¦ ¦super i ors¦ ¦for¦ ¦raising¦ ¦the¦ ¦al ar m¦ .
𐋇¦the¦ 𐊣¦who¦𐊼 ¦was¦ ¦informed¦ ¦on¦ ¦the¦ ¦same¦ ¦day¦ .
𐋇¦when¦ ¦this¦ ¦chest¦ ¦pain¦ ¦started¦ ?
𐋇¦shi a¦ ¦s hr ines¦ ¦in¦ 𐋇¦q om¦ ¦remained¦ ¦open¦ ¦to¦ ¦pil g ri ms¦ ¦until¦ ¦16¦ 𐋇¦march¦ ¦2020¦ . 𐋇¦iran¦ ¦became¦ ¦a¦ ¦ce nt re¦ ¦of¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ ¦after¦ 𐋇¦china¦ ¦during¦ 𐋇¦february¦ .
𐋇¦long¦ - ¦term¦ ¦intervention¦ ¦to¦ ¦suppress¦ ¦the¦ ¦pandemic¦ ¦causes¦ ¦social¦ ¦and¦ ¦economic¦ ¦costs¦ .
𐋇¦i¦ ' ¦ve¦ ¦very¦ ¦concerned¦ ¦of¦ ¦this¦ ¦chest¦ ¦pain¦
𐊣¦us¦𐊼 ¦authorities¦ ¦have¦ ¦also¦ ¦been¦ ¦accused¦ ¦of¦ ¦diver ting¦ ¦aid¦ ¦me ant¦ ¦for¦ ¦other¦ ¦nations¦ ¦to¦ ¦their¦ ¦own¦ ¦country¦ .
𐋇¦the¦ ¦detection¦ ¦of¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ 𐊣¦rna¦𐊼 ¦via¦ ¦reverse¦ - ¦transcript ase¦ ¦polymerase¦ ¦chain¦ ¦reaction¦ ▁( 𐊣¦rt¦ - ¦pcr¦𐊼 )▁ ¦was¦ ¦used¦ ¦as¦ ¦the¦ ¦major¦ ¦criteria¦ ¦for¦ ¦the¦ ¦diagnosis¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ .
𐋇 ¦emerging¦ ¦infectious¦ ¦disease¦ ▁–▁ 𐋇¦infectious¦ ¦disease¦ ¦of¦ ¦emerging¦ ¦path ogen¦ ,▁ ¦often¦ ¦novel¦ ¦in¦ ¦its¦ ¦outbreak¦ ¦range¦ ¦or¦ ¦transmission¦ ¦mo de¦
𐋇¦k im ber ly¦ - 𐋇 ¦cl ar k¦ ,▁ ¦which¦ ¦makes¦ 𐋇¦ kl ee ne x¦ 𐋇 ¦toilet¦ 𐋇 ¦tissue¦ ,▁ ¦and¦ 𐋇¦so la ris¦ 𐋇¦paper¦ ¦which¦ ¦makes¦ 𐋇¦s orb ent¦ ,▁ ¦emphasi zed¦ ¦they¦ ¦were¦ ¦working¦ ¦24¦ / ¦7¦ ¦to¦ ¦maintain¦ ¦the¦ ¦supply¦ ,▁ ¦according¦ ¦to¦ ¦the¦ 𐋇¦news¦ . ¦com¦ . ¦a u¦ ¦report¦ .
𐋇¦the¦ 𐋇¦a ust rian¦ ¦government¦ ¦mandated¦ ¦that¦ ¦everyone¦ ¦entering¦ ¦a¦ ¦grocery¦ ¦store¦ ¦must¦ ¦wear¦ ¦a¦ ¦face¦ ¦mask¦ .
𐋇¦based¦ ¦on¦ ¦these¦ ,▁ 𐋇¦gilead¦ ¦has¦ ¦provided¦ ¦the¦ ¦compound¦ ¦to¦ 𐋇¦china¦ ¦to¦ ¦conduct¦ ¦a¦ ¦pa ir¦ ¦of¦ ¦trials¦ ¦on¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ - ¦infected¦ ¦individuals¦ ,▁ ¦and¦ ¦the¦ ¦results¦ ¦are¦ ¦highly¦ ¦anticipated¦ .
𐋇¦as¦ ¦of¦ ¦22¦ 𐋇¦february¦ ,▁ ¦among¦ ¦9¦ , ¦3 36¦ ¦followers¦ ¦of¦ ¦the¦ ¦chur ch¦ ,▁ ¦1¦ , ¦26 1¦ ¦or¦ ¦about¦ ¦13¦ %▁ ¦reported¦ ¦symptoms¦ . 𐋇¦south¦ 𐋇¦korea¦ ¦declared¦ ¦the¦ ¦highest¦ ¦level¦ ¦of¦ ¦alert¦ ¦on¦ ¦23¦ 𐋇¦february¦ ¦2020¦ .
𐋇¦g lo ba liz ation¦ ¦and¦ ¦disease¦ ▁–▁ 𐋇 ¦over view¦ ¦of¦ ¦g lo ba liz ation¦ ¦and¦ ¦disease¦ ¦transmission¦
𐋇¦at¦ ¦least¦ ¦12¦ ¦sitting¦ ¦or¦ ¦former¦ 𐋇¦iranian¦ ¦politicians¦ ¦and¦ ¦government¦ ¦officials¦ ¦had¦ ¦died¦ ¦from¦ ¦the¦ ¦disease¦ ¦by¦ ¦17¦ 𐋇¦march¦ .
𐋇¦it¦ ¦is¦ ¦therefore¦ ¦impossible¦ ¦to¦ ¦s ac rif ice¦ ¦all¦ ¦camels¦ ¦for¦ ¦the¦ ¦control¦ ¦of¦ 𐊣¦mers¦𐊼 ,▁ ¦as¦ ¦what¦ ¦was¦ ¦done¦ ¦in¦ ¦wild¦ ¦animal¦ ¦markets¦ ¦in¦ 𐋇¦china¦ ¦to¦ ¦prevent¦ ¦the¦ ¦spreading¦ ¦of¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ ¦and¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ .
𐋇¦this¦ ¦is¦ ¦because¦ ¦outside¦ ¦the¦ ¦human¦ ¦body¦ ,▁ ¦the¦ ¦virus¦ ¦is¦ ¦killed¦ ¦by¦ ¦household¦ ¦soap¦ ,▁ ¦which¦ ¦bur s ts¦ ¦its¦ ¦protective¦ ¦b ub ble¦ .
𐋇¦the¦ 𐊣¦cdc¦𐊼 ¦recommends¦ ¦that¦ ¦people¦ ¦wash¦ ¦hands¦ ¦often¦ ¦with¦ ¦soap¦ ¦and¦ ¦water¦ ¦for¦ ¦at¦ ¦least¦ ¦twenty¦ ¦seconds¦ ,▁ ¦especially¦ ¦after¦ ¦going¦ ¦to¦ ¦the¦ ¦toilet¦ ¦or¦ ¦when¦ ¦hands¦ ¦are¦ ¦visi bly¦ ¦dirty¦ ;▁ ¦before¦ ¦eating¦ ;▁ ¦and¦ ¦after¦ ¦blowing¦ ¦one¦ ' ¦s¦ ¦nose¦ ,▁ ¦coughing¦ ,▁ ¦or¦ ¦sneezing¦ .
𐋇 ¦rapidly¦ ¦increasing¦ ¦cumulative¦ ¦incidence¦ ¦of¦ ¦coronavirus¦ ¦disease¦ ▁( 𐊣¦covid¦𐊼 - ¦19¦ )▁ ¦in¦ ¦the¦ 𐋇¦european¦ 𐋇¦union¦ / 𐋇¦european¦ 𐋇¦economic¦ 𐋇¦area¦ ¦and¦ ¦the¦ 𐋇¦united¦ 𐋇¦kingdom¦ ,▁ ¦1¦ 𐋇¦january¦ ¦to¦ ¦15¦ 𐋇¦march¦ ¦2020¦
𐋇¦the¦ ¦high¦ - ¦thr ough put¦ ¦aut om ated¦ ¦systems¦ ¦in¦ ¦many¦ ¦clinical¦ ¦laboratories¦ ¦will¦ ¦be¦ ¦able¦ ¦to¦ ¦perform¦ ¦these¦ ¦assays¦ ¦but¦ ¦their¦ ¦availability¦ ¦will¦ ¦depend¦ ¦on¦ ¦the¦ ¦rate¦ ¦of¦ ¦production¦ ¦for¦ ¦each¦ ¦system¦ .
𐋇¦the¦ ¦average¦ ¦time¦ ¦from¦ ¦onset¦ ¦to¦ ¦death¦ ¦was¦ ¦9¦ . ¦5¦ ▁( ¦4¦ . ¦8¦ - ¦13¦ )▁ ¦days¦ .
𐋇¦people¦ ¦have¦ ¦tested¦ ¦positive¦ ¦for¦ ¦the¦ ¦disease¦ ¦up¦ ¦to¦ ¦three¦ ¦days¦ ¦before¦ ¦onset¦ ¦of¦ ¦symptoms¦ ¦suggesting¦ ¦transmission¦ ¦is¦ ¦possible¦ ¦before¦ ¦developing¦ ¦significant¦ ¦symptoms¦ .
𐋇¦the¦ ¦virus¦ ¦can¦ ¦spread¦ ¦to¦ ¦different¦ ¦organs¦ ¦throughout¦ ¦the¦ ¦ch ic ken¦ .
𐋇¦the¦ ¦authorities¦ ¦also¦ ¦announced¦ ¦the¦ ¦construction¦ ¦of¦ ¦a¦ ¦temporary¦ ¦hospital¦ ,▁ 𐋇¦hu os he ns han¦ 𐋇¦hospital¦ ,▁ ¦which¦ ¦was¦ ¦completed¦ ¦in¦ ¦10¦ ¦days¦ .
𐋇 ¦int ri gu i ngly¦ ,▁ ¦sera¦ ¦of¦ ¦convalescent¦ 𐊣¦sars¦𐊼 ¦patients¦ ¦were¦ ¦capable¦ ¦of¦ ¦neutr a lizing¦ 𐊣¦wiv𐊼1¦ .
𐋇¦to¦ ¦further¦ ¦alleviate¦ ¦the¦ ¦shortage¦ ,▁ 𐋇¦coles¦ ¦ordered¦ ¦b ig ger¦ ¦p ack ages¦ ¦from¦ ¦suppliers¦ ¦and¦ ¦increased¦ ¦delivery¦ ¦fre qu ency¦ ,▁ 𐋇¦woolworths¦ ¦ordered¦ ¦extra¦ ¦stock¦ ,▁ ¦while¦ 𐊣¦a ld i¦𐊼 ¦made¦ ¦stocks¦ ¦for¦ ¦a¦ ¦planned¦ 𐋇¦wednesday¦ ¦special¦ ¦available¦ ¦early¦ .
𐋇¦there¦ ¦are¦ ¦two¦ ¦types¦ ¦of¦ ¦can ine¦ ¦coronavirus¦ ▁( 𐊣¦c c𐊼 o 𐋇v¦ ),▁ ¦one¦ ¦that¦ ¦causes¦ ¦mild¦ ¦gastrointestinal¦ ¦disease¦ ¦and¦ ¦one¦ ¦that¦ ¦has¦ ¦been¦ ¦found¦ ¦to¦ ¦cause¦ ¦respiratory¦ ¦disease¦ .
𐋇¦while¦ ¦int act¦ 𐊣¦orf𐊼 4¦ ¦could¦ ¦be¦ ¦observed¦ ¦in¦ ¦bat¦ ¦and¦ ¦c am el¦ ¦viruses¦ ¦related¦ ¦to¦ 𐊣¦hc𐊼o𐋇v¦ - ¦229𐋇e¦ ,▁ ¦the¦ ¦alpac a¦ ¦alpha¦ - 𐋇¦co𐋇v¦ ¦disp l ays¦ ¦a¦ ¦single¦ ¦nucleotide¦ ¦ins er tion¦ ,▁ ¦resulting¦ ¦in¦ ¦a¦ ¦fr am es hi ft¦ .
𐋇¦some¦ ¦countries¦ ¦in¦ 𐋇¦africa¦ ¦have¦ ¦also¦ ¦seen¦ ¦a¦ ¦rise¦ ¦in¦ ¦anti¦ - 𐋇¦chinese¦ ¦senti ment¦ .
𐋇¦these¦ ¦camels¦ ¦serve¦ ¦as¦ ¦an¦ ¦important¦ ¦tool¦ ¦for¦ ¦transportation¦ ¦as¦ ¦well¦ ¦as¦ ¦a¦ ¦main¦ ¦source¦ ¦of¦ ¦meat¦ ,▁ ¦milk¦ ,▁ ¦lea ther¦ ¦and¦ ¦wo ol¦ ¦products¦ ¦for¦ ¦the¦ ¦local¦ ¦people¦ .
𐋇¦however¦ ,▁ ¦their¦ ¦work¦ ¦also¦ ¦needs¦ ¦update¦ ¦according¦ ¦to¦ ¦the¦ ¦latest¦ 𐋇¦diagnosis¦ ¦and¦ 𐋇¦treatment¦ 𐋇¦guidelines¦ ¦for¦ 𐊣¦covid¦𐊼 - ¦19¦ ▁( 𐋇¦trial¦ ¦sevent h¦ ¦version¦ )▁ ¦and¦ ¦recently¦ ¦studies¦ .
𐋇¦coronaviruses¦ ¦can¦ ¦cause¦ ¦colds¦ ¦with¦ ¦major¦ ¦symptoms¦ ,▁ ¦such¦ ¦as¦ ¦fever¦ ,▁ ¦and¦ ¦a¦ ¦sore¦ ¦throat¦ ¦from¦ ¦sw o llen¦ ¦aden oids¦ .
𐋇¦a¦ ¦study¦ ¦published¦ ¦by¦ ¦the¦ 𐊣¦us¦𐊼 𐋇¦center¦ ¦for¦ 𐋇¦disease¦ 𐋇¦control¦ ¦and¦ 𐋇¦prevention¦ ¦has¦ ¦concluded¦ ¦that¦ ¦it¦ ¦may¦ ¦be¦ ¦5¦ . ¦7¦ .
𐋇¦however¦ ,▁ ¦it¦ ¦is¦ ¦more¦ ¦pathogenic¦ ¦than¦ ¦community¦ - ¦acquired¦ 𐊣¦hc𐊼o𐋇vs¦ ¦and¦ ¦less¦ ¦pathogenic¦ ¦than¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ ¦or¦ 𐊣¦mers¦𐊼 - 𐋇¦co𐋇v¦ .
𐋇¦at¦ ¦least¦ ¦52¦ ¦thousand¦ ¦deaths¦ ¦were¦ ¦linked¦ ¦to¦ 𐊣¦covid¦𐊼 - ¦19¦ ,▁ ¦the¦ ¦disease¦ ¦caused¦ ¦by¦ ¦the¦ ¦coronavirus¦ .
𐋇¦four¦ ¦of¦ ¦these¦ ¦coronaviruses¦ ¦continu ally¦ ¦circ ul ate¦ ¦in¦ ¦the¦ ¦human¦ ¦population¦ ¦and¦ ¦produce¦ ¦the¦ ¦generally¦ ¦mild¦ ¦symptoms¦ ¦of¦ ¦the¦ ¦common¦ ¦cold¦ ¦in¦ ¦adults¦ ¦and¦ ¦children¦ ¦worldwide¦ : ▁- 𐊣¦oc43¦ , ▁- ¦h ku 1¦ ,▁ ¦hc𐊼o𐋇v¦ - ¦229𐋇e¦ , ▁- 𐊣¦nl𐊼63¦ .
𐋇¦as¦ ¦of¦ 𐋇¦april¦ ¦7¦ ,▁ ¦2020¦ ,▁ ¦only¦ ¦a¦ ¦single¦ ¦test¦ ¦has¦ ¦been¦ ¦approved¦ ¦by¦ ¦the¦ 𐊣¦fda¦𐊼 ¦under¦ ¦an¦ ¦emergency¦ ¦use¦ ¦authorization¦ . 𐋇¦in¦ ¦late¦ 𐋇¦march¦ ¦2020¦ ,▁ 𐋇¦ eu ro im mun ¦ 𐋇¦medical¦ 𐋇¦laboratory¦ 𐋇¦diagno stics¦ ¦and¦ 𐋇 ¦ep it ope¦ 𐋇¦diagno stics¦ ¦received¦ 𐋇¦european¦ ¦appro v als¦ ¦for¦ ¦their¦ ¦test¦ ¦kits¦ ,▁ ¦which¦ ¦can¦ ¦detect¦ 𐋇¦ig𐋇g¦ ¦and¦ 𐋇¦ig𐋇 a¦ ¦antibodies¦ ¦against¦ ¦the¦ ¦virus¦ ¦in¦ ¦blood¦ ¦samples¦ .
𐋇 ¦zoonotic¦ ¦origins¦ ¦of¦ ¦human¦ ¦coronaviruses¦
𐋇¦anyone¦ ¦in¦ ¦the¦ ¦family¦ ¦have¦ ¦a¦ ¦heart¦ ¦problem¦ ¦heart¦ ¦disease¦ ¦heart¦ ¦attack¦ ¦high¦ ¦ch oles ter ol¦ ¦high¦ ¦blood¦ ¦pressure¦
𐋇 ¦show¦ ¦me¦ ¦on¦ ¦this¦ ¦image¦ ¦where¦ ¦you¦ ¦feel¦ ¦the¦ ¦pain¦
𐋇¦all¦ ¦of¦ ¦them¦ ¦had¦ ¦live¦ ¦birth¦ ¦p reg na ncies¦ ¦and¦ ¦no¦ ¦severe¦ ¦neo na tal¦ ¦as phy xi a¦ ¦was¦ ¦observed¦ .
𐋇¦in¦ ¦contrast¦ ,▁ ¦highly¦ ¦pathogenic¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ ¦and¦ 𐊣¦mers¦𐊼 - 𐋇¦co𐋇v¦ ¦have¦ ¦not¦ ¦adapted¦ ¦to¦ ¦humans¦ ¦well¦ ¦and¦ ¦their¦ ¦transmission¦ ¦within¦ ¦humans¦ ¦cannot¦ ¦be¦ ¦susta ined¦ .
𐋇¦b¦ ' 𐋇¦coronaviruses¦ ¦are¦ ¦a¦ ¦group¦ ¦of¦ ¦related¦ ¦viruses¦ ¦that¦ ¦cause¦ ¦diseases¦ ¦in¦ ¦mammals¦ ¦and¦ ¦birds¦ .
𐋇¦three¦ ¦feet¦ ¦is¦ ¦considered¦ ¦an¦ ¦appropriate¦ ¦distance¦ ¦for¦ ¦people¦ ¦to¦ ¦stay¦ ¦away¦ ¦from¦ ¦a¦ ¦patient¦ .
𐋇¦from¦ ¦another¦ ¦per sp ective¦ ,▁ ¦it¦ ¦might¦ ¦also¦ ¦be¦ ¦true¦ ¦that¦ ¦humans¦ ¦have¦ ¦been¦ ¦well¦ ¦adapted¦ ¦to¦ ¦these¦ ¦four¦ 𐊣¦hc𐊼o𐋇vs¦ .
𐋇¦as¦ ¦of¦ 𐋇¦thursday¦ ,▁ 𐋇 ¦associated¦ 𐋇¦press¦ ¦reported¦ ¦there¦ ¦were¦ ¦at¦ ¦least¦ ¦12 6¦ , ¦000¦ ¦cases¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦worldwide¦ ,▁ ¦resulting¦ ¦in¦ ¦over¦ ¦4¦ , ¦600¦ ¦deaths¦ .
𐋇¦china¦ ¦has¦ ¦also¦ ¦called¦ ¦for¦ ¦the¦ 𐊣¦us¦𐊼 ¦to¦ ¦li ft¦ ¦its¦ ¦sanctions¦ ¦off¦ ¦of¦ 𐋇 ¦sy ria¦ ,▁ 𐋇¦ve ne z u e la¦ ¦and¦ 𐋇¦iran¦ ,▁ ¦while¦ ¦reportedly¦ ¦sending¦ ¦aid¦ ¦to¦ ¦the¦ ¦l at ter¦ ¦two¦ ¦countries¦ .
𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦causes¦ ¦severe¦ ¦respiratory¦ ¦infection¦ ¦like¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ ¦and¦ 𐊣¦mers¦𐊼 - 𐋇¦co𐋇v¦ ,▁ ¦presented¦ ¦as¦ ¦fever¦ ,▁ ¦cough¦ ¦and¦ ¦dyspnea¦ .
𐋇¦meanwhile¦ ,▁ ¦the¦ ¦epidemic¦ ¦rapidly¦ ¦spread¦ ¦to¦ ¦the¦ ¦neigh bo ring¦ ¦cities¦ ,▁ ¦provinces¦ ,▁ ¦and¦ ¦countries¦ .
𐋇 ¦sports¦ ¦events¦ ¦and¦ ¦se as ons¦ ¦were¦ ¦cancelled¦ . 𐋇¦on¦ ¦11¦ 𐋇¦march¦ ,▁ 𐋇¦trump¦ ¦announced¦ ¦travel¦ ¦restrictions¦ ¦for¦ ¦most¦ ¦of¦ 𐋇¦europe¦ ,▁ ¦excluding¦ ¦the¦ 𐋇¦united¦ 𐋇¦kingdom¦ ,▁ ¦for¦ ¦30¦ ¦days¦ ,▁ ¦effective¦ ¦13¦ 𐋇¦march¦ .
𐋇¦by¦ ¦13¦ 𐋇¦march¦ ,▁ ¦more¦ ¦than¦ ¦for ty¦ ¦countries¦ ¦and¦ ¦territories¦ ¦had¦ ¦reported¦ ¦deaths¦ ,▁ ¦on¦ ¦every¦ ¦cont in ent¦ ¦except¦ 𐋇¦ ant ar ct ic a¦ . 𐋇¦several¦ ¦measures¦ ¦are¦ ¦commonly¦ ¦used¦ ¦to¦ ¦qu anti fy¦ ¦mortality¦ .
𐋇¦i ra¦ 𐋇¦lo ng ini¦ ,▁ ¦et¦ ¦al¦ .,▁ ¦established¦ ¦a¦ ¦model¦ ¦to¦ ¦predict¦ ¦the¦ ¦outcome¦ ¦of¦ ¦the¦ ¦epidemic¦ ¦and¦ ¦suggested¦ ¦that¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦could¦ ¦infect¦ ¦two¦ - ¦thirds¦ ¦of¦ ¦the¦ ¦global¦ ¦population¦ .
𐋇¦on¦ ¦31¦ 𐋇¦december¦ ¦2019¦ ,▁ ¦the¦ ¦outbreak¦ ¦was¦ ¦traced¦ ¦to¦ ¦a¦ ¦novel¦ ¦strain¦ ¦of¦ ¦coronavirus¦ ,▁ ¦which¦ ¦was¦ ¦given¦ ¦the¦ ¦interim¦ ¦name¦ ¦2019¦ - ¦n𐋇co𐋇v¦ ¦by¦ ¦the¦ 𐋇¦world¦ 𐋇¦health¦ 𐋇¦organization¦ ▁( 𐊣¦who¦𐊼 ),▁ ¦later¦ ¦re na med¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦by¦ ¦the¦ 𐋇¦international¦ 𐋇¦committee¦ ¦on¦ 𐋇¦ta x o no my¦ ¦of¦ 𐋇 ¦viruses¦ .
𐋇¦follow¦ - ¦up¦ ¦im ages¦ ¦after¦ ¦delivery¦ ¦showed¦ ¦no¦ ¦progression¦ ¦of¦ ¦pneumonia¦ . 𐋇¦media¦ ¦reports¦ ¦indicate¦ ¦that¦ ¦over¦ ¦100¦ ¦women¦ ¦with¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦might¦ ¦have¦ ¦delivered¦ ,▁ ¦and¦ ¦in¦ 𐋇¦march¦ ¦2020¦ ,▁ ¦no¦ ¦ma ter nal¦ ¦deaths¦ ¦were¦ ¦reported¦ .
𐋇¦as¦ ¦mainland¦ 𐋇¦china¦ ¦is¦ ¦a¦ ¦major¦ ¦economy¦ ¦and¦ ¦manufacturing¦ ¦hu b¦ ,▁ ¦the¦ ¦viral¦ ¦outbreak¦ ¦has¦ ¦been¦ ¦seen¦ ¦to¦ ¦p ose¦ ¦a¦ ¦major¦ ¦des ta bi lizing¦ ¦threat¦ ¦to¦ ¦the¦ ¦global¦ ¦economy¦ .
𐋇¦in¦ 𐋇¦china¦ ,▁ ¦estimates¦ ¦for¦ ¦the¦ ¦death¦ - ¦to¦ - ¦case¦ ¦ratio¦ ¦decreased¦ ¦from¦ ¦17¦ . ¦3¦ %▁( ¦for¦ ¦those¦ ¦with¦ ¦symptom¦ ¦onset¦ ¦1¦ – ¦10¦ 𐋇¦january¦ ¦2020¦ )▁ ¦to¦ ¦0¦ . ¦7¦ %▁( ¦for¦ ¦those¦ ¦with¦ ¦symptom¦ ¦onset¦ ¦after¦ ¦1¦ 𐋇¦february¦ ¦2020¦ ). 𐋇¦other¦ ¦measures¦ ¦include¦ ¦the¦ ¦case¦ ¦fatality¦ ¦rate¦ ▁( 𐊣¦cf r¦𐊼 ),▁ ¦which¦ ¦reflects¦ ¦the¦ ¦percent¦ ¦of¦ ¦diagnosed¦ ¦people¦ ¦who¦ ¦die¦ ¦from¦ ¦a¦ ¦disease¦ ,▁ ¦and¦ ¦the¦ ¦infection¦ ¦fatality¦ ¦rate¦ ▁( 𐊣¦if r¦𐊼 ),▁ ¦which¦ ¦reflects¦ ¦the¦ ¦percent¦ ¦of¦ ¦infected¦ ▁( ¦diagnosed¦ ¦and¦ ¦un dia gn osed¦ )▁ ¦who¦ ¦die¦ ¦from¦ ¦a¦ ¦disease¦ .
𐋇¦currently¦ ,▁ ¦due¦ ¦to¦ ¦the¦ ¦lack¦ ¦of¦ ¦effective¦ ¦and¦ ¦specific¦ ¦therapy¦ ¦for¦ 𐊣¦covid¦ - ¦19¦ ,▁ ¦t c m¦𐊼 ¦has¦ ¦become¦ ¦one¦ ¦of¦ ¦the¦ ¦major¦ ¦alternative¦ ¦treatments¦ ¦for¦ ¦patients¦ ¦with¦ ¦light¦ ¦to¦ ¦moderate¦ ¦symptoms¦ ¦or¦ ¦for¦ ¦those¦ ¦who¦ ¦have¦ ¦recovered¦ ¦from¦ ¦severe¦ ¦stages¦ .
𐋇¦thailand¦ ¦is¦ ¦using¦ ¦an¦ ¦app¦ ¦and¦ 𐊣 ¦si m¦𐊼 ¦cards¦ ¦for¦ ¦all¦ ¦travelers¦ ¦to¦ ¦enforce¦ ¦their¦ ¦quarantine¦ .
𐋇¦more¦ ¦than¦ ¦30¦ %▁ ¦of¦ ¦patients¦ ¦present¦ ¦with¦ ¦gastrointestinal¦ ¦symptoms¦ ,▁ ¦such¦ ¦as¦ ¦diarrhea¦ ¦and¦ ¦vomiting¦ .
𐋇 ¦misinformation¦ ¦about¦ ¦the¦ ¦virus¦ ¦has¦ ¦spread¦ ¦online¦ ,▁ ¦and¦ ¦there¦ ¦have¦ ¦been¦ ¦incidents¦ ¦of¦ ¦xenophobia¦ ¦and¦ ¦discrimination¦ ¦against¦ 𐋇¦chinese¦ ¦people¦ ,▁ ¦other¦ ¦people¦ ¦of¦ 𐋇¦east¦ ¦and¦ 𐋇¦s outh east¦ 𐋇¦asian¦ ¦desc ent¦ ¦and¦ ¦appe ar ance¦ ,▁ ¦and¦ ¦others¦ ¦from¦ ¦areas¦ ¦with¦ ¦significant¦ ¦virus¦ ¦cases¦ .
𐋇 ¦adaptive¦ ¦design s¦ ¦within¦ ¦ongoing¦ 𐋇¦phase¦ 𐊣¦i i¦ - ¦i i i¦𐊼 ¦clinical¦ ¦trials¦ ¦on¦ ¦candidate¦ ¦therap eut ics¦ ¦may¦ ¦short en¦ ¦trial¦ ¦d ur ations¦ ¦and¦ ¦use¦ ¦fewer¦ ¦sub j ects¦ ,▁ ¦possibly¦ ¦exp e di ting¦ ¦decisions¦ ¦for¦ ¦early¦ ¦termin ation¦ ¦or¦ ¦success¦ ,▁ ¦and¦ ¦coordinating¦ ¦design¦ ¦changes¦ ¦for¦ ¦a¦ ¦specific¦ ¦trial¦ ¦across¦ ¦its¦ ¦international¦ ¦locations¦ .
𐋇¦the¦ ¦upper¦ ¦estimate¦ ¦of¦ ¦this¦ ¦range¦ ¦is¦ ¦consistent¦ ¦with¦ ¦the¦ ¦results¦ ¦from¦ ¦the¦ ¦first¦ ¦rando m¦ ¦testing¦ ¦for¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦in¦ 𐋇¦germany¦ ,▁ ¦and¦ ¦a¦ ¦statistical¦ ¦study¦ ¦analy sing¦ ¦the¦ ¦impact¦ ¦of¦ ¦testing¦ ¦on¦ 𐊣¦cf r¦𐊼 ¦estimates¦ .
𐋇¦other¦ ¦countries¦ ¦also¦ ¦adopted¦ ¦a¦ ¦variety¦ ¦of¦ ¦measures¦ ¦aimed¦ ¦at¦ ¦limiting¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇¦some¦ ¦scientists¦ ¦ch ose¦ ¦to¦ ¦share¦ ¦their¦ ¦results¦ ¦quickly¦ ¦on¦ ¦pre pr int¦ ¦ser vers¦ ¦such¦ ¦as¦ ¦bio 𐋇r xi v¦ .
𐊣¦covid¦𐊼 - ¦19¦ ¦cases¦ ¦in¦ 𐊣¦eu¦ / ¦eea¦𐊼 ¦countries¦ ¦and¦ ¦the¦ 𐊣¦uk¦𐊼
𐋇¦both¦ ¦drugs¦ ¦have¦ ¦extensive¦ ¦inter actions¦ ¦with¦ ¦prescrip tion¦ ¦drugs¦ ,▁ ¦affecting¦ ¦the¦ ¦therapeutic¦ ¦dose¦ ¦and¦ ¦disease¦ ¦mitigation¦ .
𐋇¦although¦ ¦bats¦ ¦have¦ ¦many¦ ¦features¦ ¦that¦ ¦fav ours¦ ¦the¦ ¦spreading¦ ¦of¦ ¦viruses¦ ,▁ ¦the¦ ¦chance¦ ¦for¦ ¦humans¦ ¦to¦ ¦be¦ ¦in¦ ¦contact¦ ¦with¦ ¦bats¦ ¦and¦ ¦other¦ ¦wi ld li fe¦ ¦species¦ ¦can¦ ¦be¦ ¦minim ized¦ ¦if¦ ¦people¦ ¦are¦ ¦ed ucated¦ ¦to¦ ¦stay¦ ¦away¦ ¦from¦ ¦them¦ .
𐋇¦finally¦ ,▁ ¦alpac a¦ ¦alpha¦ - 𐋇¦co𐋇v¦ ¦has¦ ¦not¦ ¦been¦ ¦found¦ ¦in¦ ¦fer al¦ ¦animals¦ .
𐋇¦many¦ ¦d io ce ses¦ ¦have¦ ¦recommended¦ ¦older¦ 𐋇¦christi ans¦ ¦to¦ ¦stay¦ ¦at¦ ¦home¦ ¦rather¦ ¦than¦ ¦attending¦ 𐋇 ¦mass¦ ¦on¦ 𐋇¦s und ays¦ ;▁ ¦some¦ ¦chur ches¦ ¦have¦ ¦made¦ ¦chur ch¦ ¦services¦ ¦available¦ ¦via¦ ¦radi o¦ ,▁ ¦online¦ ¦live¦ ¦st reaming¦ ¦or¦ ¦televi sion¦ ¦while¦ ¦others¦ ¦are¦ ¦offering¦ ¦drive¦ - ¦in¦ ¦worship¦ .
𐋇 ¦ten¦ ¦years¦ ¦later¦ ,▁ ¦the¦ 𐋇¦middle¦ 𐋇¦east¦ ¦respiratory¦ ¦syndrome¦ ▁( 𐊣¦mers¦𐊼 )▁ ¦outbreak¦ ¦resulted¦ ¦in¦ ¦a¦ ¦persistent¦ ¦epidemic¦ ¦in¦ ¦the¦ 𐋇¦ ara bi an¦ 𐋇¦pe ni ns ula¦ ¦with¦ ¦spo rad ic¦ ¦spreading¦ ¦to¦ ¦the¦ ¦rest¦ ¦of¦ ¦the¦ ¦world¦ .
𐋇¦only¦ ¦few¦ ¦reports¦ ¦of¦ ¦laboratory¦ - ¦confirmed¦ ¦asymptomatic¦ ¦cases¦ ¦exist¦ ,▁ ¦but¦ ¦asymptomatic¦ ¦transmission¦ ¦has¦ ¦been¦ ¦identified¦ ¦by¦ ¦some¦ ¦countries¦ ¦during¦ ¦contact¦ ¦tracing¦ ¦investigations¦ .
𐋇¦the¦ ¦host¦ ¦ rib oso me¦ ¦transl ates¦ ¦the¦ ¦initial¦ ¦overlapping¦ ¦open¦ ¦reading¦ ¦fra me¦ ¦of¦ ¦the¦ ¦virus¦ ¦genome¦ ¦and¦ ¦forms¦ ¦a¦ ¦long¦ ¦polyp rotein¦ .
𐋇¦on¦ ¦29¦ 𐋇¦march¦ ¦it¦ ¦was¦ ¦reported¦ ¦that¦ ¦beginning¦ ¦1¦ 𐋇¦april¦ ¦all¦ ¦new¦ ¦over se as¦ ¦ar ri v als¦ ¦will¦ ¦be¦ ¦quarantined¦ ¦for¦ ¦two¦ ¦weeks¦ .
𐋇¦most¦ ¦novel¦ ¦drug¦ ¦candidates¦ ▁( 𐊣¦n ce 𐊼s¦ )▁ ¦fa il¦ ¦during¦ ¦drug¦ ¦development¦ ,▁ ¦either¦ ¦because¦ ¦they¦ ¦have¦ ¦un ac ce pt able¦ ¦tox icity¦ ¦or¦ ¦because¦ ¦they¦ ¦simply¦ ¦do¦ ¦not¦ ¦prove¦ ¦efficacy¦ ¦on¦ ¦the¦ ¦targeted¦ ¦disease¦ ,▁ ¦as¦ ¦shown¦ ¦in¦ 𐋇¦phase¦ 𐊣¦i i¦ - ¦i i i¦𐊼 ¦clinical¦ ¦trials¦ .
𐊣¦eu¦𐊼 ¦foreign¦ ¦policy¦ ¦chief¦ 𐋇¦jo se p¦ 𐋇¦b orr ell¦ ¦warned¦ ¦that¦ ¦there¦ ¦is¦ ▁" ¦a¦ ¦ge o¦ - ¦political¦ ¦comp on ent¦ ¦including¦ ¦a¦ ¦struggle¦ ¦for¦ ¦influence¦ ¦through¦ ¦sp inning¦ ¦and¦ ¦the¦ ▁' ¦politics¦ ¦of¦ ¦gener os ity¦ ' ".
𐋇¦although¦ ¦several¦ ¦countries¦ ¦use¦ ¦chloroquine¦ ¦or¦ ¦hydroxychloroquine¦ ¦for¦ ¦treatment¦ ¦of¦ ¦persons¦ ¦hospitalized¦ ¦with¦ 𐊣¦covid¦𐊼 - ¦19¦ ,▁ ¦as¦ ¦of¦ 𐋇¦march¦ ¦2020¦ ¦the¦ ¦drug¦ ¦has¦ ¦not¦ ¦been¦ ¦form ally¦ ¦approved¦ ¦through¦ ¦clinical¦ ¦trials¦ ¦in¦ ¦the¦ 𐋇¦united¦ 𐋇¦states¦ .
𐋇¦nevert heless¦ ,▁ ¦respiratory¦ ¦d ys f un ction¦ ¦and¦ ¦failure¦ ¦are¦ ¦the¦ ¦major¦ ¦threat¦ ¦to¦ ¦the¦ ¦patients¦ ¦and¦ ¦the¦ ¦major¦ ¦cause¦ ¦of¦ ¦death¦ .
𐋇¦first¦ ,▁ ¦humans¦ ¦but¦ ¦not¦ ¦alpac as¦ ¦might¦ ¦have¦ ¦contact¦ ¦with¦ ¦bats¦ ¦in¦ ¦a¦ ¦shared¦ ¦e co logical¦ ¦ni che¦ .
𐋇¦it¦ ¦has¦ ¦been¦ ¦reported¦ ¦that¦ ¦a¦ ¦bat¦ 𐋇¦co𐋇v¦ ¦ter med¦ 𐊣¦ar c𐊼 o 𐋇v¦ . ¦2¦ ▁( 𐋇 ¦ap pa la chi an¦ 𐋇¦r idge¦ 𐋇¦co𐋇v¦ )▁ ¦detected¦ ¦in¦ 𐋇¦north¦ 𐋇¦american¦ ¦tric ol ored¦ ¦bat¦ ¦dis pla yed¦ ¦close¦ ¦relationship¦ ¦with¦ 𐊣¦hc𐊼o𐋇v¦ - 𐊣¦nl𐊼63¦ .
𐋇 ¦virological¦ ¦surveillance¦ ¦is¦ ¦done¦ ¦by¦ ¦using¦ ¦molecular¦ ¦tests¦ ¦for¦ 𐊣¦covid¦𐊼 - ¦19¦ .
𐋇¦there¦ ¦has¦ ¦been¦ ¦support¦ ¦for¦ ¦the¦ 𐋇¦chinese¦ ,▁ ¦both¦ ¦on¦ ¦and¦ ¦offline¦ ,▁ ¦and¦ ¦towards¦ ¦those¦ ¦in¦ ¦virus¦ - ¦stric ken¦ ¦areas¦ .
𐋇 ¦viruses¦ ¦can¦ ¦also¦ ¦infect¦ ¦an¦ ¦individual¦ ¦through¦ ¦the¦ ¦eyes¦ .
𐋇¦on¦ ¦20¦ 𐋇¦march¦ ,▁ ¦the¦ 𐋇¦united¦ 𐋇¦states¦ ¦began¦ ¦to¦ ¦parti ally¦ ¦withdraw al¦ ¦its¦ ¦tr oo ps¦ ¦from¦ 𐋇¦iraq¦ ¦due¦ ¦to¦ ¦the¦ ¦pandemic¦ .
𐋇¦as¦ ¦a¦ ¦result¦ ,▁ ¦the¦ ¦government¦ ¦received¦ ¦criticism¦ ¦for¦ ¦the¦ ¦per cei ved¦ ¦lack¦ ¦of¦ ¦pace¦ ¦and¦ ¦intensity¦ ¦in¦ ¦its¦ ¦response¦ ¦to¦ ¦concerns¦ ¦faced¦ ¦by¦ ¦the¦ ¦public¦ . 𐋇¦on¦ ¦16¦ 𐋇¦march¦ ,▁ 𐋇¦prime¦ 𐋇¦minister¦ 𐋇¦boris¦ 𐋇¦johnson¦ ¦made¦ ¦an¦ ¦announcement¦ ¦adv ising¦ ¦against¦ ¦all¦ ¦non¦ - ¦essential¦ ¦travel¦ ¦and¦ ¦social¦ ¦contact¦ ,▁ ¦suggesting¦ ¦people¦ ¦work¦ ¦from¦ ¦home¦ ¦where¦ ¦possible¦ ¦and¦ ¦avoid¦ ¦v enu es¦ ¦such¦ ¦as¦ ¦pu bs¦ ,▁ ¦restaurants¦ ,▁ ¦and¦ ¦th ea tres¦ .
𐋇¦on¦ ¦11¦ 𐋇¦march¦ ¦2020¦ ,▁ 𐊣¦who¦𐊼 ¦characteri zed¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦as¦ ¦a¦ ¦pandemic¦ .
𐋇¦for¦ ¦example¦ ,▁ 𐋇¦be ij ing¦ ¦has¦ ¦imposed¦ ¦a¦ ¦14¦ - ¦day¦ ¦mandatory¦ ¦quarantine¦ ¦for¦ ¦all¦ ¦international¦ ¦travellers¦ ¦entering¦ ¦the¦ ¦city¦ . 𐋇¦on¦ ¦23¦ 𐋇¦march¦ ,▁ ¦mainland¦ 𐋇¦china¦ ¦only¦ ¦one¦ ¦case¦ ¦had¦ ¦transmitted¦ ¦d om es tically¦ ¦in¦ ¦the¦ ¦five¦ ¦days¦ ¦prior¦ ,▁ ¦in¦ ¦this¦ ¦instance¦ ¦via¦ ¦a¦ ¦trave ller¦ ¦returning¦ ¦to¦ 𐋇¦guang z hou¦ ¦from¦ 𐋇¦i stan b ul¦ .
𐋇¦in¦ ¦the¦ ¦past¦ ¦decades¦ ,▁ ¦seven¦ 𐊣¦hc𐊼o𐋇vs¦ ¦have¦ ¦been¦ ¦identified¦ .
𐋇¦bat¦ ¦alpha¦ - 𐋇¦co𐋇vs¦ ¦closely¦ ¦related¦ ¦to¦ 𐊣¦hc𐊼o𐋇v¦ - ¦229𐋇e¦ ¦have¦ ¦been¦ ¦found¦ .
𐋇¦however¦ ,▁ ¦on¦ ¦12¦ 𐋇¦may¦ ¦2013¦ ,▁ ¦a¦ ¦case¦ ¦of¦ ¦human¦ - ¦to¦ - ¦human¦ ¦transmission¦ ¦in¦ 𐋇¦france¦ ¦was¦ ¦confirmed¦ ¦by¦ ¦the¦ 𐋇¦french¦ 𐋇¦ministry¦ ¦of¦ 𐋇¦social¦ 𐋇¦affairs¦ ¦and¦ 𐋇¦health¦ .
𐋇¦the¦ 𐋇¦italian¦ 𐋇¦rad io logical¦ 𐋇¦society¦ ¦is¦ ¦com pi ling¦ ¦an¦ ¦international¦ ¦online¦ ¦d atab ase¦ ¦of¦ ¦imaging¦ ¦findings¦ ¦for¦ ¦confirmed¦ ¦cases¦ .
𐋇¦on¦ ¦28¦ 𐋇¦february¦ ,▁ 𐋇 ¦scope¦ 𐋇¦r at ings¦ 𐋇¦g mb 𐋇 h¦ ¦affi r med¦ 𐋇¦china¦ ' ¦s¦ ¦so ve re ig n¦ ¦credit¦ ¦r ating¦ ,▁ ¦but¦ ¦maintained¦ ¦a¦ 𐋇 ¦negative¦ 𐋇 ¦out l ook¦ .
𐋇¦the¦ ¦epidemic¦ ¦co in ci ded¦ ¦with¦ ¦the¦ 𐋇¦ch un yu n¦ ,▁ ¦a¦ ¦major¦ ¦travel¦ ¦season¦ ¦associated¦ ¦with¦ ¦the¦ 𐋇¦chinese¦ 𐋇¦new¦ 𐋇¦year¦ ¦holiday¦ .
𐋇¦the¦ ¦m il est one¦ ¦came¦ ¦the¦ ¦same¦ ¦day¦ 𐋇¦ma la w i¦ ¦confirmed¦ ¦its¦ ¦first¦ ¦coronavirus¦ ¦infections¦ ¦and¦ 𐋇¦z am bia¦ ¦had¦ ¦its¦ ¦first¦ ¦coronavirus¦ - ¦related¦ ¦death¦ .
𐋇¦the¦ ¦virus¦ ¦that¦ ¦caused¦ ¦the¦ ¦outbreak¦ ¦is¦ ¦known¦ ¦as¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ,▁ ¦a¦ ¦newly¦ ¦discovered¦ ¦virus¦ ¦closely¦ ¦related¦ ¦to¦ ¦bat¦ ¦coronaviruses¦ ,▁ ¦pangolin¦ ¦coronaviruses¦ ,▁ ¦and¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ . 𐋇¦the¦ ¦earliest¦ ¦known¦ ¦person¦ ¦with¦ ¦symptoms¦ ¦was¦ ¦later¦ ¦discovered¦ ¦to¦ ¦have¦ ¦fa llen¦ ¦ill¦ ¦on¦ ¦1¦ 𐋇¦december¦ ¦2019¦ ,▁ ¦and¦ ¦that¦ ¦person¦ ¦did¦ ¦not¦ ¦have¦ ¦visible¦ ¦connections¦ ¦with¦ ¦the¦ ¦later¦ ¦wet¦ ¦market¦ ¦cluster¦ .
𐋇¦thus¦ ,▁ ¦they¦ ¦are¦ ¦traditional¦ ¦mar kers¦ ¦for¦ ¦heart¦ ¦or¦ ¦liver¦ ¦d ys fu nc tions¦ .
𐋇¦in¦ 𐋇¦japan¦ ,▁ ¦the¦ ¦hashta g¦ ▁# 𐋇¦chi ne se 𐋇 do nt 𐋇co me 𐋇to 𐋇 j ap an¦ ¦tre nded¦ ¦on¦ 𐋇¦twitter¦ .
𐋇¦besides¦ ,▁ ¦there¦ ¦are¦ ¦more¦ ¦and¦ ¦more¦ ¦evidence¦ ¦that¦ ¦remin d¦ ¦us¦ ¦to¦ ¦caution¦ ¦with¦ ¦the¦ ¦at ypical¦ ¦symptomatic¦ ¦and¦ ¦asymptomatic¦ ¦patients¦ .
𐋇 ¦subsequent¦ ¦ser op re va lence¦ ¦investigations¦ ¦indicated¦ ¦that¦ ¦animal¦ ¦traders¦ ¦had¦ ¦a¦ ¦higher¦ ¦prevalence¦ ¦of¦ ¦anti¦ - 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ 𐋇¦ig𐋇g¦ ¦compared¦ ¦with¦ ¦that¦ ¦of¦ ¦the¦ ¦general¦ ¦population¦ .
𐋇¦on¦ ¦31¦ 𐋇¦december¦ ¦2019¦ ,▁ ¦a¦ ¦cluster¦ ¦of¦ ¦pneumonia¦ ¦cases¦ ¦of¦ ¦unknown¦ ¦a et iology¦ ¦was¦ ¦reported¦ ¦in¦ 𐋇¦wuhan¦ ,▁ 𐋇¦hubei¦ 𐋇¦province¦ ,▁ 𐋇¦china¦ .
𐋇¦the¦ 𐊣¦who¦𐊼 ¦noted¦ ¦the¦ ¦contrast¦ ¦between¦ ¦the¦ ¦2002¦ – ¦2004¦ 𐊣¦sars¦𐊼 ¦outbreak¦ ,▁ ¦where¦ 𐋇¦chinese¦ ¦authorities¦ ¦were¦ ¦accused¦ ¦of¦ ¦s ecr ec y¦ ¦that¦ ¦impe ded¦ ¦prevention¦ ¦and¦ ¦containment¦ ¦efforts¦ ,▁ ¦and¦ ¦the¦ ¦current¦ ¦crisis¦ ¦where¦ ¦the¦ ¦central¦ ¦government¦ ▁" ¦has¦ ¦provided¦ ¦regular¦ ¦updates¦ ¦to¦ ¦avoid¦ ¦panic¦ ¦ahead¦ ¦of¦ 𐋇¦l un ar¦ 𐋇¦new¦ 𐋇¦year¦ ¦holidays¦ ".
𐋇¦however¦ ,▁ ¦there¦ ¦are¦ ¦some¦ ¦remark able¦ ¦differences¦ ¦between¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦and¦ 𐊣¦sars¦𐊼 ,▁ ¦which¦ ¦are¦ ¦essential¦ ¦for¦ ¦containing¦ ¦the¦ ¦epidemic¦ ¦and¦ ¦treating¦ ¦the¦ ¦patients¦ .
𐋇¦patients¦ ¦often¦ ¦develop¦ ¦an¦ ¦at ypical¦ ¦pneumonia¦ ,▁ ¦acute¦ ¦lung¦ ¦injury¦ ,▁ ¦and¦ ¦acute¦ ¦respiratory¦ ¦distress¦ ¦syndrome¦ ▁( 𐊣¦ards¦𐊼 ).
𐋇¦ phy lo gen tically¦ ,▁ ¦mo use¦ ¦he p ati tis¦ ¦virus¦ ▁( 𐋇¦mur ine¦ ¦coronavirus¦ ),▁ ¦which¦ ¦infects¦ ¦the¦ ¦mo use¦ ' ¦s¦ ¦liver¦ ¦and¦ ¦the¦ ¦central¦ ¦ ner v ous¦ ¦system¦ ,▁ ¦is¦ ¦related¦ ¦to¦ ¦human¦ ¦coronavirus¦ 𐊣¦oc𐊼43¦ ¦and¦ ¦b ovine¦ ¦coronavirus¦ .
𐋇¦online¦ ,▁ ¦numerous¦ ¦coronavirus¦ - ¦the med¦ 𐋇 ¦internet¦ ¦mem es¦ ¦have¦ ¦spread¦ ¦as¦ ¦many¦ ¦turn¦ ¦to¦ ¦hum our¦ ¦and¦ ¦dist raction¦ ¦am id¦ ¦uncertainty¦ .
𐋇¦some¦ ¦of¦ ¦those¦ ¦infected¦ ¦may¦ ¦be¦ ¦asymptomatic¦ ,▁ ¦with¦ ¦no¦ ¦clinical¦ ¦symptoms¦ ¦but¦ ¦with¦ ¦test¦ ¦results¦ ¦that¦ ¦confirm¦ ¦infection¦ ,▁ ¦so¦ ¦researchers¦ ¦have¦ ¦issued¦ ¦advice¦ ¦that¦ ¦those¦ ¦with¦ ¦close¦ ¦contact¦ ¦to¦ ¦confirmed¦ ¦infected¦ ¦people¦ ¦should¦ ¦be¦ ¦closely¦ ¦monitored¦ ¦and¦ ¦examined¦ ¦to¦ ¦rule¦ ¦out¦ ¦infection¦ .
𐋇¦and¦ ¦along¦ ¦with¦ ¦a¦ ¦fever¦
𐋇 ¦led¦ ¦by¦ ¦the¦ 𐋇 ¦bill¦ ¦and¦ 𐋇¦me lin da¦ 𐋇¦g ates¦ 𐋇¦foundation¦ ¦with¦ ¦partners¦ ¦inv esting¦ 𐊣¦us¦𐊼 $ ¦1 25¦ ¦million¦ ¦and¦ ¦coordinating¦ ¦with¦ ¦the¦ 𐋇¦world¦ 𐋇¦health¦ 𐋇¦organization¦ ,▁ ¦the¦ 𐊣¦covid¦𐊼 - ¦19¦ 𐋇 ¦therap eut ics¦ 𐋇 ¦accel er ator¦ ¦began¦ ¦in¦ 𐋇¦march¦ ,▁ ¦fac ilit ating¦ ¦drug¦ ¦development¦ ¦researchers¦ ¦to¦ ¦rapidly¦ ¦identify¦ ,▁ ¦assess¦ ,▁ ¦develop¦ ,▁ ¦and¦ ¦scale¦ ¦up¦ ¦potential¦ ¦treatments¦ .
𐋇¦the¦ ¦number¦ ¦of¦ ¦true¦ ¦fat alities¦ ¦from¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦may¦ ¦be¦ ¦much¦ ¦higher¦ ,▁ ¦as¦ ¦it¦ ¦may¦ ¦not¦ ¦include¦ ¦people¦ ¦who¦ ¦die¦ ¦without¦ ¦testing¦ ▁-▁ ¦e¦ . ¦g¦ .▁ ¦at¦ ¦home¦ ,▁ ¦in¦ ¦nursing¦ ¦homes¦ ,▁ ¦etc¦ .
𐋇 ¦certain ly¦ ,▁ ¦this¦ ¦is¦ ¦not¦ ¦a¦ ¦good¦ ¦sign¦ ¦of¦ 𐋇¦european¦ ¦solidarity¦ ."
𐋇¦a¦ ¦median¦ ¦cost¦ ¦estimate¦ ¦of¦ ¦2015¦ - ¦16¦ ¦trials¦ ¦for¦ ¦development¦ ¦of¦ ¦10¦ ¦anti¦ - ¦cancer¦ ¦drugs¦ ¦was¦ ▁$ ¦64 8¦ ¦million¦ .
𐋇¦in¦ ¦addition¦ ,▁ ¦given¦ ¦the¦ ¦therapeutic¦ ¦effects¦ ,▁ ¦some¦ ¦dis ad v ant ages¦ ¦associated¦ ¦with¦ ¦the¦ ¦plasma¦ ¦should¦ ¦be¦ ¦considered¦ ¦carefully¦ .
𐋇¦the¦ 𐋇 ¦campaign¦ ¦for¦ 𐋇¦n ucle ar¦ 𐋇 ¦dis ar ma ment¦ ' ¦s¦ ¦general¦ ¦secretary¦ 𐋇¦k ate¦ 𐋇¦h ud s on¦ ¦criticized¦ ¦the¦ 𐋇¦def ender¦ ¦2020¦ ¦exercise¦ :▁" 𐋇¦in¦ ¦the¦ ¦current¦ ¦public¦ - ¦health¦ ¦crisis¦ ,▁ ¦it¦ ¦je op ardi zes¦ ¦the¦ ¦lives¦ ¦not¦ ¦only¦ ¦of¦ ¦the¦ ¦tr oo ps¦ ¦from¦ ¦the¦ 𐊣¦us¦𐊼 ¦and¦ ¦the¦ ¦many¦ 𐋇¦european¦ ¦countries¦ ¦participating¦ ¦but¦ ¦the¦ ¦in hab it ants¦ ¦of¦ ¦the¦ ¦countries¦ ¦in¦ ¦which¦ ¦they¦ ¦are¦ ¦operating¦ ." 𐋇¦the¦ 𐋇¦iranian¦ ¦government¦ ¦has¦ ¦been¦ ¦heavily¦ ¦affected¦ ¦by¦ ¦the¦ ¦virus¦ ,▁ ¦with¦ ¦around¦ ¦two¦ ¦do zen¦ ¦p arlia ment¦ ¦members¦ ¦infected¦ ¦as¦ ¦well¦ ¦as¦ ¦fi f teen¦ ¦other¦ ¦current¦ ¦or¦ ¦former¦ ¦political¦ ¦figures¦ .
𐋇¦as¦ ¦a¦ ¦common¦ ¦practice¦ ,▁ ¦individuals¦ ¦exposed¦ ¦to¦ ,▁ ¦or¦ ¦infected¦ ¦by¦ ,▁ ¦the¦ ¦virus¦ ¦are¦ ¦usually¦ ¦required¦ ¦to¦ ¦be¦ ¦quarantined¦ ¦for¦ ¦14¦ ¦days¦ .
𐋇¦the¦ ¦vi ru lence¦ ¦of¦ ¦the¦ ¦co me b ac k¦ ¦would¦ ¦depend¦ ¦on¦ ¦herd¦ ¦immunity¦ ¦and¦ ¦the¦ ¦extent¦ ¦of¦ ¦mutation¦ .
𐋇¦however¦ ,▁ ¦they¦ ¦are¦ ¦equally¦ ¦closely¦ ¦related¦ ¦to¦ 𐋇¦ra𐊣tg𐊼13¦ ¦with¦ ¦about¦ ¦90¦ %▁ ¦identity¦ ¦at¦ ¦the¦ ¦level¦ ¦of¦ ¦nucleotide¦ ¦sequence¦ .
𐋇¦some¦ 𐋇¦chinese¦ ¦students¦ ¦at¦ 𐋇¦american¦ ¦universities¦ ¦joined¦ ¦together¦ ¦to¦ ¦help¦ ¦send¦ ¦aid¦ ¦to¦ ¦virus¦ - ¦stric ken¦ ¦parts¦ ¦of¦ 𐋇¦china¦ ,▁ ¦with¦ ¦a¦ ¦joint¦ ¦group¦ ¦in¦ ¦the¦ ¦greater¦ 𐋇¦chi ca go¦ ¦area¦ ¦reportedly¦ ¦managing¦ ¦to¦ ¦send¦ ¦50¦ , ¦000¦ 𐋇¦n95¦ ¦masks¦ ¦to¦ ¦hospitals¦ ¦in¦ ¦the¦ 𐋇¦hubei¦ ¦province¦ ¦on¦ ¦30¦ 𐋇¦january¦ . 𐋇¦the¦ ¦hu ma nita rian¦ ¦aid¦ ¦organization¦ 𐋇¦direct¦ 𐋇¦relief¦ ,▁ ¦in¦ ¦coordination¦ ¦with¦ 𐋇¦f ed 𐋇 e x¦ ,▁ ¦sent¦ ¦200¦ , ¦000¦ ¦face¦ ¦masks¦ ¦along¦ ¦with¦ ¦other¦ ¦personal¦ ¦protective¦ ¦equipment¦ ,▁ ¦including¦ ¦gloves¦ ¦and¦ ¦g owns¦ ,▁ ¦by¦ ¦emergency¦ ¦air li ft¦ ¦to¦ ¦the¦ 𐋇¦wuhan¦ 𐋇¦union¦ 𐋇¦hospital¦ ¦by¦ ¦30¦ 𐋇¦january¦ .
𐋇¦in¦ ¦humans¦ ,▁ ¦coronaviruses¦ ¦cause¦ ¦respiratory¦ ¦tract¦ ¦infections¦ ¦that¦ ¦can¦ ¦range¦ ¦from¦ ¦mild¦ ¦to¦ ¦lethal¦ .
𐋇¦the¦ ¦emergence¦ ¦of¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦in¦ ¦central¦ 𐋇¦china¦ ¦at¦ ¦the¦ ¦end¦ ¦of¦ ¦2019¦ ¦has¦ ¦thr usted¦ 𐋇¦co𐋇vs¦ ¦into¦ ¦the¦ ¦sp ot light¦ ¦again¦ ¦and¦ ¦sur pri sed¦ ¦us¦ ¦with¦ ¦its¦ ¦high¦ ¦transmissibility¦ ¦but¦ ¦reduced¦ ¦patho genicity¦ ¦compared¦ ¦to¦ ¦its¦ ¦sister¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ .
𐋇¦for¦ 𐊣¦mers¦𐊼 ,▁ ¦based¦ ¦on¦ ¦a¦ ¦dem ographic¦ ¦study¦ ¦in¦ 𐋇¦june¦ ¦2012¦ ,▁ ¦the¦ ¦mortality¦ ¦was¦ ¦37¦ %▁ ¦of¦ ¦2¦ , ¦4 94¦ ¦confirmed¦ ¦cases¦ .
𐋇¦some¦ ¦researchers¦ ¦have¦ ¦suggested¦ ¦the¦ 𐋇¦huan an¦ 𐋇¦seafood¦ 𐋇¦wh oles ale¦ 𐋇¦market¦ ¦may¦ ¦not¦ ¦be¦ ¦the¦ ¦original¦ ¦source¦ ¦of¦ ¦viral¦ ¦transmission¦ ¦to¦ ¦humans¦ . 𐋇¦as¦ ¦of¦ ¦17¦ 𐋇¦april¦ ¦2020¦ ,▁ ¦there¦ ¦have¦ ¦been¦ ¦at¦ ¦least¦ ¦153¦ , ¦8 22¦ ¦confirmed¦ ¦deaths¦ ¦and¦ ¦more¦ ¦than¦ ¦2¦ , ¦240¦ , ¦191¦ ¦confirmed¦ ¦cases¦ ¦in¦ ¦the¦ ¦coronavirus¦ ¦pneumonia¦ ¦pandemic¦ .
𐋇¦im portantly¦ ,▁ ¦we¦ ¦compare¦ ¦and¦ ¦contrast¦ ¦the¦ ¦different¦ 𐊣¦hc𐊼o𐋇vs¦ ¦from¦ ¦a¦ ¦per sp ective¦ ¦of¦ ¦virus¦ ¦evolution¦ ¦and¦ ¦genome¦ ¦recombination¦ .
𐋇¦the¦ ¦di vers ity¦ ¦of¦ ¦bat¦ 𐋇¦co𐋇vs¦ ¦provides¦ ¦amp le¦ ¦opportunities¦ ¦for¦ ¦the¦ ¦emergence¦ ¦of¦ ¦novel¦ 𐊣¦hc𐊼o𐋇vs¦ .
𐋇¦second¦ ,▁ ¦pangolins¦ ¦could¦ ¦be¦ ¦one¦ ¦of¦ ¦intermediate¦ ¦amplifying¦ ¦host¦ ¦to¦ ¦which¦ ¦a¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ - ¦related¦ ¦virus¦ ¦had¦ ¦been¦ ¦newly¦ ¦introduced¦ .
𐋇¦for¦ ¦many¦ ¦years¦ ,▁ ¦the¦ ¦four¦ ¦community¦ - ¦acquired¦ 𐋇¦co𐋇vs¦ ¦circ ul ate¦ ¦in¦ ¦human¦ ¦populations¦ ,▁ ¦tri gg ering¦ ¦common¦ ¦cold¦ ¦in¦ ¦immunocomp et ent¦ ¦sub j ects¦ .
𐋇¦the¦ ¦clinical¦ ¦features¦ ¦of¦ 𐊣¦hc𐊼o𐋇v¦ - 𐊣¦oc𐊼43¦ ¦infection¦ ¦appear¦ ¦to¦ ¦be¦ ¦similar¦ ¦to¦ ¦those¦ ¦caused¦ ¦by¦ 𐊣¦hc𐊼o𐋇v¦ - ¦229𐋇e¦ ,▁ ¦which¦ ¦are¦ ¦sym pt om atically¦ ¦indi st in gu ish able¦ ¦from¦ ¦infection¦ ¦with¦ ¦other¦ ¦respiratory¦ ¦tract¦ ¦pathogens¦ ¦such¦ ¦as¦ ¦influenza¦ 𐋇¦a¦ ¦viruses¦ ¦and¦ ¦r hino vi ru ses¦ .
𐋇¦in¦ 𐊣¦sars¦𐊼 ¦patients¦ ,▁ ¦it¦ ¦has¦ ¦been¦ ¦demonstrated¦ ¦that¦ ¦fever¦ ▁( ¦99¦ % - ¦100¦ %),▁ ¦dry¦ ¦cough¦ ▁( ¦29¦ % - ¦75¦ %),▁ ¦dyspnea¦ ▁( ¦40¦ % - ¦42¦ %),▁ ¦diarrhea¦ ▁( ¦20¦ - ¦25¦ %),▁ ¦and¦ ¦sore¦ ¦throat¦ ▁( ¦13¦ - ¦25¦ %)▁ ¦were¦ ¦the¦ ¦major¦ ¦symptoms¦ ¦and¦ ¦ventilation¦ ¦support¦ ¦was¦ ¦required¦ ¦for¦ ¦approximately¦ ¦14¦ % - ¦20¦ %▁ ¦of¦ ¦the¦ ¦patients¦ .
𐋇¦the¦ ¦viral¦ 𐊣¦rna¦𐊼 ¦genome¦ ¦is¦ ¦released¦ ¦into¦ ¦the¦ ¦cyto pla s m¦ ;▁ ¦after¦ ¦replication¦ ¦of¦ ¦the¦ ¦viral¦ ¦genome¦ ,▁ ¦genomic¦ 𐊣¦rna¦𐊼 ¦accompanied¦ ¦by¦ ¦envelope¦ ¦gl yc op ro te ins¦ ¦and¦ ¦nucleocapsid¦ ¦proteins¦ ¦forms¦ ¦vir ion¦ - ¦containing¦ ¦v es ic les¦ ,▁ ¦which¦ ¦then¦ ¦f use¦ ¦with¦ ¦the¦ ¦plasma¦ ¦membrane¦ ¦to¦ ¦release¦ ¦the¦ ¦virus¦ .
𐋇¦the¦ 𐋇¦united¦ 𐋇¦states¦ '▁ 𐋇¦national¦ 𐋇¦institute¦ ¦of¦ 𐋇 ¦aller g y¦ ¦and¦ 𐋇¦infectious¦ 𐋇¦disease¦ ' ¦s¦ ¦director¦ ,▁ 𐋇¦dr¦ .▁ 𐋇¦an th ony¦ 𐋇¦fa uc i¦ ,▁ ¦said¦ ¦of¦ ¦the¦ ¦outbreak¦ ,▁" ¦bottom¦ ¦line¦ ,▁ ¦it¦ ' ¦s¦ ¦going¦ ¦to¦ ¦get¦ ¦worse¦ ."
𐋇¦an¦ ¦animal¦ ¦serves¦ ¦as¦ ¦the¦ ¦evolutionary¦ ¦host¦ ¦of¦ ¦an¦ 𐊣¦hc𐊼o𐋇v¦ ¦if¦ ¦it¦ ¦harb ours¦ ¦a¦ ¦closely¦ ¦related¦ ¦ancestor¦ ¦sharing¦ ¦high¦ ¦homology¦ ¦at¦ ¦the¦ ¦level¦ ¦of¦ ¦nucleotide¦ ¦sequence¦ .
𐋇¦the¦ ¦n ation¦ ' ¦s¦ ¦health¦ ¦agency¦ ¦reported¦ ¦a¦ ¦significant¦ ¦increase¦ ¦in¦ ¦confirmed¦ ¦cases¦ ¦on¦ ¦20¦ 𐋇¦february¦ ,▁ ¦largely¦ ¦att rib uted¦ ¦to¦ ¦a¦ ¦gathering¦ ¦in¦ 𐋇¦da e g u¦ ¦of¦ ¦a¦ ¦new¦ ¦religious¦ ¦movement¦ ¦known¦ ¦as¦ ¦the¦ 𐋇¦shin che on ji¦ 𐋇 ¦chur ch¦ ¦of¦ 𐋇¦j esus¦ .
𐋇 ¦emergence¦ ¦of¦ ¦novel¦ 𐊣¦hc𐊼o𐋇vs¦ :▁ ¦back¦ ¦to¦ ¦ground¦ ¦zero¦
𐋇¦tracing¦ ¦the¦ ¦zoonotic¦ ¦origins¦ ¦of¦ 𐊣¦hc𐊼o𐋇vs¦ ¦provides¦ ¦a¦ ¦fra me work¦ ¦to¦ ¦understand¦ ¦the¦ ¦natural¦ ¦history¦ ,▁ ¦driving¦ ¦force¦ ¦and¦ ¦restriction¦ ¦factors¦ ¦of¦ ¦species¦ ¦j um ping¦ .
𐋇¦there¦ ,▁ ¦the¦ 𐋇¦m¦ ¦proteins¦ ¦direct¦ ¦most¦ ¦protein¦ - ¦protein¦ ¦inter actions¦ ¦required¦ ¦for¦ ¦assembly¦ ¦of¦ ¦viruses¦ ¦following¦ ¦its¦ ¦binding¦ ¦to¦ ¦the¦ ¦nucleocapsid¦ .
𐋇¦since¦ ¦then¦ ,▁ ¦more¦ ¦knowledge¦ ¦was¦ ¦acc um ulated¦ ¦through¦ ¦extensive¦ ¦studies¦ ¦on¦ 𐊣¦hc𐊼o𐋇v¦ - ¦229𐋇e¦ ¦and¦ 𐊣¦hc𐊼o𐋇v¦ - 𐊣¦oc𐊼43¦ ,▁ ¦both¦ ¦of¦ ¦which¦ ¦cause¦ ¦self¦ - ¦limiting¦ ¦symptoms¦ .
𐋇¦despite¦ ¦this¦ ,▁ ¦it¦ ¦appears¦ ¦the¦ ¦virus¦ ¦had¦ ¦trouble¦ ¦spreading¦ ¦from¦ ¦human¦ ¦to¦ ¦human¦ ,▁ ¦as¦ ¦most¦ ¦individuals¦ ¦who¦ ¦are¦ ¦infected¦ ¦do¦ ¦not¦ ¦transmit¦ ¦the¦ ¦virus¦ .
𐋇¦it¦ ¦is¦ ¦a¦ ¦pressure¦ ¦like¦ ¦chest¦ ¦pain¦
𐋇 ¦humans¦ ¦contract¦ ¦the¦ ¦virus¦ ¦through¦ ¦b ut ch ering¦ ¦and¦ ¦con su mp tion¦ ¦of¦ ¦game¦ ¦meat¦ .
𐋇¦while¦ ¦there¦ ¦are¦ ¦concerns¦ ¦it¦ ¦may¦ ¦spread¦ ¦by¦ ¦fa e ces¦ ,▁ ¦this¦ ¦risk¦ ¦is¦ ¦believed¦ ¦to¦ ¦be¦ ¦low¦ .
𐋇¦therefore¦ ,▁ ¦building¦ ¦a¦ ¦prognosis¦ ¦model¦ ¦for¦ ¦the¦ ¦disease¦ ¦is¦ ¦essential¦ ¦for¦ ¦health¦ - ¦care¦ ¦agencies¦ ¦to¦ ¦prioritize¦ ¦their¦ ¦services¦ ,▁ ¦especially¦ ¦in¦ ¦resource¦ - ¦con st ra ined¦ ¦areas¦ .
𐋇¦does¦ ¦the¦ ¦virus¦ ¦also¦ ¦b ind¦ 𐊣¦ace𐊼2¦ - ¦expressing¦ ¦cells¦ ¦in¦ ¦other¦ ¦organs¦ ?
𐋇¦this¦ ¦is¦ ¦doctor¦ ¦ porter¦ ¦in¦ ¦the¦ ¦emergency¦ ¦room¦ ¦tri age¦ ¦center¦
𐋇¦in¦ ¦the¦ 𐋇¦u¦ . 𐋇¦s¦ .,▁ ¦the¦ 𐊣¦cdc¦𐊼 ¦recommends¦ ¦wearing¦ ¦non¦ - ¦medical¦ ¦face¦ ¦mask¦ ¦made¦ ¦out¦ ¦of¦ ¦cloth¦ . 𐋇¦china¦ ¦has¦ ¦specifically¦ ¦recommended¦ ¦the¦ ¦use¦ ¦of¦ ¦disposable¦ ¦medical¦ ¦masks¦ ¦by¦ ¦healthy¦ ¦members¦ ¦of¦ ¦the¦ ¦public¦ ,▁ ¦particularly¦ ¦when¦ ¦coming¦ ¦into¦ ¦close¦ ¦contact¦ ▁( ¦1¦ ¦met re¦ ▁( ¦3¦ ¦ ft¦ )▁ ¦or¦ ¦less¦ )▁ ¦with¦ ¦other¦ ¦people¦ .
𐋇¦l on ge v ity¦ ,▁ ¦den sely¦ ¦p acked¦ ¦col on ies¦ ,▁ ¦close¦ ¦social¦ ¦interaction¦ ¦and¦ ¦strong¦ ¦ability¦ ¦to¦ ¦f ly¦ ¦are¦ ¦all¦ ¦fav our able¦ ¦conditions¦ ¦for¦ ¦bats¦ ¦to¦ ¦be¦ ¦an¦ ¦ide al¦ ▁' ¦virus¦ ¦spreader¦ '.
𐋇 ¦pneumonia¦ ¦is¦ ¦one¦ ¦of¦ ¦the¦ ¦most¦ ¦severe¦ ¦symptoms¦ ¦and¦ ¦can¦ ¦progress¦ ¦rapidly¦ ¦to¦ ¦acute¦ ¦respiratory¦ ¦distress¦ ¦syndrome¦ .
𐋇¦in¦ ¦late¦ 𐋇¦january¦ ,▁ ¦the¦ 𐋇¦chinese¦ ¦government¦ ¦launched¦ ¦a¦ ¦radi cal¦ ¦campaign¦ ¦later¦ ¦described¦ ¦by¦ ¦the¦ 𐋇¦chinese¦ 𐋇¦comm un ist¦ 𐋇¦party¦ ¦general¦ ¦secretary¦ 𐋇¦x i¦ 𐋇¦j in ping¦ ¦as¦ ¦a¦ ▁" ¦people¦ ' ¦s¦ ¦war¦ "▁ ¦to¦ ¦contain¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇 ¦prot es ters¦ ¦in¦ 𐋇¦u k ra ine¦ ¦att acked¦ ¦buses¦ ¦carrying¦ 𐋇¦u kr ai ni an¦ ¦and¦ ¦foreign¦ ¦evacu ees¦ ¦from¦ 𐋇¦wuhan¦ ¦to¦ 𐋇¦no vi¦ 𐋇¦san z h ary¦ .
𐋇¦yesterday¦ ,▁ 𐋇¦bangladesh¦ ¦has¦ ¦confirmed¦ ¦five¦ ¦new¦ ¦deaths¦ ¦due¦ ¦to¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦on¦ ¦the¦ ¦day¦ .
𐋇¦this¦ ¦demand¦ ¦has¦ ¦led¦ ¦to¦ ¦the¦ ¦increase¦ ¦in¦ ¦prices¦ ¦of¦ ¦up¦ ¦to¦ ¦twenty¦ ¦times¦ ¦the¦ ¦normal¦ ¦price¦ ¦and¦ ¦also¦ ¦induced¦ ¦delays¦ ¦on¦ ¦the¦ ¦supply¦ ¦of¦ ¦medical¦ ¦items¦ ¦for¦ ¦four¦ ¦to¦ ¦six¦ ¦months¦ .
𐋇¦when¦ ¦it¦ ¦is¦ ¦no¦ ¦longer¦ ¦possible¦ ¦to¦ ¦contain¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦disease¦ ,▁ ¦efforts¦ ¦then¦ ¦move¦ ¦to¦ ¦the¦ ¦mitigation¦ ¦stage¦ :▁ ¦measures¦ ¦are¦ ¦taken¦ ¦to¦ ¦slow¦ ¦the¦ ¦spread¦ ¦and¦ ¦mi tig ate¦ ¦its¦ ¦effects¦ ¦on¦ ¦the¦ ¦healthcare¦ ¦system¦ ¦and¦ ¦society¦ .
𐋇 ¦beginning¦ ¦on¦ ¦15¦ 𐋇¦march¦ ,▁ ¦many¦ ¦businesses¦ ¦closed¦ ¦or¦ ¦reduced¦ ¦hours¦ ¦throughout¦ ¦the¦ 𐋇¦u¦ . 𐋇¦s¦ .▁ ¦to¦ ¦try¦ ¦to¦ ¦reduce¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇¦the¦ ¦number¦ ¦varies¦ ¦by¦ ¦region¦ .
𐋇¦pro gen y¦ ¦viruses¦ ¦are¦ ¦then¦ ¦released¦ ¦from¦ ¦the¦ ¦host¦ ¦cell¦ ¦by¦ ¦ex ocytosis¦ ¦through¦ ¦secret ory¦ ¦v es ic les¦ .
𐋇¦president¦ 𐋇¦h ass an¦ 𐋇 ¦rou hani¦ ¦said¦ ¦on¦ ¦26¦ 𐋇¦february¦ ¦2020¦ ¦that¦ ¦there¦ ¦were¦ ¦no¦ ¦plans¦ ¦to¦ ¦quarantine¦ ¦areas¦ ¦affected¦ ¦by¦ ¦the¦ ¦outbreak¦ ,▁ ¦and¦ ¦only¦ ¦individuals¦ ¦would¦ ¦be¦ ¦quarantined¦ .
𐋇¦therefore¦ ,▁ ¦infected¦ ¦patients¦ ¦at¦ ¦the¦ ¦early¦ ¦phase¦ ¦or¦ ¦incubation¦ ¦period¦ ¦can¦ ¦produce¦ ¦a¦ ¦large¦ ¦amount¦ ¦of¦ ¦virus¦ ¦during¦ ¦daily¦ ¦activities¦ ,▁ ¦causing¦ ¦great¦ ¦difficulty¦ ¦for¦ ¦the¦ ¦control¦ ¦of¦ ¦the¦ ¦epidemic¦ .
𐋇¦phylogenetic¦ ¦evidence¦ ¦of¦ ¦natural¦ ¦recombination¦ ¦has¦ ¦been¦ ¦found¦ ¦in¦ ¦both¦ 𐊣¦hc𐊼o𐋇v¦ - 𐊣¦hku𐊼1¦ ¦and¦ 𐊣¦hc𐊼o𐋇v¦ - 𐊣¦oc𐊼43¦ ,▁ ¦as¦ ¦well¦ ¦as¦ ¦animal¦ 𐋇¦co𐋇vs¦ ¦such¦ ¦as¦ ¦bat¦ 𐊣¦sl¦𐊼 - 𐋇¦co𐋇v¦ ¦and¦ ¦bat 𐋇co 𐋇v¦ - 𐊣¦hku𐊼 9¦ .
𐋇¦the¦ ¦high¦ ¦failure¦ ¦rates¦ ¦associated¦ ¦with¦ ¦pharmaceutical¦ ¦development¦ ¦are¦ ¦referred¦ ¦to¦ ¦as¦ ¦an¦ ▁" ¦attr ition¦ ¦rate¦ ",▁ ¦requiring¦ ¦decisions¦ ¦during¦ ¦the¦ ¦early¦ ¦stages¦ ¦of¦ ¦drug¦ ¦development¦ ¦to¦ ▁" ¦kill¦ "▁ ¦projects¦ ¦early¦ ¦to¦ ¦avoid¦ ¦co st ly¦ ¦fa il ures¦ .
𐋇¦the¦ ¦estimated¦ ¦mean¦ ¦incubation¦ ¦period¦ ¦of¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦is¦ ¦1¦ - ¦14¦ ¦days¦ ,▁ ¦mostly¦ ¦3¦ - ¦7¦ ¦days¦ ¦based¦ ¦on¦ ¦a¦ ¦study¦ ¦of¦ ¦the¦ ¦first¦ ¦4 25¦ ¦cases¦ ¦in¦ 𐋇¦wuhan¦ .
𐋇¦du bai¦ ,▁ 𐋇 ¦sy d n ey¦ ,▁ ¦and¦ 𐋇¦ mel b our ne¦ ¦were¦ ¦also¦ ¦reported¦ ¦as¦ ¦popular¦ ¦dest in ations¦ ¦for¦ ¦people¦ ¦trave lling¦ ¦from¦ 𐋇¦wuhan¦ .
𐋇¦and¦ ¦is¦ ¦this¦ ¦the¦ ¦right¦ ¦time¦ ¦for¦ ¦your¦ ¦h ay¦ ¦fever¦
𐋇¦by¦ ¦13¦ 𐋇¦march¦ ,▁ 𐋇¦the¦ 𐋇¦at l an tic¦ ¦reported¦ ¦that¦ ¦less¦ ¦than¦ ¦14¦ , ¦000¦ ¦tests¦ ¦had¦ ¦been¦ ¦conducted¦ .
𐋇¦the¦ ¦j ury¦ ¦is¦ ¦still¦ ¦out¦ ¦on¦ ¦the¦ ¦immediate¦ ¦zoonotic¦ ¦origin¦ ¦of¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ .
𐋇¦ebola¦ ¦was¦ ¦originally¦ ¦predicted¦ ¦to¦ ¦cause¦ ¦up¦ ¦to¦ ¦a¦ ¦million¦ ¦cases¦ ¦with¦ ¦half¦ ¦a¦ ¦million¦ ¦deaths¦ .
𐋇 ¦corpor ations¦ ¦imposed¦ ¦employee¦ ¦travel¦ ¦restrictions¦ ,▁ ¦cancelled¦ ¦conferences¦ ,▁ ¦and¦ ¦encouraged¦ ¦employees¦ ¦to¦ ¦work¦ ¦from¦ ¦home¦ .
𐊣¦c b s¦𐊼 𐋇¦news¦ ¦reported¦ ,▁ ¦citing¦ 𐋇¦johns¦ 𐋇¦hopkins¦ 𐋇¦university¦ ¦data¦ ,▁ ¦there¦ ¦were¦ ¦over¦ ¦1¦ , ¦000¦ 𐊣¦us¦𐊼 ¦deaths¦ ¦on¦ 𐋇¦wednesday¦ ¦caused¦ ¦by¦ ¦coronavirus¦ ¦infections¦ .
𐋇¦the¦ ¦remark s¦ ¦were¦ ¦later¦ ¦con dem ned¦ ¦by¦ ¦the¦ 𐋇¦chinese¦ ¦consulate¦ ¦in¦ 𐋇¦kolkata¦ ,▁ ¦calling¦ ¦it¦ ▁" ¦er ro ne ous¦ ". 𐋇¦in¦ 𐋇¦china¦ ,▁ ¦xenophobia¦ ¦and¦ ¦rac ism¦ ¦a ga ins¦ ¦non¦ - 𐋇¦chinese¦ ¦residents¦ ¦has¦ ¦been¦ ¦inf la med¦ ¦by¦ ¦the¦ ¦pandemic¦ ,▁ ¦with¦ ¦foreigners¦ ¦described¦ ¦as¦ ▁" ¦foreign¦ ¦g arb age¦ "▁ ¦and¦ ¦targeted¦ ¦for¦ ▁" ¦disposal¦ ".
𐋇¦the¦ ¦polyp ro te ins¦ ¦are¦ ¦further¦ ¦proc es sed¦ ¦to¦ ¦generate¦ ¦16¦ ¦non¦ - ¦structural¦ ¦proteins¦ ,▁ ¦designated¦ ¦n sp 1¦ ~ ¦16¦ .
𐋇¦several¦ ¦compounds¦ ¦that¦ ¦were¦ ¦previously¦ ¦approved¦ ¦for¦ ¦treatment¦ ¦of¦ ¦other¦ ¦viral¦ ¦diseases¦ ¦are¦ ¦being¦ ¦investigated¦ ¦for¦ ¦use¦ ¦in¦ ¦treating¦ 𐊣¦covid¦𐊼 - ¦19¦ .
𐊣¦covid¦𐊼 - ¦19¦ ¦ex pa nded¦ ¦in¦ ¦clusters¦ ¦mainly¦ ¦in¦ ¦and¦ ¦around¦ 𐋇¦hubei¦ .
𐋇 ¦asymptomatic¦ ¦or¦ ¦only¦ ¦mild¦ ¦symptoms¦ ¦were¦ ¦detected¦ ¦when¦ ¦bats¦ ¦were¦ ¦infected¦ ¦with¦ 𐋇¦co𐋇vs¦ ,▁ ¦indicating¦ ¦the¦ ¦mut ual¦ ¦adaptation¦ ¦between¦ 𐋇¦co𐋇vs¦ ¦and¦ ¦bats¦ .
𐋇¦human¦ ¦rights¦ ¦organizations¦ ¦have¦ ¦criticized¦ ¦some¦ ¦of¦ ¦these¦ ¦measures¦ ,▁ ¦asking¦ ¦the¦ ¦governments¦ ¦not¦ ¦to¦ ¦use¦ ¦the¦ ¦pandemic¦ ¦as¦ ¦a¦ ¦cover¦ ¦to¦ ¦introduce¦ ¦invasive¦ ¦digital¦ ¦surveillance¦ .
𐊣¦hc𐊼o𐋇v¦ - ¦229𐋇e¦ ,▁ 𐊣¦hc𐊼o𐋇v¦ - 𐊣¦oc43¦ ,▁ ¦hc𐊼o𐋇v¦ - 𐊣¦hku𐊼1¦ ¦and¦ 𐊣¦hc𐊼o𐋇v¦ - 𐊣¦nl𐊼63¦ ¦usually¦ ¦cause¦ ¦mild¦ ¦symptoms¦ ,▁ ¦like¦ ¦common¦ ¦cold¦ ¦and¦ / ¦or¦ ¦diarrhea¦ .
𐋇 ¦epidemiological¦ ¦history¦ :▁( ¦1¦ )▁ ¦a¦ ¦history¦ ¦of¦ ¦travel¦ ¦or¦ ¦residence¦ ¦in¦ 𐋇¦wuhan¦ ¦city¦ ¦and¦ ¦surrounding¦ ¦areas¦ ,▁ ¦or¦ ¦other¦ ¦communities¦ ¦where¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦cases¦ ¦had¦ ¦been¦ ¦reported¦ ¦in¦ ¦the¦ ¦last¦ ¦14¦ ¦days¦ ¦before¦ ¦symptom¦ ¦onset¦ ;▁( ¦2¦ )▁ ¦a¦ ¦history¦ ¦of¦ ¦contact¦ ¦with¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦infectious¦ ¦cases¦ ▁( ¦with¦ ¦positive¦ ¦nucleic¦ ¦acid¦ ¦test¦ ) ;▁( ¦3¦ )▁ ¦a¦ ¦history¦ ¦of¦ ¦cont acting¦ ¦with¦ ¦patients¦ ¦with¦ ¦fever¦ ¦or¦ ¦respiratory¦ ¦symptoms¦ ¦from¦ 𐋇¦wuhan¦ ¦city¦ ¦and¦ ¦surrounding¦ ¦areas¦ ,▁ ¦or¦ ¦other¦ ¦communities¦ ¦where¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦had¦ ¦been¦ ¦reported¦ ¦in¦ ¦the¦ ¦last¦ ¦14¦ ¦days¦ ¦before¦ ¦symptom¦ ¦onset¦ ;▁( ¦4¦ )▁ ¦a¦ ¦history¦ ¦of¦ ¦cont acting¦ ¦with¦ ¦cluster¦ ¦of¦ ¦confirmed¦ ¦cases¦ ▁( ≥ ▁ ¦2¦ ¦cases¦ ¦with¦ ¦fever¦ ¦and¦ / ¦or¦ ¦respiratory¦ ¦symptoms¦ ¦occurred¦ ¦within¦ ¦2¦ ¦weeks¦ ¦in¦ ¦small¦ ¦areas¦ ,▁ ¦such¦ ¦as¦ ¦home¦ ,▁ ¦office¦ ,▁ ¦class¦ ¦of¦ ¦school¦ ,▁ ¦etc¦ ).
𐋇¦do¦ ¦you¦ ¦have¦ ¦any¦ ¦other¦ ¦chronic¦ ¦like¦ ¦high¦ ¦blood¦ ¦pressure¦ ¦or¦ ¦anything¦ ¦like¦ ¦that¦ ?
𐋇¦besides¦ ,▁ ¦the¦ ¦natural¦ ¦ki ller¦ ¦cell¦ ¦activity¦ ¦in¦ ¦bats¦ ¦is¦ ¦supp ressed¦ ¦due¦ ¦to¦ ¦up reg ulation¦ ¦of¦ ¦in hib it ory¦ ¦natural¦ ¦ki ller¦ ¦cell¦ ¦receptor¦ 𐊣¦n k g 2¦ / ¦c d 𐊼 94¦ ¦and¦ ¦low¦ ¦expression¦ ¦level¦ ¦of¦ ¦major¦ ¦h is to comp ati bility¦ ¦complex¦ ¦class¦ 𐋇¦i¦ ¦mol ec u les¦ .
𐋇¦on¦ ¦the¦ ¦other¦ ¦hand¦ ,▁ 𐊣¦hc𐊼o𐋇v¦ - ¦229𐋇e¦ ¦was¦ ¦genetically¦ ¦related¦ ¦to¦ ¦another¦ ¦bat¦ 𐋇¦co𐋇v¦ ,▁ ¦ter med¦ 𐋇¦h ip posi der os¦ / 𐋇¦gha na 𐋇 k w am¦ / ¦19¦ / ¦2008¦ ,▁ ¦which¦ ¦was¦ ¦detected¦ ¦in¦ 𐋇¦gh ana¦ ,▁ ¦while¦ ¦ca me li ds¦ ¦have¦ ¦also¦ ¦been¦ ¦suspected¦ ¦as¦ ¦its¦ ¦intermediate¦ ¦host¦ .
𐋇¦there¦ ¦is¦ ¦no¦ ¦evidence¦ ¦animals¦ ¦can¦ ¦pass¦ ¦the¦ ¦virus¦ ¦on¦ ¦to¦ ¦humans¦ ,▁ ¦though¦ 𐋇¦british¦ ¦authorities¦ ¦advise¦ ¦washing¦ ¦one¦ ' ¦s¦ ¦hands¦ ¦after¦ ¦contact¦ ¦with¦ ¦animals¦ ,▁ ¦like¦ ¦after¦ ¦contact¦ ¦with¦ ¦other¦ ¦surfaces¦ ¦infected¦ ¦people¦ ¦could¦ ¦have¦ ¦touched¦ .
𐋇¦hong¦ 𐋇¦kong¦ ¦recommends¦ ¦wearing¦ ¦a¦ ¦surgical¦ ¦mask¦ ¦when¦ ¦taking¦ ¦public¦ ¦transport¦ ¦or¦ ¦staying¦ ¦in¦ ¦crowded¦ ¦places¦ .
𐋇¦the¦ 𐋇¦world¦ 𐋇¦health¦ 𐋇¦organization¦ ▁( 𐊣¦who¦𐊼 )▁ ¦declared¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦a¦ ¦pandemic¦ ¦on¦ 𐋇¦march¦ ¦11¦ .
𐋇¦she¦ ¦also¦ ¦said¦ ¦two¦ ¦of¦ ¦the¦ ¦victims¦ ¦were¦ ¦from¦ 𐋇¦d ha ka¦ .
𐋇¦and¦ ¦they¦ ' ¦re¦ ¦having¦ ¦some¦ ¦fe vers¦ ¦as¦ ¦well¦
𐋇¦even¦ ¦plasma¦ ¦from¦ ¦recovered¦ ¦patients¦ ¦was¦ ¦proposed¦ ¦to¦ ¦be¦ ¦used¦ ¦for¦ ¦treatment¦ .
𐋇 ¦inde ed¦ ,▁ ¦a¦ ¦cr y o¦ - 𐊣¦e m¦𐊼 ¦study¦ ¦indic ates¦ ¦a¦ ¦10¦ -▁ ¦to¦ ¦20¦ - ¦fo ld¦ ¦higher¦ ¦affi n ity¦ ¦of¦ ¦this¦ ¦binding¦ ¦than¦ ¦that¦ ¦between¦ ¦human¦ 𐊣¦ace𐊼2¦ ¦and¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ 𐋇¦s¦ ¦protein¦ .
𐋇¦the¦ ¦use¦ ¦of¦ ¦steroids¦ ¦may¦ ¦wor sen¦ ¦outcomes¦ .
𐋇¦there¦ ¦is¦ ¦no¦ ¦pre ference¦ ¦towards¦ ¦a¦ ¦particular¦ ¦season¦ ¦in¦ ¦trop ical¦ ¦cl im ates¦ .
𐋇 ¦investigating¦ 𐋇¦co𐋇v¦ - ¦host¦ ¦inter actions¦ ¦in¦ ¦animals¦ ¦might¦ ¦also¦ ¦de ri ve¦ ¦important¦ ¦ins ight¦ ¦on¦ 𐋇¦co𐋇v¦ ¦patho gene sis¦ ¦in¦ ¦humans¦ .
𐋇¦live¦ - ¦att enu ated¦ ¦vaccines¦ ¦have¦ ¦been¦ ¦evaluated¦ ¦in¦ ¦animal¦ ¦models¦ ¦for¦ 𐊣¦sars¦𐊼 .
𐋇¦ar ts¦ ¦and¦ ¦c ult ure¦ ¦sector¦ ¦organizations¦ ¦attemp ted¦ ¦to¦ ¦up ho ld¦ ¦their¦ ▁( ¦often¦ ¦public ly¦ ¦fu nded¦ )▁ ¦mission¦ ¦to¦ ¦provide¦ ¦access¦ ¦to¦ ¦cultural¦ ¦he rit age¦ ¦to¦ ¦the¦ ¦community¦ ,▁ ¦maintain¦ ¦the¦ ¦safety¦ ¦of¦ ¦their¦ ¦employees¦ ¦and¦ ¦the¦ ¦public¦ ,▁ ¦and¦ ¦support¦ ¦art ists¦ ¦where¦ ¦possible¦ .
𐋇¦currently¦ ,▁ ¦no¦ ¦detailed¦ ¦study¦ ¦has¦ ¦been¦ ¦reported¦ ¦regarding¦ ¦the¦ ¦immuno logical¦ ¦response¦ ¦to¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ .
𐋇¦on¦ ¦one¦ ¦hand¦ ,▁ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦infection¦ ¦ex hib its¦ ¦features¦ ¦that¦ ¦are¦ ¦more¦ ¦commonly¦ ¦seen¦ ¦during¦ ¦infection¦ ¦with¦ ¦community¦ - ¦acquired¦ 𐊣¦hc𐊼o𐋇vs¦ ,▁ ¦including¦ ¦the¦ ¦presentation¦ ¦of¦ ¦non¦ - ¦specific¦ ,▁ ¦mild¦ ¦or¦ ¦even¦ ¦no¦ ¦symptoms¦ .
𐋇¦co𐋇vs¦ ¦have¦ ¦returned¦ ¦to¦ ¦the¦ ¦li me light¦ ¦due¦ ¦to¦ ¦the¦ ¦recent¦ ¦outbreak¦ ¦of¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ .
𐋇¦the¦ 𐋇 ¦white¦ 𐋇¦house¦ 𐋇¦coronavirus¦ 𐋇¦task¦ 𐋇¦force¦ ¦was¦ ¦established¦ ¦on¦ ¦29¦ 𐋇¦january¦ .
𐋇¦and¦ ¦with¦ ¦your¦ ¦history¦ ¦of¦ ¦diabetes¦
𐋇¦on¦ ¦the¦ ¦other¦ ¦hand¦ ,▁ 𐋇¦chinese¦ ¦aid¦ ¦has¦ ¦been¦ ¦well¦ - ¦received¦ ¦in¦ ¦parts¦ ¦of¦ 𐋇¦latin¦ 𐋇¦america¦ ¦and¦ 𐋇¦africa¦ . 𐋇¦on¦ ¦2¦ 𐋇¦april¦ ,▁ ¦the¦ 𐋇¦world¦ 𐋇¦bank¦ ¦launched¦ ¦emergency¦ ¦support¦ ¦operations¦ ¦for¦ ¦developing¦ ¦countries¦ .
𐋇¦this¦ ¦is¦ ¦followed¦ ¦by¦ ¦the¦ ¦transcription¦ ¦of¦ ¦these¦ ¦negative¦ - ¦sense¦ ¦sub ge no mic¦ 𐊣¦rna¦𐊼 ¦mol ec u les¦ ¦to¦ ¦their¦ ¦corresponding¦ ¦positive¦ - ¦sense¦ ¦m 𐊣 r na 𐊼s¦ .
𐋇¦the¦ ¦global¦ 𐋇¦solidarity¦ ¦and¦ 𐋇¦european¦ 𐋇 ¦discovery¦ ¦trials¦ ¦of¦ ¦hospitalized¦ ¦people¦ ¦with¦ ¦severe¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦infection¦ ¦apply¦ ¦adaptive¦ ¦design¦ ¦to¦ ¦rapidly¦ ¦al ter¦ ¦trial¦ ¦para meters¦ ¦as¦ ¦results¦ ¦from¦ ¦the¦ ¦four¦ ¦experimental¦ ¦therapeutic¦ ¦strategies¦ ¦emerge¦ .
𐋇¦these¦ ¦statistics¦ ¦are¦ ¦not¦ ¦time bound¦ ¦and¦ ¦follow¦ ¦a¦ ¦specific¦ ¦population¦ ¦from¦ ¦infection¦ ¦through¦ ¦case¦ ¦resolution¦ .
𐋇¦in¦ ¦the¦ ¦early¦ ¦phase¦ ¦of¦ ¦the¦ 𐊣¦sars¦𐊼 ¦outbreak¦ ,▁ ¦a¦ ¦range¦ ¦of¦ ¦psychiatric¦ ¦m orb id ities¦ ¦including¦ ¦persistent¦ ¦dep ression¦ ,▁ ¦anxiety¦ ,▁ ¦panic¦ ¦attacks¦ ,▁ ¦psyc h om ot or¦ ¦ex ci te ment¦ ,▁ ¦psyc ho tic¦ ¦symptoms¦ ,▁ ¦deli ri um¦ ,▁ ¦and¦ ¦even¦ ¦su ic id ality¦ ¦were¦ ¦reported¦ .
𐋇 ¦whenever¦ ¦possible¦ ,▁ ¦we¦ ¦will¦ ¦try¦ ¦to¦ ¦compare¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦with¦ 𐊣¦sars¦𐊼 ¦and¦ ¦another¦ 𐋇¦co𐋇v¦ - ¦caused¦ ¦disease¦ ,▁ 𐋇¦middle¦ 𐋇¦east¦ ¦respiratory¦ ¦syndrome¦ ▁( 𐊣¦mers¦𐊼 ,▁ ¦an¦ ¦outbreak¦ ¦in¦ ¦2012¦ ).
𐋇¦it¦ ¦has¦ ¦attr acted¦ ¦a¦ ¦great¦ ¦attention¦ ¦since¦ ¦published¦ .
𐋇¦this¦ ¦enzyme¦ ¦is¦ ¦essential¦ ¦to¦ ¦the¦ ¦host¦ ¦cell¦ ¦to¦ ¦rep rodu ce¦ ¦the¦ ¦ rib on ucle ic¦ ¦acid¦ ¦of¦ ¦the¦ ¦virus¦ .
𐊣¦covid¦𐊼 - ¦19¦ ¦affects¦ ¦more¦ ¦elderly¦ ¦individuals¦ ¦than¦ ¦youth¦ ¦and¦ ¦more¦ ¦men¦ ¦than¦ ¦women¦ ,▁ ¦and¦ ¦the¦ ¦severity¦ ¦and¦ ¦death¦ ¦rate¦ ¦are¦ ¦also¦ ¦higher¦ ¦in¦ ¦elderly¦ ¦individual¦ ¦than¦ ¦in¦ ¦youth¦ .
𐋇¦however¦ ,▁ ¦the¦ ¦transmission¦ ¦of¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ ¦was¦ ¦considered¦ ¦to¦ ¦occur¦ ¦when¦ ¦the¦ ¦patients¦ ¦are¦ ¦severely¦ ¦ill¦ ,▁ ¦while¦ ¦most¦ ¦transmission¦ ¦did¦ ¦not¦ ¦happen¦ ¦at¦ ¦the¦ ¦early¦ ¦phase¦ .
𐋇 ¦repurposed¦ ¦antiviral¦ ¦drugs¦ ¦make¦ ¦up¦ ¦most¦ ¦of¦ ¦the¦ 𐋇¦chinese¦ ¦research¦ ,▁ ¦with¦ ¦9¦ 𐋇¦phase¦ 𐊣¦iii¦𐊼 ¦trials¦ ¦on¦ ¦remdesivir¦ ¦across¦ ¦several¦ ¦countries¦ ¦due¦ ¦to¦ ¦report¦ ¦by¦ ¦the¦ ¦end¦ ¦of¦ 𐋇¦april¦ .
𐋇¦japan¦ ¦donated¦ ¦one¦ ¦million¦ ¦face¦ ¦masks¦ ¦to¦ 𐋇¦wuhan¦ ,▁ 𐋇¦turkey¦ ¦disp at ched¦ ¦medical¦ ¦equipment¦ ,▁ 𐋇¦russia¦ ¦sent¦ ¦more¦ ¦than¦ ¦13¦ ¦tonnes¦ ¦of¦ ¦medical¦ ¦supplies¦ ¦to¦ 𐋇¦wuhan¦ ,▁ 𐋇¦malaysia¦ ¦announced¦ ¦a¦ ¦donation¦ ¦of¦ ¦18¦ ¦million¦ ¦medical¦ ¦gloves¦ ¦to¦ 𐋇¦china¦ ,▁ 𐋇¦germany¦ ¦delivered¦ ¦various¦ ¦medical¦ ¦supplies¦ ¦including¦ ¦10¦ , ¦000¦ 𐋇¦ha z m at¦ ¦su its¦ ,▁ ¦and¦ ¦the¦ 𐋇¦united¦ 𐋇¦states¦ ¦donated¦ ¦17¦ . ¦8¦ ¦tons¦ ¦of¦ ¦medical¦ ¦supplies¦ ¦to¦ 𐋇¦china¦ ¦and¦ ¦promised¦ ¦an¦ ¦additional¦ ▁$ ¦100¦ ¦million¦ ¦in¦ ¦financial¦ ¦support¦ ¦to¦ ¦affected¦ ¦countries¦ . 𐋇¦after¦ ¦cases¦ ¦in¦ 𐋇¦china¦ ¦seemed¦ ¦to¦ ¦stabi lize¦ ,▁ ¦the¦ ¦country¦ ¦has¦ ¦been¦ ¦sending¦ ¦aid¦ ¦to¦ ¦various¦ ¦nations¦ ¦hit¦ ¦by¦ ¦the¦ ¦pandemic¦ .
𐋇¦on¦ ¦22¦ 𐋇¦march¦ ,▁ ¦the¦ 𐋇 ¦associated¦ 𐋇¦press¦ ¦reported¦ :▁" 𐋇¦many¦ ¦people¦ ¦who¦ ¦have¦ ¦symptoms¦ ¦and¦ ¦a¦ ¦doctor¦ ' ¦s¦ ¦order¦ ¦have¦ ¦wai ted¦ ¦hours¦ ¦or¦ ¦days¦ ¦for¦ ¦a¦ ¦test¦ ." 𐋇¦after¦ ¦the¦ ¦first¦ ¦death¦ ¦in¦ ¦the¦ 𐋇¦united¦ 𐋇¦states¦ ¦was¦ ¦reported¦ ¦in¦ 𐋇¦washington¦ ¦state¦ ¦on¦ ¦29¦ 𐋇¦february¦ ,▁ 𐋇¦governor¦ 𐋇¦j ay¦ 𐋇 ¦ins l ee¦ ¦declared¦ ¦a¦ ¦state¦ ¦of¦ ¦emergency¦ ,▁ ¦an¦ ¦action¦ ¦that¦ ¦was¦ ¦soon¦ ¦followed¦ ¦by¦ ¦other¦ ¦states¦ .
𐋇¦patients¦ ¦infected¦ ¦with¦ 𐊣¦hc𐊼o𐋇v¦ - ¦229𐋇e¦ ¦presented¦ ¦with¦ ¦common¦ ¦cold¦ ¦symptoms¦ ,▁ ¦including¦ ¦headache¦ ,▁ ¦sneezing¦ ,▁ ¦ma la ise¦ ¦and¦ ¦sore¦ - ¦throat¦ ,▁ ¦with¦ ¦fever¦ ¦and¦ ¦cough¦ ¦seen¦ ¦in¦ ¦10¦ ~ ¦20¦ %▁ ¦cases¦ .
𐋇¦the¦ 𐋇¦thursday¦ ¦edition¦ ¦of¦ 𐊣¦n t¦𐊼 𐋇¦news¦ ,▁ ¦a¦ ¦daily¦ ¦pr inted¦ ¦in¦ 𐋇 ¦dar w in¦ ,▁ ¦included¦ ¦an¦ ¦eight¦ - ¦page¦ ¦ins ert¦ ¦me ant¦ ¦to¦ ¦be¦ ¦cut¦ ¦up¦ ¦and¦ ¦used¦ ¦as¦ ¦toilet¦ ¦paper¦ .
𐋇¦this¦ ¦means¦ ¦that¦ ¦countries¦ ¦may¦ ¦have¦ ¦more¦ ¦or¦ ¦less¦ ¦resources¦ ¦than¦ 𐋇¦italy¦ ▁( ¦12¦ . ¦5¦ ¦intensive¦ ¦care¦ ¦and¦ ¦intermediate¦ ¦care¦ ¦beds¦ ¦per¦ ¦100¦ , ¦000¦ ¦population¦ ¦in¦ ¦2010¦ – ¦11¦ ).
𐋇¦since¦ ¦particles¦ ¦can¦ ¦pe ne tr ate¦ ¦even¦ ¦five¦ ¦surgical¦ ¦masks¦ ¦st acked¦ ¦together¦ ,▁ ¦health¦ - ¦care¦ ¦providers¦ ¦in¦ ¦direct¦ ¦contact¦ ¦with¦ ¦patients¦ ¦must¦ ¦wear¦ 𐋇¦n95¦ ▁( ¦series¦ ▁#▁ ¦18 6 0s¦ )▁ ¦masks¦ ¦but¦ ¦not¦ ¦surgical¦ ¦masks¦ .
𐋇¦it¦ ¦is¦ ¦in¦ ¦my¦ ¦chest¦
𐋇¦control¦ ¦of¦ ¦public¦ ¦movement¦ ¦was¦ ¦applied¦ ¦in¦ ¦many¦ ¦cities¦ ,▁ ¦and¦ ¦it¦ ¦has¦ ¦been¦ ¦estimated¦ ¦that¦ ¦about¦ ¦7 60¦ ¦million¦ ¦people¦ ▁( ¦more¦ ¦than¦ ¦half¦ ¦the¦ ¦population¦ )▁ ¦faced¦ ¦some¦ ¦form¦ ¦of¦ ¦out do or¦ ¦restriction¦ . 𐋇¦after¦ ¦the¦ ¦outbreak¦ ¦entered¦ ¦its¦ ¦global¦ ¦phase¦ ¦in¦ 𐋇¦march¦ ,▁ 𐋇¦chinese¦ ¦authorities¦ ¦took¦ ¦strict¦ ¦measures¦ ¦to¦ ¦prevent¦ ¦the¦ ¦virus¦ ¦from¦ ▁" ¦im porting¦ "▁ ¦from¦ ¦other¦ ¦countries¦ .
𐋇¦however¦ ,▁ ¦the¦ ¦coronavirus¦ ¦disease¦ ¦2019¦ ▁( 𐊣¦covid¦𐊼 - ¦19¦ )▁ ¦is¦ ¦a¦ ¦new¦ ¦disease¦ ,▁ ¦our¦ ¦awareness¦ ¦and¦ ¦knowledge¦ ¦are¦ ¦gradually¦ ¦increasing¦ ¦based¦ ¦on¦ ¦the¦ ¦ongoing¦ ¦research¦ ¦findings¦ ¦and¦ ¦clinical¦ ¦practice¦ ¦experience¦ ;▁ ¦hence¦ ,▁ ¦the¦ ¦strategies¦ ¦of¦ ¦diagnosis¦ ¦and¦ ¦treatment¦ ¦are¦ ¦also¦ ¦continu ally¦ ¦updated¦ .
𐋇 ¦remote¦ ¦working¦ ¦measures¦ ¦were¦ ¦institu ted¦ ¦in¦ ¦several¦ 𐋇¦chinese¦ ¦regions¦ .
𐋇¦the¦ ¦experience¦ ¦from¦ 𐋇¦italy¦ ¦and¦ ¦the¦ ¦current¦ ¦trends¦ ¦in¦ ¦other¦ ¦countries¦ ¦show¦ ¦that¦ ¦the¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦pandemic¦ ¦is¦ ¦progres sing¦ ¦rapidly¦ ¦in¦ ¦the¦ 𐊣¦eu¦ / ¦eea¦𐊼 ¦and¦ ¦the¦ 𐊣¦uk¦𐊼 .
𐋇¦with¦ ¦the¦ ¦or de als¦ ¦of¦ 𐊣¦sars¦ ,▁ ¦mer s¦𐊼 ¦and¦ 𐊣¦covid¦𐊼 - ¦19¦ ,▁ ¦a¦ ¦better¦ ¦preparedness¦ ¦and¦ ¦response¦ ¦plan¦ ¦should¦ ¦be¦ ¦in¦ ¦place¦ .
𐋇¦many¦ ¦residents¦ ¦of¦ 𐋇¦wuhan¦ ¦and¦ 𐋇¦hubei¦ ¦have¦ ¦reported¦ ¦discrimination¦ ¦based¦ ¦on¦ ¦their¦ ¦regional¦ ¦origin¦ .
𐋇¦a¦ ¦statistical¦ ¦analysis¦ ¦published¦ ¦30¦ 𐋇¦march¦ ¦estimated¦ ¦that¦ ¦numbers¦ ¦of¦ ¦infections¦ ¦in¦ 𐋇¦italy¦ ¦were¦ ¦consider ably¦ ¦greater¦ ¦than¦ ¦the¦ ¦reported¦ ¦cases¦ .
𐋇¦on¦ ¦22¦ 𐋇¦march¦ ,▁ ¦after¦ ¦a¦ ¦phone¦ ¦call¦ ¦with¦ 𐋇¦italian¦ 𐋇¦prime¦ 𐋇¦minister¦ 𐋇¦gi u se pp e¦ 𐋇¦con te¦ ,▁ 𐋇¦russian¦ ¦president¦ 𐋇¦v l ad im ir¦ 𐋇¦p ut in¦ ¦arran ged¦ ¦the¦ 𐋇¦russian¦ ¦army¦ ¦to¦ ¦send¦ ¦military¦ ¦medic s¦ ,▁ ¦special¦ ¦disinf ection¦ ¦vehicles¦ ,▁ ¦and¦ ¦other¦ ¦medical¦ ¦equipment¦ ¦to¦ 𐋇¦italy¦ .
𐋇¦the¦ 𐋇¦chinese¦ ¦government¦ ¦encouraged¦ ¦businesses¦ ¦and¦ ¦factories¦ ¦to¦ ¦re¦ - ¦open¦ ¦on¦ ¦30¦ 𐋇¦march¦ ,▁ ¦and¦ ¦provided¦ ¦mon et ary¦ ¦s ti mul us¦ ¦p ack ages¦ ¦for¦ ¦f ir ms¦ . 𐋇¦the¦ 𐋇¦state¦ 𐋇¦council¦ ¦declared¦ ¦a¦ ¦day¦ ¦of¦ ¦m our ning¦ ¦to¦ ¦begin¦ ¦with¦ ¦a¦ ¦national¦ ¦three¦ - ¦minute¦ ¦moment¦ ¦of¦ ¦si lence¦ ¦on¦ ¦10¦ : ¦00¦ ¦4¦ 𐋇¦april¦ ,▁ ¦co in ci ding¦ ¦with¦ 𐋇¦q i ng ming¦ 𐋇¦festival¦ ,▁ ¦although¦ ¦the¦ ¦central¦ ¦government¦ ¦asked¦ ¦families¦ ¦to¦ ¦pay¦ ¦their¦ ¦resp ects¦ ¦online¦ ¦in¦ ¦observ ance¦ ¦of¦ ¦physical¦ ¦distancing¦ ¦as¦ ¦to¦ ¦avoid¦ ¦a¦ ¦re ne w ed¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦outbreak¦ .
𐋇¦private¦ ¦vehicle¦ ¦use¦ ¦was¦ ¦banned¦ ¦in¦ ¦the¦ ¦city¦ .
𐋇¦around¦ ¦200¦ ¦countries¦ ¦and¦ ¦territories¦ ¦have¦ ¦had¦ ¦at¦ ¦least¦ ¦one¦ ¦case¦ .
𐋇¦the¦ 𐋇¦european¦ 𐋇¦centre¦ ¦for¦ 𐋇¦disease¦ 𐋇¦prevention¦ ¦and¦ 𐋇¦control¦ ▁( 𐊣¦ecdc¦𐊼 )▁ ¦states¦ ¦that¦ ¦while¦ ¦it¦ ¦is¦ ¦not¦ ¦entirely¦ ¦clear¦ ¦how¦ ¦easily¦ ¦the¦ ¦disease¦ ¦spreads¦ ,▁ ¦one¦ ¦person¦ ¦generally¦ ¦infects¦ ¦two¦ ¦to¦ ¦three¦ ¦others¦ . 𐋇¦the¦ ¦virus¦ ¦survi ves¦ ¦for¦ ¦hours¦ ¦to¦ ¦days¦ ¦on¦ ¦surfaces¦ .
𐋇¦apart¦ ¦from¦ ¦the¦ ¦super¦ - ¦sp rea ders¦ ,▁ ¦it¦ ¦was¦ ¦estimated¦ ¦that¦ ¦each¦ ¦case¦ ¦could¦ ¦give¦ ¦rise¦ ¦to¦ ¦approximately¦ ¦two¦ ¦secondary¦ ¦cases¦ ,▁ ¦with¦ ¦an¦ ¦incubation¦ ¦period¦ ¦of¦ ¦4¦ ¦to¦ ¦7¦ ¦days¦ ¦and¦ ¦the¦ ¦peak¦ ¦of¦ ¦viral¦ ¦load¦ ¦appearing¦ ¦on¦ ¦the¦ ¦10th¦ ¦day¦ ¦of¦ ¦illness¦ .
𐋇¦for¦ ¦this¦ ¦to¦ ¦happen¦ ,▁ 𐊣¦hc𐊼o𐋇vs¦ ¦have¦ ¦to¦ ¦replicate¦ ¦in¦ ¦humans¦ ¦to¦ ¦sufficient¦ ¦extent¦ ¦to¦ ¦allow¦ ¦the¦ ¦acc um ulation¦ ¦of¦ ¦adaptive¦ ¦mutations¦ ¦that¦ ¦counter act¦ ¦host¦ ¦restriction¦ ¦factors¦ .
𐋇 ¦steroids¦ ,▁ ¦as¦ ¦immuno s up pr ess ants¦ ,▁ ¦were¦ ¦widely¦ ¦used¦ ¦in¦ ¦the¦ ¦treatment¦ ¦of¦ 𐊣¦sars¦𐊼 ¦to¦ ¦reduce¦ ¦the¦ ¦severity¦ ¦of¦ ¦inflammatory¦ ¦damage¦ .
𐋇¦it¦ ¦high l ights¦ ¦that¦ ,▁ ¦as¦ ¦at¦ ¦15¦ 𐋇¦march¦ ¦8¦ : ¦00¦ ¦a¦ . ¦m¦ .,▁ ¦15¦ ¦other¦ 𐊣¦eu¦ / ¦eea¦𐊼 ¦countries¦ ¦and¦ ¦the¦ 𐊣¦uk¦𐊼 ¦had¦ ¦already¦ ¦reported¦ ¦a¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦compar able¦ ¦to¦ ¦that¦ ¦of¦ 𐋇¦italy¦ ¦just¦ ¦3¦ ¦weeks¦ ¦prior¦ ¦or¦ ¦less¦ .
𐋇¦the¦ ¦outbreak¦ ¦disrupted¦ ¦plans¦ ¦for¦ ¦the¦ ¦2020¦ 𐋇 ¦summer¦ 𐋇¦ ol ymp ics¦ ,▁ ¦which¦ ¦were¦ ¦originally¦ ¦scheduled¦ ¦to¦ ¦start¦ ¦at¦ ¦the¦ ¦end¦ ¦of¦ 𐋇¦july¦ ;▁ ¦the¦ 𐋇¦international¦ 𐋇¦ ol ymp ic¦ 𐋇¦committee¦ ¦announced¦ ¦on¦ ¦24¦ 𐋇¦march¦ ¦that¦ ¦the¦ ¦event¦ ¦will¦ ¦be¦ ▁" ¦res che du led¦ ¦to¦ ¦a¦ ¦date¦ ¦beyond¦ ¦2020¦ ¦but¦ ¦not¦ ¦later¦ ¦than¦ ¦summer¦ ¦2021¦ ". 𐋇¦c as in os¦ ¦and¦ ¦other¦ ¦ga ming¦ ¦v enu es¦ ¦worldwide¦ ¦have¦ ¦closed¦ ¦and¦ ¦live¦ ¦po ker¦ ¦tour na ments¦ ¦have¦ ¦been¦ ¦either¦ ¦postponed¦ ¦or¦ ¦cancelled¦ .
𐋇¦are¦ ¦you¦ ¦having¦ ¦any¦ ¦shortness¦ ¦of¦ ¦breath¦ ?
𐋇¦diarrhea¦ ▁( ¦26¦ %)▁ ¦and¦ ¦sore¦ ¦throat¦ ▁( ¦21¦ %)▁ ¦were¦ ¦also¦ ¦observed¦ ¦with¦ 𐊣¦mers¦𐊼 ¦patients¦ .
𐋇¦health¦ ¦organizations¦ ¦recommended¦ ¦that¦ ¦people¦ ¦cover¦ ¦their¦ ¦mouth¦ ¦and¦ ¦nose¦ ¦with¦ ¦a¦ ¦b ent¦ ¦elbow¦ ¦or¦ ¦a¦ ¦tissue¦ ¦when¦ ¦coughing¦ ¦or¦ ¦sneezing¦ ,▁ ¦and¦ ¦disp osing¦ ¦of¦ ¦any¦ ¦tissue¦ ¦immediately¦ .
𐋇¦about¦ ¦36 4¦ , ¦000¦ ¦people¦ ¦have¦ ¦recovered¦ .
𐋇¦coronaviruses¦ ¦can¦ ¦cause¦ ¦pneumonia¦ ▁( ¦either¦ ¦direct¦ ¦viral¦ ¦pneumonia¦ ¦or¦ ¦secondary¦ ¦bacterial¦ ¦pneumonia¦ )▁ ¦and¦ ¦bronchitis¦ ▁( ¦either¦ ¦direct¦ ¦viral¦ ¦bronchitis¦ ¦or¦ ¦secondary¦ ¦bacterial¦ ¦bronchitis¦ ).
𐋇¦in¦ ¦the¦ ¦19 5 0s¦ ,▁ ¦the¦ ¦human¦ ¦coronavirus¦ 𐊣¦oc𐊼43¦ ¦began¦ ¦to¦ ¦diver ge¦ ¦into¦ ¦its¦ ¦present¦ ¦ gen ot yp es¦ .
𐋇¦before¦ ¦discussing¦ ¦the¦ ¦animal¦ ¦origins¦ ¦of¦ 𐊣¦hc𐊼o𐋇vs¦ ,▁ ¦it¦ ¦will¦ ¦serve¦ ¦us¦ ¦well¦ ¦to¦ ¦discuss¦ ¦the¦ ¦defini tions¦ ¦and¦ ¦characteri stics¦ ¦of¦ ¦evolutionary¦ ,▁ ¦natural¦ ,▁ ¦reservoir¦ ,▁ ¦intermediate¦ ¦and¦ ¦amplifying¦ ¦hosts¦ ¦of¦ 𐊣¦hc𐊼o𐋇vs¦ .
𐋇¦the¦ 𐊣¦who¦𐊼 ¦has¦ ¦issued¦ ¦instructions¦ ¦on¦ ¦when¦ ¦and¦ ¦how¦ ¦to¦ ¦use¦ ¦masks¦ .
𐋇¦another¦ ¦hospital¦ ¦was¦ ¦built¦ ¦afterwards¦ ,▁ 𐋇 ¦le is he ns han¦ 𐋇¦hospital¦ ,▁ ¦to¦ ¦handle¦ ¦additional¦ ¦patients¦ .
𐋇¦on¦ ¦6¦ 𐋇¦february¦ ¦2020¦ ,▁ ¦our¦ ¦team¦ ¦had¦ ¦published¦ ¦a¦ ¦rapid¦ ¦advice¦ ¦guideline¦ ¦for¦ ¦diagnosis¦ ¦and¦ ¦treatment¦ ¦of¦ ¦2019¦ ¦novel¦ ¦coronavirus¦ ▁( ¦2019¦ - ¦n𐋇co𐋇v¦ )▁ ¦infection¦ ,▁ ¦and¦ ¦this¦ ¦guideline¦ ¦provided¦ ¦our¦ ¦experience¦ ¦and¦ ¦make¦ ¦well¦ ¦reference¦ ¦for¦ ¦fighting¦ ¦against¦ ¦this¦ ¦pandemic¦ ¦worldwide¦ .
𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦has¦ ¦features¦ ¦that¦ ¦are¦ ¦similar¦ ¦to¦ ¦both¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ / 𐊣¦mers¦𐊼 - 𐋇¦co𐋇v¦ ¦and¦ ¦the¦ ¦four¦ ¦community¦ - ¦acquired¦ 𐊣¦hc𐊼o𐋇vs¦ .
𐋇¦their¦ ¦guidelines¦ ¦thus¦ ¦advise¦ ¦that¦ ¦any¦ ¦pregnant¦ ¦person¦ ¦admitted¦ ¦to¦ ¦hospital¦ ¦with¦ ¦a¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦infection¦ ¦should¦ ¦receive¦ ¦at¦ ¦least¦ ¦10¦ ¦days¦ ¦of¦ ¦pro ph yl ac tic¦ ¦low¦ - ¦molecular¦ - ¦weight¦ ¦he parin¦ ¦after¦ ¦being¦ ¦discharged¦ ¦from¦ ¦the¦ ¦hospital¦ .
𐋇¦the¦ ¦origin¦ ¦and¦ ¦intermediate¦ ¦host¦
𐋇¦for¦ ¦those¦ ¦who¦ ¦do¦ ¦not¦ ,▁ ¦the¦ ¦time¦ ¦from¦ ¦development¦ ¦of¦ ¦symptoms¦ ¦to¦ ¦death¦ ¦has¦ ¦been¦ ¦between¦ ¦6¦ ¦and¦ ¦41¦ ¦days¦ ,▁ ¦with¦ ¦the¦ ¦most¦ ¦common¦ ¦being¦ ¦14¦ ¦days¦ .
𐋇¦a¦ ¦small¦ ¦study¦ ¦involving¦ ¦6¦ ¦confirmed¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦mothers¦ ¦showed¦ ¦no¦ ¦indic ation¦ ¦of¦ 𐊣¦sars¦ - ¦cov¦𐊼 - ¦19¦ ¦in¦ ¦their¦ ¦newborns¦ '▁ ¦thro ats¦ ¦or¦ ¦serum¦ ¦but¦ ¦antibodies¦ ¦were¦ ¦present¦ ¦in¦ ¦neo na tal¦ ¦blood¦ ¦sera¦ ¦samples¦ ,▁ ¦including¦ 𐋇¦ig𐋇m¦ ¦in¦ ¦two¦ ¦of¦ ¦the¦ ¦infants¦ .
𐋇¦in¦ ¦patients¦ ¦with¦ ¦severe¦ ¦cases¦ ,▁ ¦the¦ ¦level¦ ¦of¦ 𐋇¦d¦ - ¦di mer¦ ,▁ ¦a¦ ¦fibr in¦ ¦de g rad ation¦ ¦product¦ ¦present¦ ¦in¦ ¦the¦ ¦blood¦ ,▁ ¦was¦ ¦elevated¦ ,▁ ¦and¦ ¦lymphocyte¦ ¦count¦ ¦was¦ ¦progres sively¦ ¦reduced¦ .
𐋇¦on¦ ¦23¦ 𐋇¦january¦ ,▁ ¦in¦ ¦reaction¦ ¦to¦ ¦the¦ ¦central¦ ¦authorities¦ '▁ ¦decision¦ ¦to¦ ¦implement¦ ¦a¦ ¦transportation¦ ¦ban¦ ¦in¦ 𐋇¦wuhan¦ ,▁ 𐊣¦who¦𐊼 ¦representative¦ 𐋇¦ga u den¦ 𐋇¦gal ea¦ ¦remark ed¦ ¦that¦ ¦while¦ ¦it¦ ¦was¦ ▁" ¦certain ly¦ ¦not¦ ¦a¦ ¦recommendation¦ ¦the¦ 𐊣¦who¦𐊼 ¦has¦ ¦made¦ ",▁ ¦it¦ ¦was¦ ¦also¦ ▁" ¦a¦ ¦very¦ ¦important¦ ¦indic ation¦ ¦of¦ ¦the¦ ¦commitment¦ ¦to¦ ¦contain¦ ¦the¦ ¦epidemic¦ ¦in¦ ¦the¦ ¦place¦ ¦where¦ ¦it¦ ¦is¦ ¦most¦ ¦concentr ated¦ "▁ ¦and¦ ¦called¦ ¦it¦ ▁" ¦unprecedented¦ ¦in¦ ¦public¦ ¦health¦ ¦history¦ ". 𐋇¦on¦ ¦30¦ 𐋇¦january¦ ,▁ ¦following¦ ¦confirmation¦ ¦of¦ ¦human¦ - ¦to¦ - ¦human¦ ¦transmission¦ ¦outside¦ 𐋇¦china¦ ¦and¦ ¦the¦ ¦increase¦ ¦in¦ ¦the¦ ¦number¦ ¦of¦ ¦cases¦ ¦in¦ ¦other¦ ¦countries¦ ,▁ ¦the¦ 𐊣¦who¦𐊼 ¦declared¦ ¦the¦ ¦outbreak¦ ¦a¦ 𐋇¦public¦ 𐋇¦health¦ 𐋇¦emergency¦ ¦of¦ 𐋇¦international¦ 𐋇¦concern¦ ▁( 𐊣¦p he i c¦𐊼 ),▁ ¦the¦ ¦sixth¦ 𐊣¦p he i c¦𐊼 ¦since¦ ¦the¦ ¦measure¦ ¦was¦ ¦first¦ ¦inv o ked¦ ¦during¦ ¦the¦ ¦2009¦ ¦swine¦ ¦flu¦ ¦pandemic¦ .
𐋇¦these¦ ¦therapies¦ ¦include¦ ¦current¦ ¦and¦ ¦potential¦ ¦treatments¦ ¦with¦ ¦antiviral¦ ¦drugs¦ ,▁ ¦immuno s up pr ess ants¦ ,▁ ¦steroids¦ ,▁ ¦plasma¦ ¦from¦ ¦recovered¦ ¦patients¦ ,▁ 𐋇¦chinese¦ ¦medicine¦ ,▁ ¦and¦ ¦psychological¦ ¦support¦ .
𐋇¦several¦ ¦recent¦ ¦studies¦ ¦based¦ ¦on¦ ¦me ta ge no mic¦ ¦sequencing¦ ¦have¦ ¦suggested¦ ¦that¦ ¦a¦ ¦group¦ ¦of¦ ¦endang ered¦ ¦small¦ ¦mammals¦ ¦known¦ ¦as¦ ¦pangolins¦ ▁( 𐋇¦man is¦ ¦j av an ic a¦ )▁ ¦could¦ ¦also¦ ¦harb our¦ ¦a nc es tr al¦ ¦beta¦ - 𐋇¦co𐋇vs¦ ¦related¦ ¦to¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ .
𐋇¦they¦ ¦are¦ ¦widely¦ ¦distributed¦ ¦across¦ ¦the¦ 𐋇¦middle¦ 𐋇¦east¦ ¦and¦ 𐋇¦africa¦ .
𐋇¦if¦ ¦you¦ ¦continue¦ ¦to¦ ¦have¦ ¦high¦ ¦fe vers¦
𐋇¦prime¦ 𐋇¦minister¦ 𐋇¦gi u se pp e¦ 𐋇¦con te¦ ¦said¦ ,▁" 𐋇¦in¦ ¦the¦ ¦outbreak¦ ¦areas¦ ,▁ ¦entry¦ ¦and¦ ¦ex it¦ ¦will¦ ¦not¦ ¦be¦ ¦provided¦ .
𐋇¦the¦ ¦source¦ ¦accused¦ 𐋇¦russia¦ ¦of¦ ¦emb ar king¦ ¦on¦ ¦a¦ ▁" ¦ge opol it ical¦ ¦and¦ ¦diplo matic¦ "▁ ¦char m¦ ¦o ff en sive¦ .
𐋇¦in¦ ¦addition¦ ,▁ ¦the¦ ¦requirements¦ ¦for¦ ¦successful¦ ¦host¦ ¦swit ches¦ ¦and¦ ¦the¦ ¦implications¦ ¦of¦ ¦virus¦ ¦evolution¦ ¦on¦ ¦disease¦ ¦severity¦ ¦are¦ ¦also¦ ¦high l igh ted¦ .
𐋇¦sales¦ ¦went¦ ¦up¦ ¦in¦ ¦a¦ ▁" ¦sharp¦ ¦increase¦ "▁ ¦last¦ ¦week¦ ,▁ ¦according¦ ¦to¦ ¦a¦ 𐋇¦woolworths¦ ¦spokesperson¦ .
𐋇¦through¦ ¦different¦ ¦path ways¦ ,▁ ¦the¦ ¦virus¦ ¦indu ces¦ ¦the¦ ¦expression¦ ¦of¦ ¦inflammatory¦ ¦factors¦ ,▁ ¦ma tur ation¦ ¦of¦ ¦d end ri tic¦ ¦cells¦ ,▁ ¦and¦ ¦synthe sis¦ ¦of¦ ¦type¦ 𐋇¦i¦ ¦inter fer ons¦ ▁( 𐊣¦if n 𐊼s¦ )▁ ¦which¦ ¦limit¦ ¦the¦ ¦spreading¦ ¦of¦ ¦the¦ ¦virus¦ ¦and¦ ¦accelerate¦ ¦ mac ro ph age¦ ¦pha g ocytosis¦ ¦of¦ ¦viral¦ ¦antigens¦ .
𐋇¦among¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ ¦acc ess ory¦ ¦proteins¦ ,▁ 𐊣¦orf𐊼 8¦ ¦has¦ ¦been¦ ¦thought¦ ¦to¦ ¦be¦ ¦important¦ ¦in¦ ¦adaptation¦ ¦to¦ ¦humans¦ ,▁ ¦as¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦related¦ ¦bat¦ ¦viruses¦ ¦were¦ ¦isolated¦ ¦but¦ ¦found¦ ¦to¦ ¦enco de¦ ¦diver gent¦ 𐊣¦orf𐊼 8¦ ¦proteins¦ .
𐋇¦a¦ ¦number¦ ¦of¦ ¦provi n cial¦ - ¦level¦ ¦administr ators¦ ¦of¦ ¦the¦ 𐋇¦comm un ist¦ 𐋇¦party¦ ¦of¦ 𐋇¦china¦ ▁( 𐊣¦cp c¦𐊼 )▁ ¦were¦ ¦dismiss ed¦ ¦over¦ ¦their¦ ¦handling¦ ¦of¦ ¦the¦ ¦quarantine¦ ¦efforts¦ ¦in¦ 𐋇¦central¦ 𐋇¦china¦ ,▁ ¦a¦ ¦sign¦ ¦of¦ ¦dis co nt ent¦ ¦with¦ ¦the¦ ¦political¦ ¦establishment¦ ' ¦s¦ ¦response¦ ¦to¦ ¦the¦ ¦outbreak¦ ¦in¦ ¦those¦ ¦regions¦ .
𐋇¦in¦ ¦the¦ 𐊣¦us¦𐊼 ¦there¦ ¦is¦ ¦also¦ ¦the¦ ¦recommendation¦ ¦that¦ ¦newborns¦ ¦and¦ ¦mothers¦ ¦should¦ ¦be¦ ¦temporarily¦ ¦separ ated¦ ¦until¦ ¦transmission¦ - ¦based¦ ¦precautions¦ ¦are¦ ¦discontinu ed¦ ,▁ ¦and¦ ¦that¦ ¦where¦ ¦this¦ ¦is¦ ¦not¦ ¦possible¦ ¦the¦ ¦new bor n¦ ¦should¦ ¦be¦ ¦kept¦ ¦2¦ ¦metres¦ ¦away¦ ¦from¦ ¦the¦ ¦mother¦ .
𐋇¦reports¦ ¦from¦ 𐋇¦february¦ ▁( ¦when¦ ¦the¦ ¦majority¦ ¦of¦ ¦the¦ ¦cases¦ ¦had¦ ¦still¦ ¦been¦ ¦confined¦ ¦to¦ 𐋇¦china¦ )▁ ¦have¦ ¦doc umented¦ ¦racist¦ ¦senti ments¦ ¦expressed¦ ¦in¦ ¦various¦ ¦groups¦ ¦worldwide¦ ¦of¦ 𐋇¦chinese¦ ¦people¦ ¦des er ving¦ ¦the¦ ¦virus¦ ¦or¦ ¦receiving¦ ¦what¦ ¦has¦ ¦been¦ ¦claimed¦ ¦as¦ ¦j us ti fied¦ ¦ret ribu tion¦ .
𐋇¦in¦ ¦this¦ ¦sense¦ ,▁ ¦the¦ ¦longer¦ ¦the¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦outbreak¦ ¦pers ists¦ ¦and¦ ¦the¦ ¦more¦ ¦people¦ ¦that¦ ¦it¦ ¦infects¦ ,▁ ¦the¦ ¦greater¦ ¦chance¦ ¦that¦ ¦it¦ ¦will¦ ¦fully¦ ¦adapt¦ ¦to¦ ¦humans¦ .
𐋇¦this¦ ¦vari ability¦ ¦is¦ ¦also¦ ¦likely¦ ¦to¦ ¦be¦ ¦significantly¦ ¦affecting¦ ¦reported¦ ¦case¦ ¦fatality¦ ¦rates¦ ,▁ ¦which¦ ¦are¦ ¦likely¦ ¦to¦ ¦be¦ ¦significantly¦ ¦over¦ - ¦estimated¦ ¦in¦ ¦some¦ ¦countries¦ .
𐋇 ¦compar ably¦ ,▁ ¦the¦ ¦mortality¦ ¦of¦ 𐊣¦sars¦𐊼 ¦by¦ 𐋇¦november¦ ¦2002¦ ¦was¦ ¦10¦ %▁ ¦of¦ ¦8¦ , ¦0 96¦ ¦confirmed¦ ¦cases¦ .
𐋇¦many¦ ¦of¦ 𐋇¦china¦ ' ¦s¦ ¦nearly¦ ¦300¦ ¦million¦ ¦rural¦ ¦migrant¦ ¦workers¦ ¦have¦ ¦been¦ ¦stranded¦ ¦at¦ ¦home¦ ¦in¦ ¦in land¦ ¦provinces¦ ¦or¦ ¦tra pped¦ ¦in¦ 𐋇¦hubei¦ ¦province¦ . 𐋇¦in¦ 𐋇¦march¦ ¦2020¦ ,▁ ¦more¦ ¦than¦ ¦10¦ ¦million¦ 𐋇¦ame ricans¦ ¦lost¦ ¦their¦ ¦jobs¦ ¦and¦ ¦applied¦ ¦for¦ ¦government¦ ¦aid¦ .
𐋇¦clinical¦ ¦manifestations¦ ¦of¦ 𐊣¦mers¦𐊼 ¦re semb le¦ ¦those¦ ¦of¦ 𐊣¦sars¦𐊼 ,▁ ¦characteri zed¦ ¦by¦ ¦prog ressive¦ ¦acute¦ ¦pneumonia¦ .
𐋇 ¦containment¦ ¦is¦ ¦undertaken¦ ¦in¦ ¦the¦ ¦early¦ ¦stages¦ ¦of¦ ¦the¦ ¦outbreak¦ ¦and¦ ¦aims¦ ¦to¦ ¦trace¦ ¦and¦ ¦isolate¦ ¦those¦ ¦infected¦ ¦as¦ ¦well¦ ¦as¦ ¦introduce¦ ¦other¦ ¦measures¦ ¦of¦ ¦infection¦ ¦control¦ ¦and¦ ¦vaccinations¦ ¦to¦ ¦stop¦ ¦the¦ ¦disease¦ ¦from¦ ¦spreading¦ ¦to¦ ¦the¦ ¦rest¦ ¦of¦ ¦the¦ ¦population¦ .
𐋇¦hong¦ 𐋇¦kong¦ ¦has¦ ¦set¦ ¦up¦ ¦a¦ ¦scheme¦ ¦where¦ ¦suspected¦ ¦patients¦ ¦can¦ ¦stay¦ ¦home¦ ,▁" ¦emergency¦ ¦department¦ ¦will¦ ¦give¦ ¦a¦ ¦specimen¦ ¦tube¦ ¦to¦ ¦the¦ ¦patient¦ ",▁ ¦they¦ ¦sp it¦ ¦into¦ ¦it¦ ,▁ ¦send¦ ¦it¦ ¦back¦ ¦and¦ ¦get¦ ¦a¦ ¦test¦ ¦result¦ ¦a¦ ¦while¦ ¦after¦ . 𐋇¦the¦ 𐋇¦british¦ 𐊣¦nhs¦𐊼 ¦has¦ ¦announced¦ ¦that¦ ¦it¦ ¦is¦ ¦pi lo ting¦ ¦a¦ ¦scheme¦ ¦to¦ ¦test¦ ¦suspected¦ ¦cases¦ ¦at¦ ¦home¦ ,▁ ¦which¦ ¦removes¦ ¦the¦ ¦risk¦ ¦of¦ ¦a¦ ¦patient¦ ¦infecting¦ ¦others¦ ¦if¦ ¦they¦ ¦come¦ ¦to¦ ¦a¦ ¦hospital¦ ¦or¦ ¦having¦ ¦to¦ ¦disinfect¦ ¦an¦ ¦ambulance¦ ¦if¦ ¦one¦ ¦is¦ ¦used¦ . 𐋇¦in¦ ¦drive¦ - ¦through¦ ¦testing¦ ¦for¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦for¦ ¦suspected¦ ¦cases¦ ,▁ ¦a¦ ¦healthcare¦ ¦professional¦ ¦takes¦ ¦sample¦ ¦using¦ ¦appropriate¦ ¦precautions¦ .
𐋇¦for¦ ¦example¦ ,▁ 𐋇¦sh u¦ 𐋇¦f en g¦ 𐋇¦ji e¦ 𐋇¦d u¦ ¦capsules¦ ¦and¦ 𐋇¦li an¦ 𐋇¦hu a¦ 𐋇¦q ing¦ 𐋇¦w en¦ ¦capsules¦ ¦were¦ ¦found¦ ¦to¦ ¦be¦ ¦effective¦ ¦for¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦treatment¦ .
𐋇¦in¦ 𐋇¦december¦ ¦2019¦ ,▁ ¦the¦ ¦2019¦ ¦novel¦ ¦coronavirus¦ ▁( ¦2019¦ - ¦n𐋇co𐋇v¦ )▁ ¦has¦ ¦caused¦ ¦an¦ ¦outbreak¦ ,▁ ¦which¦ ¦is¦ ¦now¦ ¦officially¦ ¦named¦ ¦as¦ ¦the¦ ¦coronavirus¦ ¦disease¦ ¦2019¦ ▁( 𐊣¦covid¦𐊼 - ¦19¦ )▁ ¦and¦ ¦the¦ ¦virus¦ ¦has¦ ¦been¦ ¦named¦ ¦severe¦ ¦acute¦ ¦respiratory¦ ¦syndrome¦ ¦coronavirus¦ ¦2¦ ▁( 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ).
𐋇¦rus s ell¦ 𐋇¦z im mer man¦ ¦added¦ ¦that¦ ¦other¦ ¦products¦ ¦are¦ ¦also¦ ¦in¦ ¦high¦ ¦demand¦ ,▁ ¦including¦ ¦masks¦ ,▁ ¦sanitis er¦ ,▁ ¦d ried¦ ¦goods¦ ,▁ ¦hand w ash¦ ¦and¦ ¦fl our¦ .
𐋇¦ oc ca si on ally¦ 𐋇¦i¦ ¦have¦ ¦some¦ ¦chest¦ ¦pain¦
𐋇¦they¦ ¦can¦ ¦be¦ ¦divided¦ ¦into¦ ¦four¦ ¦gene ra¦ ,▁ ¦i¦ . ¦e¦ .,▁ ¦alpha¦ ,▁ ¦beta¦ ,▁ ¦g am ma¦ ,▁ ¦and¦ ¦d el ta¦ ,▁ ¦of¦ ¦which¦ ¦alpha¦ -▁ ¦and¦ ¦beta¦ - 𐋇¦co𐋇vs¦ ¦are¦ ¦known¦ ¦to¦ ¦infect¦ ¦humans¦ .
𐋇¦thus¦ ,▁ ¦it¦ ¦is¦ ¦more¦ ¦critical¦ ¦and¦ ¦practical¦ ¦to¦ ¦isolate¦ 𐋇¦b¦ ¦cells¦ ¦from¦ ¦recovered¦ ¦patients¦ ¦and¦ ¦identify¦ ¦the¦ ¦genetic¦ ¦codes¦ ¦enco ding¦ ¦effective¦ ¦antibodies¦ ¦or¦ ¦screen¦ ¦for¦ ¦effective¦ ¦antibodies¦ ¦against¦ ¦essential¦ ¦proteins¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇¦in¦ ¦the¦ 𐊣¦us¦𐊼 ¦a¦ ¦serological¦ ¦test¦ ¦developed¦ ¦by¦ 𐋇¦c el le x¦ ¦has¦ ¦been¦ ¦approved¦ ¦for¦ ¦emergency¦ ¦use¦ ¦by¦ ¦certi fied¦ ¦laboratories¦ ¦only¦ .
𐋇¦it¦ ¦is¦ ¦also¦ ¦suggested¦ ¦that¦ 𐋇¦u¦ . 𐋇¦s¦ .▁ ¦sanctions¦ ¦on¦ 𐋇¦iran¦ ¦may¦ ¦be¦ ¦affecting¦ ¦the¦ ¦country¦ ' ¦s¦ ¦financial¦ ¦ability¦ ¦to¦ ¦respond¦ ¦to¦ ¦the¦ ¦viral¦ ¦outbreak¦ .
𐋇¦in¦ ¦contrast¦ ,▁ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ ,▁ 𐊣¦mers¦𐊼 - 𐋇¦co𐋇v¦ ¦and¦ ¦the¦ ¦newly¦ - ¦identified¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦are¦ ¦highly¦ ¦pathogenic¦ ,▁ ¦causing¦ ¦severe¦ ¦lower¦ ¦respiratory¦ ¦tract¦ ¦infection¦ ¦in¦ ¦relatively¦ ¦more¦ ¦patients¦ ¦with¦ ¦a¦ ¦higher¦ ¦chance¦ ¦to¦ ¦develop¦ ¦acute¦ ¦respiratory¦ ¦distress¦ ¦syndrome¦ ▁( 𐊣¦ards¦𐊼 )▁ ¦and¦ ¦extr ap ulmon ary¦ ¦manifestations¦ .
𐋇 ¦up¦ ¦to¦ ¦now¦ ,▁ ¦no¦ ¦live¦ 𐊣¦mers¦𐊼 - 𐋇¦co𐋇v¦ ¦can¦ ¦be¦ ¦found¦ ¦in¦ ¦wild¦ ¦bats¦ .
𐋇¦he¦ ¦said¦ ,▁ ¦in¦ ¦remark s¦ ¦published¦ ¦by¦ 𐊣¦cn n¦𐊼 ¦in¦ 𐋇¦february¦ ,▁" ¦other¦ ¦than¦ ¦influenza¦ ,▁ ¦no¦ ¦other¦ ¦respiratory¦ ¦virus¦ ¦has¦ ¦been¦ ¦tr acked¦ ¦from¦ ¦emergence¦ ¦to¦ ¦continu ous¦ ¦global¦ ¦spread¦ ."
𐋇¦in¦ ¦response¦ ¦to¦ ¦the¦ ¦imp le ment ations¦ ¦of¦ ¦travel¦ ¦restrictions¦ ,▁ 𐋇¦tedros¦ ¦stated¦ ¦that¦ ▁" ¦there¦ ¦is¦ ¦no¦ ¦reason¦ ¦for¦ ¦measures¦ ¦that¦ ¦unnecessarily¦ ¦inter fe re¦ ¦with¦ ¦international¦ ¦travel¦ ¦and¦ ¦trade¦ "▁ ¦and¦ ¦that¦ ¦the¦ ▁" 𐊣¦who¦𐊼 ¦doesn¦ ' ¦t¦ ¦recommend¦ ¦limiting¦ ¦trade¦ ¦and¦ ¦movement¦ ."
𐋇¦this¦ ¦dele tion¦ ¦sp l its¦ 𐊣¦orf𐊼 8¦ ¦into¦ 𐊣¦orf𐊼 8 a¦ ¦and¦ 𐊣¦orf𐊼 8 b¦ ¦and¦ ¦is¦ ¦thought¦ ¦to¦ ¦be¦ ¦an¦ ¦adaptive¦ ¦mutation¦ ¦that¦ ¦promo tes¦ ¦the¦ ¦swit ch¦ ¦of¦ ¦hosts¦ .
𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦shares¦ ¦96¦ . ¦2¦ %▁ ¦nucleotide¦ ¦homology¦ ¦with¦ ¦a¦ ¦bat¦ 𐋇¦co𐋇v¦ 𐋇¦ra𐊣tg𐊼13¦ ¦isolated¦ ¦from¦ 𐋇¦r hino lo ph us¦ ¦affi n is¦ ¦bats¦ .
𐋇¦a¦ 𐊣¦un¦𐊼 𐋇 ¦crisis¦ 𐋇¦management¦ 𐋇¦team¦ ¦was¦ ¦ac tivated¦ ¦as¦ ¦a¦ ¦result¦ ,▁ ¦allowing¦ ¦coordination¦ ¦of¦ ¦the¦ ¦entire¦ 𐋇¦united¦ 𐋇¦nations¦ ¦response¦ ,▁ ¦which¦ ¦the¦ 𐊣¦who¦𐊼 ¦states¦ ¦will¦ ¦allow¦ ¦them¦ ¦to¦ ▁" ¦focus¦ ¦on¦ ¦the¦ ¦health¦ ¦response¦ ¦while¦ ¦the¦ ¦other¦ ¦agencies¦ ¦can¦ ¦bring¦ ¦their¦ ¦exp ert ise¦ ¦to¦ ¦bear¦ ¦on¦ ¦the¦ ¦wi der¦ ¦social¦ ,▁ ¦economic¦ ¦and¦ ¦develop mental¦ ¦implications¦ ¦of¦ ¦the¦ ¦outbreak¦ ".
𐋇¦all¦ ¦these¦ ¦four¦ ¦community¦ - ¦acquired¦ 𐊣¦hc𐊼o𐋇vs¦ ¦have¦ ¦been¦ ¦well¦ ¦adapted¦ ¦to¦ ¦humans¦ ¦and¦ ¦are¦ ¦generally¦ ¦less¦ ¦likely¦ ¦to¦ ¦mut ate¦ ¦to¦ ¦cause¦ ¦highly¦ ¦pathogenic¦ ¦diseases¦ ,▁ ¦though¦ ¦accidents¦ ¦did¦ ¦occur¦ ¦for¦ ¦unknown¦ ¦reasons¦ ¦as¦ ¦in¦ ¦the¦ ¦rare¦ ¦case¦ ¦of¦ ¦a¦ ¦more¦ ¦virulent¦ ¦sub t yp e¦ ¦of¦ 𐊣¦hc𐊼o𐋇v¦ - 𐊣¦nl𐊼63¦ ,▁ ¦which¦ ¦has¦ ¦recently¦ ¦been¦ ¦reported¦ ¦to¦ ¦cause¦ ¦severe¦ ¦lower¦ ¦respiratory¦ ¦tract¦ ¦infection¦ ¦in¦ 𐋇¦china¦ .
𐋇¦in¦ ¦an¦ ¦online¦ ¦news¦ ¦br ie f ing¦ ,▁ ¦the¦ ¦director¦ ¦of¦ 𐊣¦i edc r¦𐊼 ,▁ 𐋇¦dr¦ 𐋇¦me er j ady¦ 𐋇¦s ab ri na¦ 𐋇¦f lo ra¦ ,▁ ¦said¦ ¦the¦ ¦fat alities¦ ¦included¦ ¦four¦ ¦ma les¦ ¦and¦ ¦one¦ ¦female¦ .
𐊣¦mers¦𐊼 - 𐋇¦co𐋇v¦ ¦and¦ ¦its¦ ¦clos est¦ ¦relative¦ ¦bat¦ 𐋇¦co𐋇v¦ - 𐊣¦hku𐊼 25¦ ¦share¦ ¦only¦ ¦87¦ %▁ ¦nucleotide¦ ¦sequence¦ ¦homology¦ .
𐋇¦in¦ ¦the¦ ¦5¦ 𐋇¦march¦ ¦issue¦ ¦of¦ 𐋇¦e ur os ur ve i ll ance¦ ¦2020¦ ,▁ 𐋇¦s pi te ri¦ ¦et¦ ¦al¦ .▁ ¦reported¦ ¦on¦ ¦the¦ ¦first¦ 𐋇¦european¦ ¦confirmed¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦cases¦ ¦according¦ ¦to¦ ¦the¦ 𐊣¦who¦𐊼 ¦case¦ ¦defini tion¦ .
𐋇¦generally¦ ,▁ ¦when¦ ¦these¦ 𐊣¦hc𐊼o𐋇vs¦ ¦ac qui re¦ ¦the¦ ¦ abilities¦ ¦to¦ ¦transmit¦ ¦efficie ntly¦ ¦and¦ ¦to¦ ¦maintain¦ ¦themselves¦ ¦continuously¦ ¦within¦ ¦humans¦ ,▁ ¦they¦ ¦also¦ ¦become¦ ¦less¦ ¦virulent¦ ¦or¦ ¦pathogenic¦ .
𐋇¦si al od ac r yo a de ni tis¦ ¦virus¦ ▁( 𐊣¦s d a v¦𐊼 )▁ ¦is¦ ¦highly¦ ¦infectious¦ ¦coronavirus¦ ¦of¦ ¦laboratory¦ ¦r ats¦ ,▁ ¦which¦ ¦can¦ ¦be¦ ¦transmitted¦ ¦between¦ ¦individuals¦ ¦by¦ ¦direct¦ ¦contact¦ ¦and¦ ¦indir ect ly¦ ¦by¦ ¦aerosol¦ .
𐋇 ¦immuno su pp ression¦ ¦is¦ ¦essential¦ ¦in¦ ¦the¦ ¦treatment¦ ¦of¦ ¦cytokine¦ ¦stor ms¦ ,▁ ¦especially¦ ¦in¦ ¦severe¦ ¦patients¦ .
𐋇¦a¦ ¦large¦ ¦study¦ ¦in¦ 𐋇¦china¦ ¦compared¦ ¦chest¦ 𐊣¦ct¦𐊼 ¦results¦ ¦to¦ 𐊣¦pcr¦𐊼 ¦and¦ ¦demonstrated¦ ¦that¦ ¦though¦ ¦imaging¦ ¦is¦ ¦less¦ ¦specific¦ ¦for¦ ¦the¦ ¦infection¦ ,▁ ¦it¦ ¦is¦ ¦faster¦ ¦and¦ ¦more¦ ¦sensitive¦ ,▁ ¦suggesting¦ ¦its¦ ¦consider ation¦ ¦as¦ ¦a¦ ¦screening¦ ¦tool¦ ¦in¦ ¦epidemic¦ ¦areas¦ .
𐋇¦however¦ ,▁ 𐊣¦covid¦𐊼 - ¦19¦ ¦has¦ ¦lower¦ ¦severity¦ ¦and¦ ¦mortality¦ ¦than¦ 𐊣¦sars¦𐊼 ¦but¦ ¦is¦ ¦much¦ ¦more¦ ¦trans mis sive¦ ¦and¦ ¦affects¦ ¦more¦ ¦elderly¦ ¦individuals¦ ¦than¦ ¦youth¦ ¦and¦ ¦more¦ ¦men¦ ¦than¦ ¦women¦ .
𐋇¦and¦ ¦there¦ ¦have¦ ¦been¦ ¦mask¦ - ¦related¦ ¦disp u tes¦ ¦reported¦ ¦between¦ ¦other¦ ¦countries¦ ,▁ ¦such¦ ¦as¦ 𐋇¦germany¦ ,▁ 𐋇¦austria¦ ¦and¦ 𐋇¦switzerland¦ ;▁ ¦and¦ ¦the¦ 𐋇¦cz ech¦ 𐋇¦republic¦ ¦and¦ 𐋇¦italy¦ .
𐋇¦in¦ ¦addition¦ ¦to¦ ¦cellular¦ ¦receptors¦ ,▁ ¦the¦ ¦outcome¦ ¦of¦ ¦interspecies¦ ¦transmission¦ ¦of¦ 𐊣¦hc𐊼o𐋇vs¦ ¦is¦ ¦also¦ ¦govern ed¦ ¦by¦ ¦other¦ ¦host¦ ¦dep end ency¦ ¦and¦ ¦restriction¦ ¦factors¦ .
𐋇¦schools¦ ¦in¦ ¦the¦ 𐋇¦seattle¦ ¦area¦ ¦cancelled¦ ¦classes¦ ¦on¦ ¦3¦ 𐋇¦march¦ ,▁ ¦and¦ ¦by¦ ¦mid¦ - 𐋇¦march¦ ,▁ ¦schools¦ ¦across¦ ¦the¦ ¦country¦ ¦were¦ ¦shut ting¦ ¦down¦ . 𐋇¦on¦ ¦6¦ 𐋇¦march¦ ¦2020¦ ,▁ ¦the¦ 𐋇¦united¦ 𐋇¦states¦ ¦was¦ ¦advised¦ ¦of¦ ¦pro j ections¦ ¦for¦ ¦the¦ ¦impact¦ ¦of¦ ¦the¦ ¦new¦ ¦coronavirus¦ ¦on¦ ¦the¦ ¦country¦ ¦by¦ ¦a¦ ¦group¦ ¦of¦ ¦epidemi ologists¦ ¦at¦ 𐋇¦imperial¦ 𐋇¦college¦ 𐋇¦london¦ .
𐋇¦many¦ ¦scientific¦ ¦publ ish ers¦ ¦made¦ ¦scientific¦ ¦papers¦ ¦related¦ ¦to¦ ¦the¦ ¦outbreak¦ ¦available¦ ¦with¦ ¦open¦ ¦access¦ .
𐋇¦many¦ 𐋇¦l un ar¦ 𐋇¦new¦ 𐋇¦year¦ ¦events¦ ¦and¦ ¦tour ist¦ ¦attractions¦ ¦have¦ ¦been¦ ¦closed¦ ¦to¦ ¦prevent¦ ¦mass¦ ¦gatherings¦ ,▁ ¦including¦ ¦the¦ 𐋇¦f orbidden¦ 𐋇¦city¦ ¦in¦ 𐋇¦be ij ing¦ ¦and¦ ¦traditional¦ ¦temple¦ ¦fa irs¦ .
𐋇¦there¦ ¦is¦ ¦no¦ ¦data¦ ¦yet¦ ¦on¦ ¦early¦ ¦pregnancy¦ .
𐋇¦although¦ ¦the¦ ¦word¦ ▁" ¦pandemic¦ "▁ ¦only¦ ¦refers¦ ¦to¦ ¦how¦ ¦widely¦ ¦a¦ ¦disease¦ ¦has¦ ¦spread¦ ,▁ ¦not¦ ¦how¦ ¦dangerous¦ ¦specific¦ ¦cases¦ ¦are¦ ,▁ ¦the¦ 𐊣¦who¦𐊼 ¦noted¦ ¦the¦ ¦need¦ ¦to¦ ¦drive¦ ¦governments¦ ¦to¦ ¦action¦ :
𐋇 ¦per va sive¦ ¦evidence¦ ¦has¦ ¦shown¦ ¦that¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ ,▁ 𐊣¦mers¦𐊼 - 𐋇¦co𐋇v¦ ¦and¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦have¦ ¦a¦ ¦bat¦ ¦origin¦ ¦and¦ ¦are¦ ¦transmitted¦ ¦to¦ ¦humans¦ ¦via¦ ¦intermediate¦ ¦hosts¦ .
𐋇¦are¦ ¦you¦ ¦having¦ ¦any¦ ¦other¦ ¦symptoms¦ ?
𐋇¦a¦ ¦global¦ ¦safety¦ ¦monitoring¦ ¦board¦ ¦of¦ 𐊣¦who¦𐊼 ¦phys i cians¦ ¦examine¦ ¦interim¦ ¦results¦ ¦to¦ ¦assist¦ ¦decisions¦ ¦on¦ ¦safety¦ ¦and¦ ¦effectiveness¦ ¦of¦ ¦the¦ ¦trial¦ ¦drugs¦ ,▁ ¦and¦ ¦al ter¦ ¦the¦ ¦trial¦ ¦design¦ ¦or¦ ¦recommend¦ ¦an¦ ¦effective¦ ¦therapy¦ .
𐊣¦hc𐊼o𐋇v¦ - 𐊣¦nl𐊼63¦ ¦is¦ ¦associated¦ ¦with¦ ¦obstruc tive¦ ¦l ar yn gi tis¦ ,▁ ¦also¦ ¦known¦ ¦as¦ ¦cro up¦ .
𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦is¦ ¦ap pa rently¦ ¦less¦ ¦pathogenic¦ ¦but¦ ¦more¦ ¦transmissible¦ ¦compared¦ ¦to¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ ¦and¦ 𐊣¦mers¦𐊼 - 𐋇¦co𐋇v¦ .
𐋇¦the¦ ¦initial¦ ¦estimates¦ ¦of¦ ¦the¦ ¦basic¦ ¦reproduction¦ ¦number¦ ▁( 𐋇¦r0¦ )▁ ¦for¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦were¦ ¦1¦ . ¦4¦ ¦to¦ ¦2¦ . ¦4¦ .
𐋇¦it¦ ¦stated¦ ¦that¦ ¦much¦ ¦was¦ ¦yet¦ ¦to¦ ¦be¦ ¦discovered¦ ¦about¦ 𐊣¦covid¦𐊼 - ¦19¦ ,▁ ¦and¦ ¦that¦ 𐋇¦australia¦ ¦would¦ ¦emphasi ze¦ ¦border¦ ¦control¦ ¦and¦ ¦communication¦ ¦in¦ ¦its¦ ¦response¦ ¦to¦ ¦the¦ ¦pandemic¦ .
𐋇¦as¦ ¦of¦ 𐋇¦february¦ ¦14¦ ,▁ ¦2020¦ ,▁ ¦over¦ ¦25 00¦ ¦laboratory¦ ¦confirmed¦ ¦cases¦ ¦were¦ ¦reported¦ ¦with¦ ¦a¦ ¦high¦ ¦case¦ ¦fatality¦ ¦of¦ ¦34¦ . ¦4¦ %,▁ ¦making¦ 𐊣¦mers¦𐊼 - 𐋇¦co𐋇v¦ ¦one¦ ¦of¦ ¦the¦ ¦most¦ ¦devastating¦ ¦viruses¦ ¦known¦ ¦to¦ ¦humans¦ .
𐋇¦within¦ ¦a¦ ¦month¦ ,▁ ¦the¦ ¦number¦ ¦of¦ ¦coronavirus¦ ¦cases¦ ¦in¦ 𐋇¦hubei¦ ¦gradually¦ ¦increased¦ .
𐋇¦the¦ 𐋇¦world¦ 𐋇¦health¦ 𐋇¦organization¦ ¦and¦ 𐋇¦centers¦ ¦for¦ 𐋇¦disease¦ 𐋇¦control¦ ¦and¦ 𐋇¦prevention¦ ¦of¦ ¦the¦ 𐋇¦united¦ 𐋇¦states¦ ¦advis es¦ ¦pregnant¦ ¦women¦ ¦to¦ ¦do¦ ¦the¦ ¦same¦ ¦things¦ ¦as¦ ¦the¦ ¦general¦ ¦public¦ ¦to¦ ¦avoid¦ ¦infection¦ ,▁ ¦such¦ ¦as¦ ¦covering¦ ¦cough¦ ,▁ ¦avoid¦ ¦interacting¦ ¦with¦ ¦sick¦ ¦people¦ ,▁ ¦cleaning¦ ¦hands¦ ¦with¦ ¦soap¦ ¦and¦ ¦water¦ ¦or¦ ¦sanitizer¦ .
𐋇¦in¦ 𐋇¦australia¦ ,▁ ¦the¦ ¦pandemic¦ ¦provided¦ ¦a¦ ¦new¦ ¦opportunity¦ ¦for¦ ¦d ai go u¦ ¦sho pp ers¦ ¦to¦ ¦sell¦ 𐋇¦australian¦ ¦products¦ ¦into¦ 𐋇¦china¦ .
𐋇¦these¦ ¦modi fications¦ ¦based¦ ¦on¦ ¦the¦ ¦researchers¦ ¦continued¦ ¦work¦ ¦that¦ ¦to¦ ¦search¦ ¦for¦ ¦an¦ ¦opti mal¦ ¦nucleic¦ ¦acid¦ ¦detection¦ ¦kit¦ ¦for¦ ¦rapid¦ ¦diagnosis¦ ,▁ ¦as¦ ¦well¦ ¦as¦ ¦the¦ ¦samples¦ ¦from¦ ¦respiratory¦ ¦tract¦ ¦including¦ ¦blood¦ ¦sampling¦ ,▁ ¦which¦ ¦increased¦ ¦the¦ ¦availability¦ ¦of¦ ¦different¦ ¦specimens¦ ,▁ ¦and¦ ¦supported¦ ¦bringing¦ ¦the¦ ¦specific¦ ¦antibody¦ ¦positive¦ ¦result¦ ¦into¦ ¦the¦ ¦confirmed¦ ¦criteria¦ .
𐋇 ¦continu ous¦ ¦surveillance¦ ¦in¦ ¦mammals¦ ¦is¦ ¦necessary¦ ¦for¦ ¦better¦ ¦understanding¦ ¦of¦ ¦the¦ ¦ ec ology¦ ¦of¦ 𐋇¦co𐋇vs¦ ¦and¦ ¦their¦ ¦natural¦ ¦hosts¦ ,▁ ¦which¦ ¦will¦ ¦prove¦ ¦useful¦ ¦in¦ ¦preventing¦ ¦animal¦ - ¦to¦ - ¦human¦ ¦transmission¦ ¦and¦ ¦future¦ ¦outbreaks¦ .
𐋇¦it¦ ¦hur ts¦ ¦in¦ ¦the¦ ¦middle¦ ¦of¦ ¦my¦ ¦chest¦
𐋇¦the¦ ¦entire¦ ¦human¦ ¦population¦ ¦generally¦ ¦l acks¦ ¦immunity¦ ¦to¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦and¦ ¦hence¦ ¦is¦ ¦susceptible¦ ¦to¦ ¦the¦ ¦novel¦ ¦virus¦ .
𐋇¦to¦ ¦conclu de¦ ,▁ ¦the¦ ¦most¦ ¦effective¦ ¦way¦ ¦to¦ ¦prevent¦ ¦viral¦ ¦z o on osis¦ ¦is¦ ¦for¦ ¦humans¦ ¦to¦ ¦stay¦ ¦away¦ ¦from¦ ¦the¦ ¦e co logical¦ ¦ni ches¦ ¦of¦ ¦the¦ ¦natural¦ ¦reserv o irs¦ ¦of¦ ¦the¦ ¦zoonotic¦ ¦viruses¦ .
𐋇 ¦mental¦ ¦stress¦ :▁ 𐋇¦as¦ ¦described¦ ¦above¦ ,▁ ¦during¦ ¦the¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦outbreak¦ ¦many¦ ¦patients¦ ¦have¦ ¦suffered¦ ¦from¦ ¦ext ra ord inary¦ ¦stress¦ ¦as¦ ¦they¦ ¦often¦ ¦end ured¦ ¦long¦ ¦periods¦ ¦of¦ ¦quarantine¦ ¦and¦ ¦extreme¦ ¦uncertainty¦ ¦and¦ ¦witnessed¦ ¦the¦ ¦death¦ ¦of¦ ¦close¦ ¦family¦ ¦members¦ ¦and¦ ¦f ellow¦ ¦patients¦ .
𐋇¦pr et ty¦ ¦much¦ ¦the¦ ¦same¦ ¦with¦ ¦the¦ ¦fever¦ ¦and¦ ¦the¦ ¦cough¦ ¦headache¦ ¦and¦ ¦muscle¦ ¦pa ins¦
𐋇¦besides¦ ¦the¦ ¦highly¦ ¦pathogenic¦ 𐊣¦hc𐊼o𐋇vs¦ ,▁ ¦the¦ ¦zoonotic¦ ¦origin¦ ¦of¦ 𐊣¦hc𐊼o𐋇v¦ - ¦229𐋇e¦ ,▁ 𐊣¦hc𐊼o𐋇v¦ - 𐊣¦oc43¦ ,▁ ¦hc𐊼o𐋇v¦ - 𐊣¦nl𐊼63¦ ¦and¦ 𐊣¦hc𐊼o𐋇v¦ - 𐊣¦hku𐊼1¦ ¦have¦ ¦also¦ ¦been¦ ¦studied¦ .
𐋇¦a¦ ¦study¦ ¦published¦ ¦on¦ ¦16¦ 𐋇¦march¦ ¦found¦ ¦that¦ ¦in¦ 𐋇¦china¦ ,▁ ¦up¦ ¦to¦ ¦23¦ 𐋇¦january¦ ,▁ ¦an¦ ¦estimated¦ ¦86¦ %▁ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦infections¦ ¦had¦ ¦not¦ ¦been¦ ¦detected¦ ,▁ ¦and¦ ¦that¦ ¦these¦ ¦ und oc umented¦ ¦infections¦ ¦were¦ ¦the¦ ¦infection¦ ¦source¦ ¦for¦ ¦79¦ %▁ ¦of¦ ¦doc umented¦ ¦cases¦ .
𐋇¦medical¦ ¦screening¦ ¦was¦ ¦performed¦ ¦prior¦ ¦to¦ ¦dep art ure¦ ,▁ ¦and¦ ¦four¦ 𐋇¦south¦ 𐋇 ¦af ricans¦ ¦who¦ ¦were¦ ¦showing¦ ¦signs¦ ¦of¦ ¦coronavirus¦ ¦were¦ ¦left¦ ¦behind¦ ¦to¦ ¦mi tig ate¦ ¦risk¦ .
𐋇¦pharmaceutical¦ ¦companies¦ ¦are¦ ¦r acing¦ ¦to¦ ¦develop¦ ¦antibodies¦ ¦and¦ ¦vaccines¦ ¦against¦ ¦the¦ ¦virus¦ .
𐋇¦its¦ ¦spo rad ic¦ ¦transmission¦ ¦to¦ ¦humans¦ ¦is¦ ¦an¦ ¦accident¦ ¦and¦ ¦humans¦ ¦remain¦ ¦a¦ ¦dead¦ - ¦end¦ ¦host¦ ¦of¦ 𐊣¦mers¦𐊼 - 𐋇¦co𐋇v¦ ¦as¦ ¦its¦ ¦transmission¦ ¦cannot¦ ¦be¦ ¦susta ined¦ .
𐋇¦the¦ ¦open¦ ¦reading¦ ¦frames¦ ¦1 a¦ ¦and¦ ¦1 b¦ ,▁ ¦which¦ ¦occ up y¦ ¦the¦ ¦first¦ ¦two¦ - ¦thirds¦ ¦of¦ ¦the¦ ¦genome¦ ,▁ ¦enco de¦ ¦the¦ ¦replic ase¦ / ¦transcript ase¦ ¦polyp rotein¦ .
𐋇¦although¦ ¦these¦ ¦actions¦ ¦have¦ ¦been¦ ¦dr am atically¦ ¦da ma ging¦ ¦the¦ ¦economy¦ ¦and¦ ¦other¦ ¦sectors¦ ¦of¦ ¦the¦ ¦country¦ ,▁ ¦the¦ ¦number¦ ¦of¦ ¦new¦ ¦patients¦ ¦is¦ ¦declining¦ ,▁ ¦indicating¦ ¦the¦ ¦sl ow d own¦ ¦of¦ ¦the¦ ¦epidemic¦ .
𐋇¦by¦ ¦23¦ 𐋇¦march¦ ,▁ ¦no¦ ¦country¦ ¦had¦ ¦tested¦ ¦more¦ ¦than¦ ¦3¦ %▁ ¦of¦ ¦their¦ ¦population¦ ,▁ ¦and¦ ¦there¦ ¦are¦ ¦massive¦ ¦vari ations¦ ¦in¦ ¦how¦ ¦much¦ ¦testing¦ ¦has¦ ¦been¦ ¦done¦ ¦across¦ ¦countries¦ .
𐋇¦hong¦ 𐋇¦kong¦ ¦raised¦ ¦its¦ ¦infectious¦ ¦disease¦ ¦response¦ ¦level¦ ¦to¦ ¦the¦ ¦highest¦ ¦and¦ ¦declared¦ ¦an¦ ¦emergency¦ ,▁ ¦closing¦ ¦schools¦ ¦until¦ 𐋇¦march¦ ¦and¦ ¦cancelling¦ ¦its¦ 𐋇¦new¦ 𐋇¦year¦ ¦celebr ations¦ . 𐋇¦the¦ ¦retail¦ ¦sector¦ ¦has¦ ¦been¦ ¦impacted¦ ¦globally¦ ,▁ ¦with¦ ¦red uc tions¦ ¦in¦ ¦store¦ ¦hours¦ ¦or¦ ¦temporary¦ ¦closures¦ .
𐋇¦despite¦ ¦doing¦ ¦so¦ ,▁ ¦the¦ 𐋇¦united¦ 𐋇¦states¦ ¦had¦ ¦a¦ ¦slow¦ ¦start¦ ¦in¦ ¦testing¦ ,▁ ¦which¦ ¦ob sc ured¦ ¦the¦ ¦true¦ ¦extent¦ ¦of¦ ¦the¦ ¦outbreak¦ ¦at¦ ¦the¦ ¦time¦ .
𐋇¦these¦ ¦viruses¦ ¦do¦ ¦not¦ ¦need¦ ¦an¦ ¦animal¦ ¦reservoir¦ .
𐋇¦some¦ ¦have¦ ¦proposed¦ ¦that¦ ¦the¦ ¦virus¦ ¦may¦ ¦also¦ ¦be¦ ¦transmitted¦ ¦by¦ ¦small¦ ¦droplets¦ ¦that¦ ¦stay¦ ¦for¦ ¦more¦ ¦pr ol on ged¦ ¦periods¦ ¦in¦ ¦the¦ ¦air¦ ,▁ ¦that¦ ¦may¦ ¦be¦ ¦generated¦ ¦during¦ ¦speech¦ . 𐋇¦respiratory¦ ¦droplets¦ ¦may¦ ¦also¦ ¦be¦ ¦produced¦ ¦during¦ ¦breathing¦ ¦out¦ ,▁ ¦including¦ ¦when¦ ¦talking¦ ,▁ ¦though¦ ¦the¦ ¦virus¦ ¦is¦ ¦not¦ ¦generally¦ ¦airborne¦ .
𐋇 ¦whereas¦ ¦civets¦ ¦and¦ ¦other¦ ¦animals¦ ¦in¦ ¦the¦ ¦markets¦ ¦have¦ ¦been¦ ¦found¦ ¦to¦ ¦harb our¦ ¦viruses¦ ¦identical¦ ¦to¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ ,▁ ¦immediate¦ ¦intermediate¦ ¦hosts¦ ¦for¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦have¦ ¦not¦ ¦been¦ ¦identified¦ .
𐋇¦use¦ ¦of¦ ¦steroids¦ :▁ 𐋇¦as¦ ¦described¦ ¦above¦ ,▁ ¦steroids¦ ¦are¦ ¦immuno s up pr ess ant¦ ¦commonly¦ ¦used¦ ¦as¦ ¦an¦ ¦ad j u nc tive¦ ¦therapy¦ ¦for¦ ¦infectious¦ ¦diseases¦ ¦to¦ ¦reduce¦ ¦the¦ ¦severity¦ ¦of¦ ¦inflammatory¦ ¦damage¦ .
𐋇¦a¦ ¦comparison¦ ¦of¦ ¦the¦ ¦epidemic¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦with¦ ¦that¦ ¦of¦ 𐊣¦sars¦𐊼 ¦and¦ 𐊣¦mers¦𐊼 ¦is¦ ¦provided¦ ¦below¦ ▁( 𐋇¦fig¦ .▁ ​( 𐋇¦fig¦ . ¦55¦ ).
𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦was¦ ¦found¦ ¦to¦ ¦be¦ ¦a¦ ¦new¦ ¦type¦ ¦of¦ ¦beta¦ - 𐋇¦co𐋇v¦ ¦with¦ ¦more¦ ¦than¦ ¦99¦ . ¦98¦ %▁ ¦genetic¦ ¦identity¦ ¦among¦ ¦10¦ ¦seque nced¦ ¦samples¦ ¦collected¦ ¦from¦ ¦the¦ ¦original¦ ¦site¦ ¦of¦ ¦the¦ ¦outbreak¦ ,▁ ¦the¦ 𐋇¦huan an¦ 𐋇¦seafood¦ 𐋇¦market¦ ¦in¦ 𐋇¦wuhan¦ .
𐋇¦on¦ 𐋇¦january¦ ¦23¦ ,▁ ¦the¦ ¦city¦ ¦of¦ 𐋇¦wuhan¦ ¦was¦ ¦locked¦ ¦down¦ ¦with¦ ¦all¦ ¦its¦ ¦public¦ ¦transportation¦ ¦stopped¦ .
𐋇¦second¦ ,▁ 𐊣¦hc𐊼o𐋇v¦ - ¦229𐋇e¦ - ¦related¦ ¦bat¦ ¦alpha¦ - 𐋇¦co𐋇vs¦ ¦are¦ ¦diver se¦ ¦and¦ ¦non¦ - ¦pathogenic¦ ¦in¦ ¦bats¦ ,▁ ¦whereas¦ ¦alpac a¦ ¦alpha¦ - 𐋇¦co𐋇v¦ ¦caused¦ ¦an¦ ¦outbreak¦ ¦of¦ ¦respiratory¦ ¦disease¦ ¦in¦ ¦infected¦ ¦animals¦ .
𐋇¦but¦ ¦you¦ ' ¦re¦ ¦breathing¦ ¦all¦ ¦right¦ ¦right¦ ¦now¦ ¦right¦ ?
𐋇¦in¦ ¦a¦ ¦20 16¦ ¦review¦ ¦of¦ ¦10 6¦ ¦drug¦ ¦candidates¦ ¦assessed¦ ¦through¦ ¦clinical¦ ¦trials¦ ,▁ ¦the¦ ¦total¦ ¦capital¦ ¦expenditure¦ ¦for¦ ¦a¦ ¦manufacturer¦ ¦having¦ ¦a¦ ¦drug¦ ¦approved¦ ¦through¦ ¦successful¦ 𐋇¦phase¦ 𐊣¦iii¦𐊼 ¦trials¦ ¦was¦ ▁$ ¦2¦ . ¦6¦ ¦billion¦ ▁( ¦in¦ ¦2013¦ ¦doll ars¦ ),▁ ¦an¦ ¦amount¦ ¦increasing¦ ¦at¦ ¦an¦ ¦annual¦ ¦rate¦ ¦of¦ ¦8¦ . ¦5¦ %.
𐋇¦as¦ ¦of¦ ¦5¦ 𐋇¦march¦ ¦2020¦ 𐋇 ¦lab 𐋇co r p¦ ¦announced¦ ¦nationwide¦ ¦availability¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦testing¦ ¦based¦ ¦on¦ 𐊣¦rt¦ - ¦pcr¦𐊼 .
𐋇¦tests¦ ¦using¦ ¦two¦ ¦components¦ ¦were¦ ¦not¦ ¦determined¦ ¦to¦ ¦be¦ ¦reliable¦ ¦until¦ ¦28¦ 𐋇¦february¦ ¦2020¦ ,▁ ¦and¦ ¦it¦ ¦was¦ ¦not¦ ¦until¦ ¦then¦ ¦that¦ ¦state¦ ¦and¦ ¦local¦ ¦laboratories¦ ¦were¦ ¦permitted¦ ¦to¦ ¦begin¦ ¦testing¦ .
𐋇¦in¦ ¦a¦ ¦host¦ ¦that¦ ¦serves¦ ¦as¦ ¦the¦ ¦mi x ing¦ ¦v ess el¦ ,▁ ¦str and¦ ¦swit ching¦ ¦occurs¦ ¦frequently¦ ¦during¦ 𐋇¦co𐋇v¦ 𐊣¦rna¦𐊼 ¦transcription¦ .
𐋇¦in¦ ¦early¦ ¦2020¦ ,▁ ¦numerous¦ ¦established¦ ¦antiviral¦ ¦compounds¦ ¦for¦ ¦treating¦ ¦other¦ ¦infections¦ ¦were¦ ¦being¦ ¦repurposed¦ ¦or¦ ¦developed¦ ¦in¦ ¦new¦ ¦clinical¦ ¦research¦ ¦efforts¦ ¦to¦ ¦alleviate¦ ¦the¦ ¦illness¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ .
𐋇¦the¦ ¦first¦ ¦recorded¦ ¦incidents¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦infection¦ ¦in¦ 𐋇¦bangladesh¦ ¦were¦ ¦on¦ 𐋇¦march¦ ¦8¦ ,▁ ¦in¦ ¦two¦ ¦people¦ ¦who¦ ¦returned¦ ¦from¦ 𐋇¦italy¦ ¦and¦ ¦also¦ ¦the¦ ¦wife¦ ¦of¦ ¦one¦ ¦of¦ ¦them¦ .
𐋇¦cases¦ ¦refers¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦people¦ ¦who¦ ¦have¦ ¦been¦ ¦tested¦ ¦for¦ 𐊣¦covid¦𐊼 - ¦19¦ ,▁ ¦and¦ ¦whose¦ ¦test¦ ¦has¦ ¦been¦ ¦confirmed¦ ¦positive¦ ¦according¦ ¦to¦ ¦official¦ ¦protocols¦ .
𐋇¦diarrhea¦ ¦is¦ ¦also¦ ¦seen¦ ¦in¦ ¦some¦ ¦patients¦ .
𐋇¦the¦ 𐊣¦who¦𐊼 ¦has¦ ¦com me nded¦ ¦the¦ ¦efforts¦ ¦of¦ 𐋇¦chinese¦ ¦authorities¦ ¦in¦ ¦managing¦ ¦and¦ ¦containing¦ ¦the¦ ¦epidemic¦ .
𐋇¦they¦ ¦stay¦ ¦in¦ ¦their¦ ¦own¦ ¦natural¦ ¦reserv o irs¦ ¦until¦ ¦there¦ ¦is¦ ¦a¦ ¦chance¦ ¦for¦ ¦spillover¦ .
𐋇 ¦whereas¦ ¦the¦ ¦highest¦ ¦sequence¦ ¦homology¦ ¦has¦ ¦been¦ ¦found¦ ¦in¦ ¦the¦ 𐊣¦rb d 𐊼s¦ ¦between¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦and¦ ¦pangolin¦ ,▁ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ - ¦related¦ ¦beta¦ - 𐋇¦co𐋇vs¦ ,▁ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦and¦ 𐋇¦ra𐊣tg𐊼13¦ ¦share¦ ¦the¦ ¦highest¦ ¦genome¦ - ¦wide¦ ¦sequence¦ ¦homology¦ .
𐋇¦second¦ ,▁ ¦if¦ ¦bats¦ ¦play¦ ¦a¦ ¦more¦ ¦direct¦ ¦role¦ ¦in¦ ¦human¦ ¦transmission¦ ,▁ ¦how¦ ¦humans¦ ¦get¦ ¦into¦ ¦contact¦ ¦with¦ ¦bats¦ ¦should¦ ¦be¦ ¦determined¦ .
𐋇¦thailand¦ ' ¦s¦ ¦health¦ ¦officials¦ ¦are¦ ¦encouraging¦ ¦people¦ ¦to¦ ¦make¦ ¦cloth¦ ¦face mas ks¦ ¦at¦ ¦home¦ ¦and¦ ¦wash¦ ¦them¦ ¦daily¦ .
𐋇¦they¦ ¦should¦ ,▁ ¦however¦ ,▁ ¦be¦ ¦collected¦ ¦in¦ ¦a¦ ¦systematic¦ ¦f ash ion¦ ¦to¦ ¦comple ment¦ ¦current¦ ¦surveillance¦ ¦data¦ ¦that¦ ¦focus¦ ¦on¦ ¦the¦ ¦number¦ ¦of¦ ¦reported¦ ¦cases¦ ¦and¦ ¦the¦ ¦number¦ ¦of¦ ¦deaths¦ .
𐋇¦particularly¦ ,▁ ¦bat¦ 𐋇¦co𐋇vs¦ ¦with¦ ¦zoonotic¦ ¦potential¦ ¦are¦ ¦so¦ ¦diver se¦ .
𐋇 ¦per¦ ¦media¦ ¦reports¦ ¦on¦ ¦1¦ 𐋇¦april¦ ,▁ 𐋇¦south¦ 𐋇¦korea¦ ¦has¦ ¦received¦ ¦requ ests¦ ¦for¦ ¦virus¦ ¦testing¦ ¦assistance¦ ¦from¦ ¦12 1¦ ¦different¦ ¦countries¦ .
𐋇¦supp ression¦ ¦requires¦ ¦more¦ ¦extreme¦ ¦measures¦ ¦so¦ ¦as¦ ¦to¦ ¦reverse¦ ¦the¦ ¦pandemic¦ ¦by¦ ¦reducing¦ ¦the¦ ¦basic¦ ¦reproduction¦ ¦number¦ ¦to¦ ¦less¦ ¦than¦ ¦1¦ . 𐋇 ¦part¦ ¦of¦ ¦managing¦ ¦an¦ ¦infectious¦ ¦disease¦ ¦outbreak¦ ¦is¦ ¦trying¦ ¦to¦ ¦decrease¦ ¦the¦ ¦epidemic¦ ¦peak¦ ,▁ ¦known¦ ¦as¦ ¦fl at te ning¦ ¦the¦ ¦epidemic¦ ¦cur ve¦ .
𐋇 ¦tell¦ ¦me¦ ¦about¦ ¦your¦ ¦chest¦ ¦pain¦
𐋇¦most¦ ¦businesses¦ ¦were¦ ¦ordered¦ ¦to¦ ¦close¦ ,▁ ¦with¦ ¦excep tions¦ ¦for¦ ¦businesses¦ ¦d ee med¦ ▁" ¦essential¦ ",▁ ¦including¦ ¦super mar kets¦ ,▁ ¦pharmac ies¦ ,▁ ¦banks¦ ,▁ ¦hard ware¦ ¦shops¦ ,▁ ¦petrol¦ ¦stations¦ ,▁ ¦and¦ ¦gar ages¦ .
𐋇¦this¦ ¦might¦ ¦also¦ ¦guide¦ ¦or¦ ¦facilitate¦ ¦the¦ ¦search¦ ¦for¦ ¦the¦ ¦reservoir¦ ,▁ ¦intermediate¦ ¦and¦ ¦amplifying¦ ¦animal¦ ¦host¦ ( ¦s¦ )▁ ¦of¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ,▁ ¦with¦ ¦important¦ ¦implications¦ ¦in¦ ¦the¦ ¦prevention¦ ¦of¦ ¦future¦ ¦sp il lo vers¦ .
𐋇¦they¦ ¦might¦ ¦also¦ ¦account¦ ¦for¦ ¦successful¦ ¦adaptation¦ ¦of¦ ¦these¦ 𐋇¦co𐋇vs¦ ¦in¦ ¦humans¦ ¦after¦ ¦interspecies¦ ¦transmission¦ ¦from¦ ¦their¦ ¦animal¦ ¦hosts¦ .
𐋇¦it¦ ¦is¦ ¦thought¦ ¦to¦ ¦have¦ ¦a¦ ¦zoonotic¦ ¦origin¦ .
𐋇¦an¦ ¦un ass o ci ated¦ ¦cluster¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦cases¦ ¦was¦ ¦later¦ ¦detected¦ ,▁ ¦starting¦ ¦with¦ ¦16¦ ¦confirmed¦ ¦cases¦ ¦in¦ 𐋇¦lo mb ard y¦ ¦on¦ ¦21¦ 𐋇¦february¦ . 𐋇¦on¦ ¦22¦ 𐋇¦february¦ ,▁ ¦the¦ 𐋇¦council¦ ¦of¦ 𐋇¦ministers¦ ¦announced¦ ¦a¦ ¦new¦ ¦d ecr ee¦ - ¦law¦ ¦to¦ ¦contain¦ ¦the¦ ¦outbreak¦ ,▁ ¦including¦ ¦quarantining¦ ¦more¦ ¦than¦ ¦50¦ , ¦000¦ ¦people¦ ¦from¦ ¦11¦ ¦different¦ ¦m uni cip alities¦ ¦in¦ ¦northern¦ 𐋇¦italy¦ .
𐋇¦on¦ ¦the¦ ¦same¦ ¦day¦ ,▁ ¦the¦ 𐊣¦us n s¦𐊼 𐋇 ¦comfort¦ ,▁ ¦a¦ ¦hospital¦ ¦ship¦ ¦with¦ ¦about¦ ¦1 000¦ ¦beds¦ ,▁ ¦made¦ ¦an ch or¦ ¦in¦ 𐋇¦new¦ 𐋇¦york¦ .
𐋇¦some¦ ¦organizations¦ ¦have¦ ¦created¦ ¦cr ow d s our ced¦ ¦apps¦ ¦for¦ ¦sy nd ro mic¦ ¦surveillance¦ ,▁ ¦where¦ ¦people¦ ¦can¦ ¦report¦ ¦their¦ ¦symptoms¦ ¦to¦ ¦help¦ ¦researchers¦ ¦map¦ ¦areas¦ ¦with¦ ¦concentr ation¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦symptoms¦ .
𐋇¦schools¦ ¦and¦ ¦universities¦ ¦have¦ ¦closed¦ ¦either¦ ¦on¦ ¦a¦ ¦nationwide¦ ¦or¦ ¦local¦ ¦basis¦ ¦in¦ ¦19 3¦ ¦countries¦ ,▁ ¦affecting¦ ¦approximately¦ ¦99¦ . ¦4¦ ¦percent¦ ¦of¦ ¦the¦ ¦world¦ ' ¦s¦ ¦student¦ ¦population¦ .
𐋇¦in¦ ¦response¦ ¦to¦ ¦a¦ ¦developing¦ ¦outbreak¦ ¦in¦ 𐋇¦iran¦ ,▁ ¦the¦ 𐊣¦who¦𐊼 ¦sent¦ ¦a¦ 𐋇¦joint¦ 𐋇¦mission¦ 𐋇¦team¦ ¦there¦ ¦to¦ ¦assess¦ ¦the¦ ¦situation¦ . 𐋇¦on¦ ¦28¦ 𐋇¦february¦ ,▁ 𐊣¦who¦𐊼 ¦officials¦ ¦said¦ ¦that¦ ¦the¦ ¦coronavirus¦ ¦threat¦ ¦assessment¦ ¦at¦ ¦the¦ ¦global¦ ¦level¦ ¦would¦ ¦be¦ ¦raised¦ ¦from¦ ▁" ¦high¦ "▁ ¦to¦ ▁" ¦very¦ ¦high¦ ",▁ ¦its¦ ¦highest¦ ¦level¦ ¦of¦ ¦alert¦ ¦and¦ ¦risk¦ ¦assessment¦ .
𐋇¦by¦ ¦the¦ ¦time¦ ¦of¦ ¦this¦ ¦report¦ ,▁ ¦the¦ ¦disease¦ ¦has¦ ¦already¦ ¦spread¦ ¦throughout¦ 𐋇¦china¦ ¦and¦ ¦near¦ ¦50¦ ¦other¦ ¦countries¦ ¦all¦ ¦over¦ ¦the¦ ¦world¦ ▁( 𐋇¦fig¦ .▁ ​( 𐋇¦fig¦ . ¦2¦ ). ¦2¦ ).
𐋇¦the¦ 𐋇¦iranian¦ 𐋇¦parliament¦ ¦was¦ ¦shut¦ ¦down¦ ,▁ ¦with¦ ¦23¦ ¦of¦ ¦its¦ ¦290¦ ¦members¦ ¦reported¦ ¦to¦ ¦have¦ ¦had¦ ¦tested¦ ¦positive¦ ¦for¦ ¦the¦ ¦virus¦ ¦on¦ ¦3¦ 𐋇¦march¦ .
𐋇¦r d 𐋇r p¦ ¦directly¦ ¦medi ates¦ ¦the¦ ¦synthe sis¦ ¦of¦ ¦negative¦ - ¦sense¦ ¦genomic¦ 𐊣¦rna¦𐊼 ¦from¦ ¦the¦ ¦positive¦ - ¦sense¦ ¦genomic¦ 𐊣¦rna¦𐊼 .
𐋇¦am id st¦ ¦claims¦ ¦of¦ ¦a¦ ¦cover¦ - ¦up¦ ¦of¦ ¦the¦ ¦extent¦ ¦of¦ ¦the¦ ¦outbreak¦ ¦in¦ 𐋇¦iran¦ ,▁ ¦more¦ ¦than¦ ¦ten¦ ¦countries¦ ¦had¦ ¦traced¦ ¦their¦ ¦cases¦ ¦back¦ ¦to¦ 𐋇¦iran¦ ¦by¦ ¦28¦ 𐋇¦february¦ ,▁ ¦indicating¦ ¦that¦ ¦the¦ ¦extent¦ ¦of¦ ¦the¦ ¦outbreak¦ ¦may¦ ¦be¦ ¦more¦ ¦severe¦ ¦than¦ ¦the¦ ¦388¦ ¦cases¦ ¦reported¦ ¦by¦ ¦the¦ 𐋇¦iranian¦ ¦government¦ ¦by¦ ¦that¦ ¦date¦ .
𐋇¦a¦ ¦number¦ ¦of¦ ¦li ne age¦ - ¦specific¦ ¦acc ess ory¦ ¦proteins¦ ¦are¦ ¦also¦ ¦enco ded¦ ¦by¦ ¦different¦ ¦lineages¦ ¦of¦ 𐋇¦co𐋇vs¦ .
𐋇¦all¦ ¦countries¦ ¦can¦ ¦still¦ ¦change¦ ¦the¦ ¦course¦ ¦of¦ ¦this¦ ¦pandemic¦ .
𐋇¦co𐋇vs¦ ¦are¦ ¦a¦ ¦sub fa mi ly¦ ¦of¦ ¦large¦ ¦and¦ ¦enveloped¦ ¦viruses¦ ¦containing¦ ¦a¦ ¦single¦ ¦str and¦ ¦of¦ ¦sense¦ 𐊣¦rna¦𐊼 .
𐋇¦the¦ ¦test¦ ¦uses¦ ¦real¦ - ¦time¦ ¦reverse¦ ¦transcription¦ ¦polymerase¦ ¦chain¦ ¦reaction¦ ▁( ¦r𐊣rt¦ - ¦pcr¦𐊼 ).
𐋇¦following¦ ¦the¦ ¦progression¦ ¦of¦ ¦the¦ ¦outbreak¦ ¦to¦ ¦new¦ ¦hotspot¦ ¦countries¦ ,▁ ¦people¦ ¦from¦ 𐋇¦italy¦ ,▁ ¦the¦ ¦first¦ ¦country¦ ¦in¦ 𐋇¦europe¦ ¦to¦ ¦experience¦ ¦a¦ ¦serious¦ ¦outbreak¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ ,▁ ¦could¦ ¦also¦ ¦be¦ ¦sub jected¦ ¦to¦ ¦suspicion¦ ¦and¦ ¦xenophobia¦ . 𐋇¦citizens¦ ¦in¦ ¦countries¦ ¦including¦ 𐋇¦malaysia¦ ,▁ 𐋇¦new¦ 𐋇¦zealand¦ ,▁ 𐋇¦singapore¦ ,▁ ¦and¦ 𐋇¦south¦ 𐋇¦korea¦ ¦initially¦ ¦signed¦ ¦pe titions¦ ¦lo bb ying¦ ¦to¦ ¦ban¦ 𐋇¦chinese¦ ¦people¦ ¦from¦ ¦entering¦ ¦their¦ ¦countries¦ ¦in¦ ¦an¦ ¦effort¦ ¦to¦ ¦stop¦ ¦the¦ ¦disease¦ .
𐋇¦in¦ ¦addition¦ ¦to¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ,▁ ¦this¦ ¦also¦ ¦app lies¦ ¦to¦ 𐊣¦mers¦𐊼 - 𐋇¦co𐋇v¦ ,▁ ¦which¦ ¦is¦ ¦well¦ ¦adapted¦ ¦to¦ ¦dromedary¦ ¦camels¦ .
𐋇¦as¦ ¦of¦ ¦yesterday¦ ,▁ 𐋇¦bangladesh¦ ' ¦s¦ 𐋇¦institute¦ ¦of¦ 𐋇 ¦epidemiology¦ ,▁ 𐋇¦disease¦ 𐋇¦control¦ ¦and¦ 𐋇¦research¦ ▁( 𐊣¦i edc r¦𐊼 )▁ ¦reported¦ ¦the¦ ¦number¦ ¦of¦ ¦recorded¦ ¦infected¦ ¦cases¦ ¦included¦ ¦1 14¦ ¦active¦ ¦cases¦ ¦and¦ ¦33¦ ¦recovered¦ ¦cases¦ ¦who¦ ¦were¦ ¦staying¦ ¦home¦ .
𐋇¦most¦ ¦of¦ ¦the¦ ¦effective¦ ¦components¦ ¦remain¦ ¦unknown¦ ¦or¦ ¦are¦ ¦va gue¦ ¦as¦ ¦it¦ ¦is¦ ¦difficult¦ ¦to¦ ¦extr act¦ ¦and¦ ¦ve ri fy¦ ¦such¦ ¦components¦ ¦or¦ ¦their¦ ¦opti mal¦ ¦comb in ations¦ .
𐋇¦it¦ ¦is¦ ¦possible¦ ,▁ ¦similar¦ ¦to¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ ,▁ ¦that¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦might¦ ¦become¦ ¦wea ker¦ ¦in¦ ¦inf ec tivity¦ ¦and¦ ¦eventually¦ ¦die¦ ¦down¦ ¦or¦ ¦become¦ ¦a¦ ¦less¦ ¦pathogenic¦ ¦virus¦ ¦co¦ - ¦e xi st ent¦ ¦with¦ ¦humans¦ .
𐋇¦on¦ 𐋇¦february¦ ¦18¦ ,▁ ¦2020¦ ,▁ ¦the¦ ¦first¦ ¦pat hological¦ ¦analysis¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦demonstrated¦ ¦the¦ ¦des qu a mation¦ ¦of¦ ¦pneumocytes¦ ,▁ ¦h ya line¦ ¦membrane¦ ¦for mation¦ ,▁ ¦and¦ ¦inters ti tial¦ ¦lymphocyte¦ ¦infil tration¦ ,▁ ¦and¦ ¦mult in ucle ated¦ ¦sy nc y tial¦ ¦cells¦ ¦in¦ ¦the¦ ¦lungs¦ ¦of¦ ¦a¦ ¦patient¦ ¦who¦ ¦died¦ ¦of¦ ¦the¦ ¦disease¦ ,▁ ¦consistent¦ ¦with¦ ¦the¦ ¦pathology¦ ¦of¦ ¦viral¦ ¦infection¦ ¦and¦ 𐊣¦ards¦𐊼 ¦and¦ ¦similar¦ ¦to¦ ¦that¦ ¦of¦ 𐊣¦sars¦𐊼 ¦and¦ 𐊣¦mers¦𐊼 ¦patients¦ .
𐋇¦wi ld li fe¦ ¦sm u gg ling¦ ¦and¦ ¦z oo no ses¦ ▁–▁ 𐋇¦health¦ ¦risks¦ ¦associated¦ ¦with¦ ¦the¦ ¦trade¦ ¦in¦ ¦ex o tic¦ ¦wi ld li fe¦
𐋇¦for¦ 𐊣 ¦cl t¦𐊼 ¦a¦ ¦single¦ ¦specimen¦ ¦of¦ ¦peripheral¦ ¦blood¦ ¦is¦ ¦commonly¦ ¦used¦ ,▁ ¦although¦ ¦se rial¦ ¦specimens¦ ¦can¦ ¦be¦ ¦used¦ ¦to¦ ¦follow¦ ¦the¦ ¦immune¦ ¦response¦ .
𐋇¦this¦ ¦virus¦ ¦may¦ ¦be¦ ¦on¦ ¦its¦ ¦way¦ ¦and¦ ¦you¦ ¦need¦ ¦to¦ ¦be¦ ¦ready¦ ,"▁ ¦urging¦ ¦that¦ ¦the¦ ¦right¦ ¦response¦ ¦measures¦ ¦could¦ ¦help¦ ¦the¦ ¦world¦ ¦avoid¦ ▁" ¦the¦ ¦worst¦ ¦of¦ ¦it¦ ".
𐋇¦our¦ ¦team¦ ¦will¦ ¦also¦ ¦timely¦ ¦update¦ ¦our¦ ¦guideline¦ ¦to¦ ¦offer¦ ¦help¦ .
𐋇¦a¦ ¦study¦ ¦performed¦ ¦in¦ ¦2010¦ – ¦11¦ ¦showed¦ ¦a¦ ¦large¦ ¦vari ation¦ ¦in¦ ¦the¦ ¦availability¦ ¦of¦ ¦intensive¦ ¦care¦ ¦and¦ ¦intermediate¦ ¦care¦ ¦beds¦ ¦in¦ 𐋇¦europe¦ ,▁ ¦ranging¦ ¦from¦ ¦29¦ . ¦2¦ ¦in¦ 𐋇¦germany¦ ¦to¦ ¦4¦ . ¦2¦ ¦beds¦ ¦per¦ ¦100¦ , ¦000¦ ¦population¦ ¦in¦ 𐋇¦p ort ug al¦ .
𐋇¦in¦ ¦contrast¦ ,▁ ¦if¦ ¦the¦ 𐊣¦hc𐊼o𐋇v¦ ¦is¦ ¦newly¦ ¦introduced¦ ¦to¦ ¦an¦ ¦intermediate¦ ¦host¦ ¦right¦ ¦before¦ ¦or¦ ¦around¦ ¦its¦ ¦int rodu ction¦ ¦to¦ ¦humans¦ ,▁ ¦it¦ ¦is¦ ¦not¦ ¦well¦ ¦adapted¦ ¦to¦ ¦the¦ ¦new¦ ¦host¦ ¦and¦ ¦is¦ ¦often¦ ¦pathogenic¦ .
𐋇¦thus¦ ,▁ ¦it¦ ¦is¦ ¦much¦ ¦more¦ ¦challenging¦ ¦to¦ ¦control¦ ¦the¦ ¦epidemic¦ ¦of¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦than¦ ¦those¦ ¦of¦ 𐊣¦mers¦𐊼 - 𐋇¦co𐋇v¦ ¦and¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ .
𐋇¦first¦ ,▁ ¦if¦ ¦bats¦ ¦transmit¦ ¦an¦ ¦a nc es tr al¦ ¦virus¦ ¦of¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦to¦ ¦pangolins¦ ,▁ ¦it¦ ¦will¦ ¦be¦ ¦of¦ ¦interest¦ ¦to¦ ¦see¦ ¦under¦ ¦what¦ ¦circumstances¦ ¦bats¦ ¦and¦ ¦pangolins¦ ¦could¦ ¦share¦ ¦the¦ ¦same¦ ¦e co logical¦ ¦ni che¦ .
𐋇¦iran¦ ¦alloc ated¦ ¦five¦ ¦tri ll ion¦ ¦ri als¦ ¦to¦ ¦combat¦ ¦the¦ ¦virus¦ .
𐋇¦li ke w ise¦ ,▁ ¦a¦ ¦reservoir¦ ¦host¦ ¦harb ours¦ 𐊣¦hc𐊼o𐋇v¦ ¦continuously¦ ¦and¦ ¦for¦ ¦long¦ ¦term¦ .
𐋇¦however¦ ,▁ ¦via¦ ¦strict¦ ¦quarantine¦ ¦and¦ ¦isolation¦ ,▁ ¦the¦ ¦disease¦ ¦has¦ ¦eventually¦ ¦been¦ ¦put¦ ¦under¦ ¦control¦ .
𐊣¦mers¦𐊼 - 𐋇¦co𐋇v¦ ¦serves¦ ¦as¦ ¦an¦ ¦ex cell ent¦ ¦example¦ ¦of¦ ¦interspecies¦ ¦transmission¦ ¦from¦ ¦bats¦ ¦to¦ ¦dromedary¦ ¦camels¦ ¦and¦ ¦from¦ ¦dromedary¦ ¦camels¦ ¦to¦ ¦humans¦ .
𐋇¦an¦ 𐊣¦hc𐊼o𐋇v¦ ¦can¦ ¦undergo¦ ¦a¦ ¦dead¦ - ¦end¦ ¦infection¦ ¦if¦ ¦it¦ ¦cannot¦ ¦susta in¦ ¦its¦ ¦transmission¦ ¦within¦ ¦the¦ ¦intermediate¦ ¦host¦ .
𐋇¦the¦ ¦search¦ ¦for¦ ¦the¦ ¦animal¦ ¦origins¦ ¦of¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦is¦ ¦still¦ ¦on¦ .
𐋇¦now¦ ¦our¦ ¦guideline¦ ¦received¦ ¦a¦ ¦comment¦ ¦by¦ 𐋇¦z hou¦ ¦et¦ ¦al¦ .,▁ ¦they¦ ¦introduced¦ ¦a¦ ¦simple¦ ¦s co ring¦ ¦proposal¦ ¦based¦ ¦on¦ ¦their¦ ¦clinical¦ ¦experience¦ .
𐋇¦numerous¦ ¦candidate¦ ¦drugs¦ ¦under¦ ¦study¦ ¦as¦ ▁" ¦supportive¦ "▁ ¦treatments¦ ¦to¦ ¦relie ve¦ ¦discomfort¦ ¦during¦ ¦illness¦ ,▁ ¦such¦ ¦as¦ 𐊣¦n sa id 𐊼s¦ ¦or¦ ¦b ron ch od il ators¦ ,▁ ¦are¦ ¦not¦ ¦included¦ ¦in¦ ¦the¦ ¦table¦ ¦below¦ .
𐋇 ¦whereas¦ ¦a¦ ¦bat¦ ¦beta¦ - 𐋇¦co𐋇v¦ ¦sharing¦ ¦95¦ %▁ ¦nucleotide¦ ¦homology¦ ¦with¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ ¦has¦ ¦been¦ ¦found¦ ,▁ ¦there¦ ¦also¦ ¦ex ists¦ ¦a¦ ¦bat¦ - 𐋇¦co𐋇v¦ ¦sharing¦ ¦96¦ %▁ ¦nucleotide¦ ¦homology¦ ¦with¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ .
𐋇¦this¦ ¦is¦ ¦not¦ ¦usually¦ ¦passed¦ ¦from¦ ¦mother¦ ¦to¦ ¦f et us¦ ¦so¦ ¦further¦ ¦research¦ ¦is¦ ¦required¦ ¦to¦ ¦know¦ ¦whether¦ ¦the¦ ¦virus¦ ¦crossed¦ ¦the¦ ¦pl ac en ta¦ ¦or¦ ¦whether¦ ¦pla ce nt as¦ ¦of¦ ¦women¦ ¦in¦ ¦the¦ ¦study¦ ¦were¦ ¦damaged¦ ¦or¦ ¦abnormal¦ .
𐋇¦on¦ 𐋇¦february¦ ¦11¦ ,▁ ¦2020¦ ,▁ ¦a¦ ¦multi¦ - ¦center¦ ¦study¦ ¦on¦ ¦8¦ , ¦86 6¦ ¦patients¦ ¦including¦ ¦4¦ , ¦0 2 1¦ ¦confirmed¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦patients¦ ¦presented¦ ¦a¦ ¦more¦ ¦updated¦ ¦i ll us tration¦ ¦of¦ ¦the¦ ¦epidemic¦ ¦as¦ ¦follows¦ ▁( ¦https¦ :// ¦m p¦ . ¦we i x in¦ . ¦ q q¦ . ¦com¦ / ¦s¦ / 𐋇¦ ul 𐋇 b i¦ - 𐊣¦h x 𐊼 _ r 𐊣 h p x 𐊼 a 1 q 𐊣 ha 𐊼 2 b h d 𐋇 a¦ ).
𐋇¦but¦ ¦also¦ ¦we¦ ¦sh ouldn¦ ' ¦t¦ ¦be¦ ¦put¦ ¦aside¦ ¦for¦ ¦the¦ ¦heart¦ ¦cardiac¦ ¦origin¦ ¦chest¦ ¦pain¦
𐋇¦several¦ ¦loc alities¦ ¦also¦ ¦witnessed¦ ¦panic¦ ¦buying¦ ¦that¦ ¦led¦ ¦to¦ ¦shel ves¦ ¦being¦ ¦clea red¦ ¦of¦ ¦grocery¦ ¦essenti als¦ ¦such¦ ¦as¦ ¦food¦ ,▁ ¦toilet¦ ¦paper¦ ,▁ ¦and¦ ¦bo tt led¦ ¦water¦ ,▁ ¦indu cing¦ ¦supply¦ ¦shortages¦ .
𐋇¦it¦ ¦is¦ ¦in¦ ¦the¦ ¦center¦ ¦of¦ ¦the¦ ¦chest¦
𐋇 ¦econom ically¦ ¦significant¦ ¦coronaviruses¦ ¦of¦ ¦farm¦ ¦animals¦ ¦include¦ ¦ por c ine¦ ¦coronavirus¦ ▁( ¦transmissible¦ ¦gastroen teri tis¦ ¦coronavirus¦ ,▁ 𐊣¦t ge ¦𐊼 )▁ ¦and¦ ¦b ovine¦ ¦coronavirus¦ ,▁ ¦which¦ ¦both¦ ¦result¦ ¦in¦ ¦diarrhea¦ ¦in¦ ¦young¦ ¦animals¦ .
𐋇¦i¦ ¦had¦ ¦a¦ ¦fever¦ ¦yesterday¦
𐋇¦as¦ ¦these¦ ¦noti fications¦ ¦occurred¦ ,▁ ¦doctors¦ ¦in¦ 𐋇¦wuhan¦ ¦were¦ ¦warned¦ ¦by¦ ¦police¦ ¦for¦ ▁" ¦spreading¦ ¦r um ours¦ "▁ ¦about¦ ¦the¦ ¦outbreak¦ .
𐋇 ¦identifying¦ ¦the¦ ¦animal¦ ¦hosts¦ ¦has¦ ¦direct¦ ¦implications¦ ¦in¦ ¦the¦ ¦prevention¦ ¦of¦ ¦human¦ ¦diseases¦ .
𐋇¦mandatory¦ ¦contact¦ ¦tracing¦ ¦and¦ ¦quarantine¦ ,▁ ¦as¦ ¦a¦ ¦part¦ ¦of¦ ¦the¦ ¦public¦ ¦health¦ ¦responses¦ ¦to¦ ¦the¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦outbreak¦ ,▁ ¦can¦ ¦make¦ ¦people¦ ¦more¦ ¦an xi ous¦ ¦and¦ ¦gu il ty¦ ¦about¦ ¦the¦ ¦effects¦ ¦of¦ ¦the¦ ¦contagion¦ ,▁ ¦quarantine¦ ,▁ ¦and¦ ¦s tig ma¦ ¦on¦ ¦their¦ ¦families¦ ¦and¦ ¦friends¦ .
𐋇¦on¦ ¦19¦ 𐋇¦february¦ ,▁ ¦the¦ 𐋇¦singapore¦ 𐋇¦red¦ 𐋇 ¦cross¦ ¦announced¦ ¦that¦ ¦it¦ ¦would¦ ¦send¦ ▁$ ¦2¦ . ¦26¦ ¦million¦ ¦worth¦ ¦of¦ ¦aid¦ ¦to¦ 𐋇¦china¦ .
𐋇¦similar¦ ¦to¦ 𐊣¦hc𐊼o𐋇v¦ - 𐊣¦nl 63¦ ,▁ ¦hc𐊼o𐋇v¦ - ¦229𐋇e¦ ¦and¦ 𐊣¦hc𐊼o𐋇v¦ - 𐊣¦oc43¦ ,▁ ¦hc𐊼o𐋇v¦ - 𐊣¦hku𐊼1¦ ¦was¦ ¦found¦ ¦worldwide¦ ,▁ ¦causing¦ ¦mild¦ ¦respiratory¦ ¦diseases¦ .
𐋇¦it¦ ¦is¦ ¦spec ulated¦ ¦that¦ ¦the¦ ¦flu¦ ¦pandemic¦ ¦of¦ ¦18 90¦ ¦may¦ ¦have¦ ¦been¦ ¦caused¦ ¦by¦ ¦this¦ ¦spillover¦ ¦event¦ ,▁ ¦and¦ ¦not¦ ¦by¦ ¦the¦ ¦influenza¦ ¦virus¦ ,▁ ¦because¦ ¦of¦ ¦the¦ ¦related¦ ¦ti ming¦ ,▁ ¦neuro logical¦ ¦symptoms¦ ,▁ ¦and¦ ¦unknown¦ ¦ca us ative¦ ¦agent¦ ¦of¦ ¦the¦ ¦pandemic¦ .
𐋇¦all¦ ¦seven¦ 𐊣¦hc𐊼o𐋇vs¦ ¦have¦ ¦a¦ ¦zoonotic¦ ¦origin¦ ¦from¦ ¦bats¦ ,▁ ¦mice¦ ¦or¦ ¦domestic¦ ¦animals¦ .
𐋇¦do¦ ¦you¦ ¦have¦ ¦some¦ ¦shortness¦ ¦of¦ ¦breath¦ ¦goes¦ ¦with¦ ¦that¦ ?
𐋇¦this¦ ,▁ ¦however¦ ,▁ ¦varies¦ ¦based¦ ¦on¦ ¦the¦ ¦hum id ity¦ ¦and¦ ¦temperature¦ . 𐋇 ¦pets¦ ¦and¦ ¦other¦ ¦animals¦ ¦have¦ ¦tested¦ ¦positive¦ ¦for¦ 𐊣¦covid¦𐊼 - ¦19¦ .
𐋇 ¦qu est¦ 𐋇¦diagno stics¦ ¦similar ly¦ ¦made¦ ¦nationwide¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦testing¦ ¦available¦ ¦as¦ ¦of¦ ¦9¦ 𐋇¦march¦ ¦2020¦ .
𐋇¦as¦ ¦a¦ ¦novel¦ ¦disease¦ ,▁ 𐊣¦covid¦𐊼 - ¦19¦ ¦has¦ ¦just¦ ¦started¦ ¦to¦ ¦ma ni f est¦ ¦its¦ ¦full¦ ¦clinical¦ ¦course¦ ¦throughout¦ ¦thousands¦ ¦of¦ ¦patients¦ .
𐋇¦by¦ 𐋇¦february¦ ¦14¦ ,▁ ¦the¦ ¦mortality¦ ¦of¦ 𐊣¦covid¦𐊼 - ¦19¦ ¦was¦ ¦2¦ %▁ ¦when¦ ¦the¦ ¦confirmed¦ ¦cases¦ ¦reached¦ ¦66¦ , ¦5 7 6¦ ¦globally¦ .
𐋇¦most¦ ¦imp res sively¦ ,▁ ¦the¦ ¦rate¦ ¦for¦ ¦symptomatic¦ ¦worse ning¦ ▁( ¦from¦ ¦light¦ ¦to¦ ¦severe¦ )▁ ¦was¦ ¦remark ably¦ ¦lower¦ ¦for¦ ¦the¦ 𐊣¦w m¦ + ¦t c m¦𐊼 ¦group¦ ¦than¦ ¦for¦ ¦the¦ 𐊣¦w m¦𐊼 ¦only¦ ¦group¦ ▁( ¦7¦ . ¦4¦ %▁ ¦versus¦ ¦46¦ . ¦2¦ %)▁ ¦and¦ ¦the¦ ¦mortality¦ ¦was¦ ¦lower¦ ¦in¦ ¦the¦ 𐊣¦w m¦ + ¦t c m¦𐊼 ¦group¦ ¦than¦ 𐊣¦w m¦𐊼 ¦only¦ ¦group¦ ▁( ¦8¦ . ¦8¦ %▁ ¦versus¦ ¦39¦ %).
𐋇¦drug¦ ¦candidates¦ ¦in¦ 𐋇¦phase¦ 𐋇¦i¦ - 𐊣¦ii¦𐊼 ¦trials¦ ¦have¦ ¦a¦ ¦low¦ ¦rate¦ ¦of¦ ¦success¦ ▁( ¦under¦ ¦12¦ %)▁ ¦to¦ ¦pass¦ ¦through¦ ¦all¦ ¦trial¦ ¦phases¦ ¦to¦ ¦gain¦ ¦e vent ual¦ ¦approval¦ .
𐋇 ¦cytokine¦ ¦storm¦ ¦is¦ ¦a¦ ¦form¦ ¦of¦ ¦systemic¦ ¦inflammatory¦ ¦response¦ ¦fe at ured¦ ¦by¦ ¦the¦ ¦release¦ ¦of¦ ¦a¦ ¦series¦ ¦of¦ ¦cyto k ines¦ ¦including¦ 𐊣¦t n f 𐊼 α ¦ ,▁ 𐊣¦il¦𐊼 - ¦1 β ¦ ,▁ 𐊣¦ il¦ - ¦2¦ ,▁ ¦ il¦ - ¦6¦ ,▁ ¦i f n 𐊼 α ¦ ,▁ 𐊣¦if n 𐊼 β ¦ ,▁ 𐊣¦if n 𐊼 γ ¦ ,▁ ¦and¦ 𐊣¦m c p¦𐊼 - ¦1¦ .
𐋇¦based¦ ¦on¦ ¦the¦ ¦compar ative¦ ¦analysis¦ ¦between¦ ¦is ol ates¦ ¦of¦ ¦human¦ ¦and¦ ¦civet¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇vs¦ ,▁ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ ¦is¦ ¦thought¦ ¦to¦ ¦undergo¦ ¦rapid¦ ¦adaptation¦ ¦in¦ ¦different¦ ¦hosts¦ ,▁ ¦particularly¦ ¦with¦ ¦mutations¦ ¦at¦ ¦the¦ 𐊣¦rbd¦𐊼 ¦of¦ ¦the¦ 𐋇¦s¦ ¦protein¦ .
𐋇¦particularly¦ ,▁ ¦pangolin¦ ¦beta¦ - 𐋇¦co𐋇vs¦ ¦are¦ ¦highly¦ ¦pathogenic¦ ¦in¦ ¦pangolins¦ .
𐋇 ¦face¦ ¦masks¦ ¦have¦ ¦also¦ ¦been¦ ¦widely¦ ¦used¦ ¦in¦ 𐋇¦japan¦ ,▁ 𐋇¦south¦ 𐋇¦korea¦ ,▁ 𐋇¦malaysia¦ ,▁ ¦and¦ 𐋇¦singapore¦ .
𐋇¦in¦ ¦this¦ ¦regard¦ ,▁ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦follows¦ ¦the¦ ¦general¦ ¦trend¦ ¦of¦ ¦the¦ ¦other¦ ¦six¦ 𐊣¦hc𐊼o𐋇vs¦ .
𐋇¦in¦ 𐋇¦march¦ ¦2020¦ ,▁ ¦the¦ ¦main¦ ¦protease¦ ¦of¦ ¦the¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦virus¦ ¦was¦ ¦identified¦ ¦as¦ ¦a¦ ¦target¦ ¦for¦ ¦post¦ - ¦infection¦ ¦drugs¦ .
𐋇¦the¦ ¦first¦ ¦known¦ ¦case¦ ¦of¦ ¦the¦ ¦novel¦ ¦coronavirus¦ ¦may¦ ¦trace¦ ¦back¦ ¦to¦ ¦1¦ 𐋇¦december¦ ¦2019¦ ¦in¦ 𐋇¦wuhan¦ ,▁ 𐋇¦hubei¦ ,▁ 𐋇¦china¦ .
𐋇¦all¦ ¦features¦ ¦of¦ ¦the¦ ¦novel¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦virus¦ ¦occur¦ ¦in¦ ¦related¦ ¦coronaviruses¦ ¦in¦ ¦nature¦ . 𐋇¦outside¦ ¦the¦ ¦human¦ ¦body¦ ,▁ ¦the¦ ¦virus¦ ¦is¦ ¦killed¦ ¦by¦ ¦household¦ ¦soap¦ ,▁ ¦which¦ ¦diss ol ves¦ ¦its¦ ¦protective¦ ¦envelope¦ . 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ - ¦2¦ ¦is¦ ¦closely¦ ¦related¦ ¦to¦ ¦the¦ ¦original¦ 𐊣¦sars¦𐊼 - 𐋇¦co𐋇v¦ .
𐋇¦and¦ ¦can¦ ¦you¦ ¦tell¦ ¦me¦ ¦what¦ ¦other¦ ¦symptoms¦ ¦are¦ ¦you¦ ¦having¦ ¦along¦ ¦with¦ ¦this¦ ?
𐊣¦sars¦𐊼 ¦has¦ ¦higher¦ ¦mortality¦ ¦than¦ 𐊣¦covid¦𐊼 - ¦19¦ ▁( ¦10¦ . ¦91¦ %▁ ¦versus¦ ¦1¦ . ¦44¦ %).
𐋇¦any¦ ¦other¦ ¦symptoms¦ ¦or¦ ¦problems¦ ¦that¦ ¦you¦ ¦notice¦ ¦with¦ ¦the¦ ¦muscle¦ ¦aches¦ ?
𐋇¦the¦ ¦experts¦ ¦under sc ored¦ ¦that¦ ¦every¦ ¦individual¦ ¦has¦ ¦the¦ ¦right¦ ¦to¦ ¦health¦ ,▁ ¦including¦ ¦people¦ ¦with¦ ¦dis abilities¦ ,▁ ¦bel on ging¦ ¦to¦ ¦min or ity¦ ¦groups¦ ,▁ ¦older¦ ¦people¦ ,▁ ¦inter n ally¦ ¦dis pla ced¦ ¦people¦ ,▁ ¦the¦ ¦homeless¦ ,▁ ¦those¦ ¦living¦ ¦in¦ ¦extremely¦ ¦poor¦ ¦conditions¦ ,▁ ¦people¦ ¦in¦ ¦det ention¦ ,▁ ¦as¦ ¦well¦ ¦as¦ ¦ref ug ees¦ ¦and¦ ¦other¦ ¦un speci fied¦ ¦groups¦ ¦in¦ ¦need¦ ¦of¦ ¦government¦ ¦support¦ .
